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The work described in this thesis used crystallographic and biochemical methods to 
study the complexes of immunophilins (human Cyclophilin A (hCypA) and FK506 
binding protein (FKBP)) with a series of chemically synthesised ligands. 
HCypA is the cytosolic receptor of the immunosuppressant Cyclosporin A (CsA), and 
FKBP is the receptor for the immunosuppressant FK506. Both hCypA and FKBP 
possess peptidyl-prolyl isomerization (PPIase) enzymatic activity. 
In this project hCypA was produced and characterised in house. SDS page 
electrophoresis, mass spectrometry and PPIase enzymatic assays were used to 
characterise hCypA, which was expressed in E.coli and purified using 
chromatographic techniques. 
PPIase assays and fluorescence spectrometry were used to identify nine novel ligand 
complexes. The ligands were synthesised in the Chemistry department of Edinburgh 
University. Crystals of the nine hCypA ligand complexes were obtained and structures 
were solved up to a resolution of 1 .8A. It was observed that all nine ligands bind 
hCypA in a similar mode, and the relationship between the binding strength and 
structural features was evaluated. The following equation was developed to relate 
measured dissociation constant (Kd) and structural features: 
Kd = 238 - 0.815 x (Buried area) - 17.9 x (Number of Hydrogen bonds less than 3A) - 
6.7 x (Number of Hydrogen bonds greater than3.OA) 
FKBP was also crystallized. The complex crystal of FKBP and the dipeptide 
leucylproline (Leu-Pro) was prepared. The crystal structure of FKBP and Leu-Pro 
shows that the amide bond of bound Leu-Pro is twisted and provides an insight into 
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Chapter one 
Introduction of Cyclophilin A 
1. hnmunophilins 
hnmunophilins are the cytosolic targets of immunosuppressants such as cyclosporin A 
(CsA), FK506, and rapamycin'. To date, two immunophilin families have been 
identified: the cyclophilin family (CypA is the cytosolic target of CsA) and the FKBP 
family (FKBP is the target of FK506 and of rapamycin). Members of both protein 
families possess peptidyl-prolyl isomerase activity. 
The cyclophilins (Cyps) are a large protein family, members of which are ubiquitous in 
many different organisms. In the human genome there are 24 cyclophilins. Nineteen 
cyclophilin genes have been identified 2 in the nematode C.elegans. Some of the 
cyclophilins have been structurally characterised. For example, the single domain 
cyclophilins include, CypA3, CypB4, CypC5, CypD6, and the multi-domain 
cyclophilins include Cyp40 7 and Cyp_NK8 . 
Cyclophilins 	Mr 	Kd, nM (C5A) kcat/Km , i'M 1 s' Cellular localization 
cyclophilin A3 	17 737 	2 	 10 	cytosol 
cyclophilin B4 	23 500 	84 	 6.3 	ER 
(Endoreticulum) 
cyclophilin C5 	22763 	4 	 ND 	cytosol 
cyclophilin D6 19981 3.6 0.9 mitochondria 
cyclophilin-407 40763 300 1.9 cytosol 
cyclophilin-N K8 	150000 	ND 	 ND 	NK cell surface 
cyclophilin-cpr3p9 	175656 	ND 	 ND 	mitochondria 
cyclophilin-20 10 	20000 	ND 	 ND 	mitochondria 
ND: No data available from literature. Cyclophilin A with molecular weight of 17737 is from 
bovine. 











An alignment of the amino acid sequence of CypA, CypB, CypC and the Cyp domains 
of Cyp-NK and Cyp4O illustrates the close homology between the different structurally 
charactensed human isoforms (Figure (1)). It can be seen from Figure (1) that CypA, 
the smallest of the four proteins, is the core sequence around which the others are 
based. 
. 	*. .......... .. 	*0• .** ** 
CypB_buman_ 
CypC_human -PGP- - 	 -Pc8 
CypA_human_ ------------------------------------ 
Cyp-40_human_ ------------------------ BVSPQKPSNP8 





****t * 	 :*. . 	*:* *t ****:: 	:**** t**** * •*** ** 	* :*t**** ****** 
CypB_hum8n 	 : 	 CV.T1cI RKVI . 210 
------- ------------- 
Cyp-40_homan_ P 	 211 
ruler ....... 170....  ... 180 ....... 190 ....... 200 ....... 210 ....... 220 ....... 230 ....... 240 
Figure (1) Sequence alignment of human cyclophilins A, B, C, NK and 40. 
2. 1 The discovery of CypA 
CsA is used to inhibit rejection after organ transplantation. In an attempt to understand 
the mechanism of action of CsA on the immune system in 1984 Handschumacher, et 
al. " used CsA as a probe in order to identify its target in an extract from calf thymus 
glands. A specific protein which bound CsA was discovered, purified and 
characterised. The specific protein was named cyclophilin because of its high affinity 
to CsA. Around the same time, Gunther Fischer' 2 identified an 18000Da protein which 
could speed up the interconversion between cis and trans rotamers of amide bonds at 
proline residues. In 1986, the sequence of CypA was determined, and in 1989, two 
papers were published in the same issue of Nature confirming that the PPIase had the 
same sequence as CypA 13" 4 . 
CypA has the properties of binding CsA and PPIase (peptidyl-prolyl isomerization) 
enzymatic activity (described later). The question was therefore asked as to whether 
there was any relationship between these two functions. Actually, the PPIase active 
An alignment of the amino acid sequence of CypA. CypB, CypC and the Cyp domains 
of Cyp-NK and Cyp40 illustrates the close homology between the different structurally 
characterised human isoforms (Figure (1)). It can be seen from Figure (1) that CypA. 
the smallest of the four proteins, is the core sequence around which the others are 
based. 
CypE human IGL.DVGBV I FGLFGVP 	VALA 	80 
CypC human NQPQPI -. LLLP.VLVOLGAIVFSSG - -* 	 Jc TIJBGPIV vFiVV. tOt KDVGR IV IGLFG F.VP VALA 74 
	
cYP& human ------------------------------------ MV$p - - - -VFFDXAVDQ$PZVFFELFADVP BAL 	40 
Cyp-40 human ------------------------ NspsPgPswP4P- --- 	 RALC 52 
ruler 1 ....... 10 .................. 30 ........ 40 ................. 60 .................. 
CypB human 	AGFG FFllAVIXtFMI 0 	 F IYGAFP FKLA8YGPGW 	 F 152 
CypC human c2Y0 KF8BVUWFMI DI T 	. ITGtTFPD IcLYGIGW' 06 	• F 	146 
CypA human 	FO - - -• 	C IIPGFM 	A F ITGIc7 	. 	TGPGX 	3 F 112 
Cyp-40 human I - ji— L4ToCP - I 	 IYum,J DRE 132 
ruler 	........ 90 ....... 100 ...... 110 ....... 120. 	. 	. 	I .......... 140. 	 160 
Cyp8 human Ft 	 -------------------- 	210 
CypC human Ft I4APCALDGX*VVFGIcVXDG)r.VVHSX*LQ 	kDPLTN 	INSGR.IDVXTP ---------------------- 204 
CypA human FtC 	WLDGK1IVVFGWVKZGXNXVEMSR -DS L1 - ---------------------- - - 	165 
Cyp- 40 human F P*LDGK$VVTGVIKGXGVAR lLZNvEvFG - 	 211 
ruie 	............. . 	. 	1'40 ....... 190 ....... 200 ..... .....1- ...... 220 ....... 230 ....... 240 
Figure (1) Sequence alignment of human cyclophilins A. B. C. NK and 40. 
2. 1 The discovery of CypA 
CsA is used to inhibit rejection after organ transplantation. In an attempt to understand 
the mechanism of action of CsA on the immune system in 1984 Handschumacher, et 
al. II  used CsA as a probe in order to identify its target in an extract from calf thymus 
glands. A specific protein which bound CsA was discovered, purified and 
characterised. The specific protein was named cyclophilin because of its high affinity 
to CsA. Around the same time. Gunther Fischer' 2 identified an 1800013a protein which 
could speed up the interconversion between cis and trans rotamers of amide bonds at 
proline residues. In 1986, the sequence of CypA was determined, and in 1989, two 
papers were published in the same issue of Nature confirming that the PPIase had the 
same sequence as CypA 1314 . 
CypA has the properties of binding CsA and PPlase (peptidyl-prolyl isomerization) 
enzymatic activity (described later). The question was therefore asked as to whether 
there was any relationship between these two functions. Actually. the PPIase active 
2 
site is the same as the CsA binding site, therefore cyclophilin A can not perform 
PPIase activity when bound by CsA. Mutation analysis has also shown that mutant 
CypA with no PPIase activity could still bind CsA and inhibit the phosphatase 
caicineurin 15 . Other evidence is that drug concentrations of CsA necessary to inhibit T-
cell activation would not saturate the abundant prolyl isomerases' 6" 7 . 
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Figure (2) CypA-CsA complex inhibits the activation of T cells. 
As shown in figure (2), the interactions between antigenlMlllC and T cell receptor 
cause the• influx of Ca 2 , which binds calmodulin to form the Ca2 /ca1modu1in 
9-1 
complex. The C2/calmodulin complex activates a phosphatase calcineurin, which can 
sequentially dephosphorylate NF-AT (nuclear factor of activated T cell). 
Phosphorylated NF-AT can not translocate into the nucleus 182° and initiate 
transcription of the gene for interleukin-2 until it is dephosphorylated by the active 
phosphatase calcineurin2123 . The complex CypA-CsA can bind activated calcineurin, 
resulting in the inhibition of dephosphorylation of NF-AT 24'. Therefore the complex 
of CypA-CsA inhibits the transcription of IL-2 (and possibly other lymphokines), 
preventing the activation and proliferation ofT-cells, resulting in immunosuppression. 
2.3 The biological functions of CypA 
CypA interacts with several targets in the cell to play various roles. CypA helps a 
variety of proteins correctly fold and regulates the infectivity of HJV- 1 virions26, which 
will be described in detail later. 
of all the organs or tissues where hCypA is active, it has been shown that it is at its 
highest concentration in the brain, indicating that CypA may play a role in the nervous 
system, although its functions here has not yet been well defined. CypA was shown to 
augment the proliferation of human embryonic brain cells in vitro27 . Capano 
discovered that CsA inhibited the activation of the four caspases (caspase-3, 6, 8, 9) in 
the nervous system. In order to identify the target of CsA in the neuron cells, an 
antisense oligodeoxynucleotide was used to suppress the level of cyclophilin A to less 
than 5% of its control value and the effect of CsA was largely reproduced; therefore, it 
was thought that CypA is at least partially involved in the neuroprotection by 
cyclosporin A against excitotoxin-induced apoptosis 28 . 
CypA was recently reported to bind peroxiredoxin and act as its immediate electron 
donor to support its peroxidase activity, which is involved in the inhibition of 
apoptosis, the inhibition of c-Abl tyrosine kinase activity, a peroxinitrite reductase 
activity 29and also protects cells against oxidative stress 30 ' 31 . 
Nuclear CypA in complex with zinc ions recognizes DNA sequences and is involved 
in the transcription modulating process 32; the zinc bound CypA does not bind CsA. 
4 
CypA can possibly act as a cytokine in a secreted form, and contribute to the 
pathogenesis of inflammatory diseases 33 . 
2.4 The role of CypA in lilY infection 
CypA binds the I{IV-1 gag polyprotein p55gag in vitro and Smith et al.34 found that 
viral particles formed by p55gag, rather than gag polyproteins of other retroviruses, 
contain significant amounts of CypA. The 25mer fragment of HIV-1 gag was bound at 
the active site on the molecular surface of CypA. Fourteen CypA residues(Arg55, 
11e57, Phe60, Met6l, G1n63, Asn7l, G1y72, Thr73, Ala101, Asn102, Ginlil, Phell3, 
Leu122,and His 126) were involved in the interactions with the 25mer residues 35.The 
experiments also showed that a non-immunosuppressive cyclosporin A analogue 
inhibited the replication of HIV-1 but was inactive against S1VMAC, a primate 
immunodeficiency virus closely related to HIV- 1, which does not incorporate CypA; 
therefore the association of CypA with virion is functionally relevant. Genetic and 
biochemical studies showed that CypA is required for H1V-1 replication and 
infectivity, but not for HTV-1 virion assembly36 ' 37 . It is likely that in HIV- 1 infectivity 
CypA functions as a chaperone or an essential functional component, rather than acting 
as a cis-trans isomerase35 . 
2.5 CypA structure 
The structure of CypA consists of an eight-stranded antiparallel 13-barrel with an a - 
helix sitting at each end 38. There is an obvious cleft on the surface of the CypA 
structure, containing a hydrophobic pocket formed by hydrophobic residues. The 
hydrophobic core of the CypA structure formed by a phenylalanine cluster is thought 
to account for the fast folding behaviour of CypA 39. CypA seems to be a rather rigid 
protein that does not undergo significant structural changes upon ligand binding. The 
structure of CypA is shown in figure (3). 
5 
I i-p I 2 1 
Figure (3) Structure of hCypA. Multicoloured ball-stick model represents amino acids 
around the active site, which are Arg55. Phe60. Met6l, G1n63, G1y72, Ala101, 
Asn 102, A1a103, Glnl 11, Phel 13, Trpl2l, Leu122. 
3. The PPIase activity of immunophilins 
PPIase activity is the abilit) to speed up the interconversion between cis and trans 








Figure (4) Cis-trans isomerization around peptidyl-prolyl bond 
Since the identification of PPlase activity in CypA, other enzymes have also been 
identified as having this activity, such as FKBP ( FK506 binding protein) °'41 and the 
6 
parvulin family4243 . So far, no in-mrnnosuppressant has been found to bind parvulin. 
These three proteins have no sequence similarity and therefore they represent 3 
different families of PPlases. 
The isomerization of peptidyl-prolyl bonds is a slow step in protein folding. CypA was 
44 reported to accelerate protein or oligopeptide folding and has an in vivo function.The 
PPIase activity may be related to some signalling pathway since a PPIase-defective 
CypA mutant can not initiate signalling events 45 . 
Substrates of PPIase activity bind CypA in a conformation of cis, trans or distorted 
intermediate. For instance, in the complex of CypA-25mer the peptide bond between 
G1y89 and Pro90 of 25mer is in the trans conformation while the cis conformation has 
been observed in other much smaller CypA-peptide structures 3850. Figure (5) shows 
the conformation of a bound 25mer substrate and cyclophilin; and figure (6) shows the 
conformation of a bound substrate Ala-Pro and cyclophilin. 
Prolinc residue 
Figure (5) The complex structure of CypA-25mer. 25mer binds CypA in the trans 
conformation 35 . Red ribbon model represents CypA, the golden stick model represents 
25mer with the peptidyl-prolyl in trans conformation. (This figure is from reference 
35). 
7 
Figure (6) Stereo pictures of complex structure of CypA-Ala-Pro. Ala-Pro binds CypA 
in the cis conformation47 . (This figure is from reference 47) 
Although the mechanism of the reaction is poorly understood, several proposals have 
been put forward. 
Substrate binding with distorted peptidyl-prolyl bond and self-catalysis of substrate. 
In this mechanism the C-N bond of the substrate is distorted and maintained by the 
interactions between substrate and enzymes. The distorted arnide bond N-C 
deconjugates the double bond character, reducing the energy barrier to rotation. The 
distorted C-N bond of the substrate is observed in both the cyclophilinSLS2  and the 
FKBP catalysis system. In the case of the complex of FKBP with FK506, the substrate 
can form intra-molecular bond to facilitate lowering the intrinsic energy barrier 51 '52 . 
Protonation of amide nitrogen. Molecular orbital calculations have shown that 
protonation of the amide N can dramatically reduce the energy barrier of rotation 
between cis and trans conformations; therefore, in this mechanism the amide N is 
protonated on the tetrahedral nitrogen lone pair by hydrogen bonding interaction, 
which stabilizes the transition state 53 . 
Solvent assisted catalysis. In this mechanism the substrate binds the enzyme with a 
distorted conformation (about ±300),  this substrate transition state is stabilized by a 
conserved water molecule at the active site, which also forms a water-bridged 
hydrogen bond between enzyme and substrate47. 
All the mechanisms described are supported experimentally, although they are, as yet 
poorly understood. A more general, comprehensive mechanism may exist, and awaits 
elucidation. 
Immunophilins in protein folding 
In vitro and in vivo experiments have demonstrated that CsA specifically inhibits 
procollagen folding in chicken fibroblasts. Steinmann et a154 reported that CsA slowed 
down the folding rate of procollagen I by about 1.5 times in vitro and caused the 
production of procollagen I and ifi to decrease by about 3% in cultured human 
fibroblasts. Since the cytosolic target of CsA is cyclophilin, cyclophilin appeared to 
accelerate the rate of protein folding in living cells. Cyclophilin B, in association with 
hsp47 (heat-shock protein47), is involved in the export of procollagen from the 
endoplasmic reticulum. Experiments have shown that treatment of cells with 
cyclosporin A results in a lower level of cyclophilin B bound to procollagen and a 
reduction in the rates of hsp-47 release from procollagen, and of procollagen 
secretion55 . Mitochondrial cyclophilin-20 in cooperation with hsp70 and hsp60, has 
been implicated in protein folding in this organelle, and cyclophilin Cpr3p catalyses 
protein-folding in yeast mitochondria' °'56 . In addition, a chaperone complex, required 
for the folding of steroid receptors, was formed between cyclophilin-40, heat shock 
proteins(Hsp70 and Hsp90) and the protein p23 57 . 
Immunophilin.s in cell signalling 
CypA can be secreted by cells under inflammatory stimuli to initiate the signalling 
through binding to a cell-surface receptor CD 147. Cyclophilin-40, a member of the 
large immunophilin family consisting of a cyclophilin domain or FKBP domain and a 
tetratricopeptide (TPR) domain, together with Hsp90 plays a role in signal transduction 
and protein recognition. Experiments show that the deletion of CPR7, a 
Saccharomyces cerevisiae homolog of cyclophilin-40 caused growth defects when 
combined with mutations that decrease the amount of Hsp90, which suggests that 
cyclophilin-40 plays a general role in Hsp90-dependent signal transduction pathways 
under normal growth conditions 58.59 
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Immunophilins in ischaemia 
Cyclophilin I) is involved in the inhibition of the mitochondrial permeability transition 
(MPT), which is a Ca2 dependent pore in the mitochondrial inner membrane. It is 
involved in ischaemja-related disease and cell death, through the binding of CsA or 
other nonimmunosuppressive CsA derivatives60 . 
Immunophilins in nerve regeneration 
Some FKBP ligand complexes which do not inhibit calcineurin appear to accelerate 
nerve regeneration, suggesting that some immunophilins have a target in the cell other 
than calcineurin. The study shows that the potent FKBP-12 inhibitor V-10,367, which 
could not cause calcineurin inhibition, increases neurite outgrowth in SH-SY5Y 
neuroblastoma cells and speeds nerve regeneration in the rat sciatic nerve crush model. 
Therefore, FKBP-12 ligands lacking calcineurin inhibitory activity were thought to be 
the potential drugs to treat human peripheral nerve disorders 61 . 
Imniunosuppressants 
CSA62-64 FK50665, rapamycin' 6 and SfA(sanglifehrin A)66 are known immunophiuin-
binding metabolites. These are shown in figure (7). 
FK506 
	
Rapaniycln 	 Cyclosporin A 
Me 
Figure (7) Four classes of immunosuppressants 
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CsA and FK506 have the same mechanism of inhibition of the immune reaction 
provoked by transplanted foreign organs. The complexes of CsA with CypA and 
FK506 with FKBP12 inhibit the activity of the phosphatase calcineurin so that NFAT 
can not be dephosphorylated, thus inhibiting the proliferation of T cells 67 . CsA and 
FK506 and their derivatives have also been found to be neuroprotective in ischemia, 
Parkinson's disease and excitotoxic insults 68. Independent of its immunosuppressive 
activity through forming a complex with CypA and calcineurin, CsA has powerful 
killing properties against a wide range of infectious organisms including large 
multicellular helminth parasites69 . 
Rapamycin complexed with FKBP suppresses the immune reaction by inhibiting the 
kinase FRAP (FKBP Rapamycin Associated Protein). SfA, however, has no apparent 
effect on the phosphatase activity of calcineurin, and it is not involved CypA binding. 
There is no literature describing SfA's binding to FKBP or the interactions between 
CypA or FKBP. However, it does have the effect of inhibiting T cell proliferation 
induced by IL-2 in the G(l) stage of the cell cycle with no appreciable effect on IL-2 
receptor expression in a manner similar to that of rapamycin 70 , indicating that SfA has 
a new mechanism of immune suppression 71 . 
9. Interactions between CsA and CypA 
CsA is a cyclic undecapeptide with the sequence of MeBmt-Abu-Sar-MeLeu-Val-
MeLeu-Ala-D-Alla-MeLeu_MeVal, where the prefix Me indicates N-methylation and 
the uncommon amino acids in positions 1 and 2 are (4R)-4-((E)-2-butenyl)-Sar, N-
dimethyl-L-threonine and L-a-aniinobutyric acid, respectively 72 ' 73 . 
The crystal structure shows that CsA binds to CypA with the side chains of MeBmt-1, 
Abu-2, Sar-3, MeLeu-9, MeLeu-1O and MeVal-1 1 of CsA making contacts of less than 
4A with the CypA residues Arg55, Phe60, Met6l, G1n63, G1y72, Ala101, Asn102, 
A1a103, Gini 11, Phel 13, Trpl2l, Leu122, His126 74. Five direct hydrogen bonds and a 
network of water-mediated contacts stabilize the interactions between CsA and 
CypA74. CsA has been shown to have a weaker affinity 75-fold for human cyclophilin 
11 
when Trpl2l of hCypA is mutated to Phe 7 . The CypAICsA complex structure is 
shown in figure (8). 
J5 
1 rp_121 
Figure (8) HCypA structure complexed with CsA. The green ball and stick model 
represents CsA and other labelled residues are around the active site of CypA. CsA 
binds in the hydrophobic pocket of CypA. 
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Chapter two 
Part A. Introduction of structure-based Drug Design 
1. Introduction 
The traditional way to find new drugs is by screening. This approach has now been 
automated to test hundreds of thousands of compounds using so called 'High 
Throughput Screening' (HTS) techniques. For example the company Pharmacopoeia 
has an internal collection of three million compounds for high throughput screening 1 . 
New drugs are discovered by screening the compounds library against target 
molecules. Once a lead compound is known, some systematic modifications may 
produce potential drugs. Another alternative approach to drug discovery is to make 
use of the structural information of potential drug target proteins. With the dramatic 
increase of available protein crystal structures archived in the protein data bank 
(PDB), structure-based drug design has developed rapidly in the last two decades. 
Completion of the human genome projects has led to the birth of high throughput 
structural genomics, with the knowledge of more potential drug targets available for 
structure-based drug design. 
The first drug on the market, developed from insights from molecular modelling of 
the protein-ligand structure, was the carbonic anhydrase inhibitor dorzolanine 2 . 
Structure-based drug design has also played very important roles in the drug 
development of HIV protease inhibitors 3 ' 4, the neuraminidase inhibitors of influenza 
virus 5,6  and thymidylate synthase inhibitors with anticancer effects 7 . 
The basic concept for structure-based drug design is that every disease has a drug 
target at the molecular level, usually a protein. Drug target identification normally 
involves a huge amount of work. Some of the drug targets in the immunology field 
are the T cell receptor (TCR), CD4, (which is involved in the binding and 
recognition of the major histocompatibility complex HMC) immunoglobulins, 
cytokines and immunophilins 8 . 
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Combinatorial chemistry is a technique with much potential in drug design, and can 
be used to generate a library of compounds for a specific target protein. A semi-
automatic combinatorial chemical synthesis system has recently shown how this 
system can rapidly produce thousands of compounds in milligram quantities in one 
day 9. The advantage of combinatorial chemistry is that it can produce a large amount 
of different, but structurally related compounds (lead-like compounds). The 
challenge in combinatorial chemistry is in screening the lead library in order to 
discover a high affinity compound. Mass spectrometry integrated screening methods 
are being explored and some exciting results have been recently published 10-15 
2. Structure-based design 
Structure-based drug design requires accurate knowledge of the 3D structure of the 
target molecule; and of particular importance are the active site and any effector sites. 
The active site of a protein normally has distinctive geometry, such as clefts, areas 
surrounded by loops, or hydrophobic pockets. A useful way of identifying the active 
site of a target protein is to determine the 3D structure of a complex of target protein 
with substrate or natural ligands using X-ray crystallography or NMR. Alternatively, 
site-directed mutations or chemical modification of specific amino acids can also 
provide useful information regarding the active site of target protein. There are also 
some computer algorithms for mapping the active site of the target proteins 16. The 
algorithm ConSurf' 7  is based on the idea that the functionally important residues 
should be conserved during evolution. Lewis 18 proposed a Voronoi tessellation-based 
algorithm which can find the cleft on the surface of a protein. Voronoi tessellation is 
a mathematical method that divides a given space into domains according to the 
fundamental properties of all the points in the given space. Kleywegt et al.'9 put 
forward an algorithm based on the so-called 'flood-fill' method. This method maps 
the protein structure onto a 3D grid, and then assigns a value of zero to each grid 
point. Subsequently, each point of the grid whose distance to the nearest atom is less 
than the sum of the van der Waals radius of that atom and the probe radius is 
assigned a value of one. All the grid points on the surface have a value of zero so that 
the boundary between the protein and the outside world can be distinguished. 
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According to the 3D structure of the active site of the target protein, a ligand can be 
designed which potentially fits the active site of target protein geometrically and 
chemically (figure (9)). An actual ligand which matches the designed virtual ligand 
can subsequently be synthesized or found by searching in databases of commercially 
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Figure (10) Illustration of database mining 
3. Interactions between ligand and protein 
The main approaches for analysing the interactions between ligands and target 
proteins are a force field-based technique and the techniques based on geometric 
complementarities between the active site and ligand, including shape 
complementarities and favoured contact geometry between ligand and active site. 
The popular techniques utilized to analyse the interactions between protein and 
ligand are molecular mechanics (MM), on which program MCSS is based 20, and the 
hybrid quantum mechanical/molecular mechanic (QMIMM) 21 . The program MCSS 
places from 1000 to 5000 copies of functional groups in the active site of the protein 
with known 3D structure and simultaneously performs the energy minimization 
andlor quenched molecular dynamics to find out the energetically favoured positions 
and orientations of the functional groups. The program LUDI 2223 and DOCK 24'2 use 
a different method to dock the small ligand into the active site. The statistical 
information about the interactions between functional groups is extracted from the 
database 26 ' 27 , and combined with information about shape and electronic 
complementarity, and then applied to dock the ligands into the active site. 
In the past most of programs assumed the active site of the target protein to be rigid. 
In fact, the active site of a target protein can be quite flexible. The conformation of 
the active site may change in order to adapt to the ligand chemically, electronically 
or geometrically. Furthermore the ligand can also adopt more than one conformation. 
The whole process of calculating interactions between ligand and active site is 
therefore quite complicated. With increased computer power, it is now becoming 
possible to take the conformation changes of either protein or ligand into account. 
For example, the script SOPTSPOTS 28 and PLASTIC28 together can deal with the 
protein conformation changes induced by the ligand binding. Firstly, the script 
SOPTSPOTS identifies regions of possible conformation changes in the active site of 
the protein, PLASTIC then builds a minimal manifold of possible conformations of a 
protein target for drug design. 
4. Finding new ligands 
In general, there are two computational ways to discover a new ligand. One is to 
mine the small molecule databases (e.g. CSD) and dock a known molecule into the 
active site. The alternative is to try de novo design of ligands. One of the most 
challenging problems in this process is the determination of a 'scoring function', 
which is used to calculate the affinity constants of ligands binding to the target 
protein. A two-step approach is widely used in the calculation of scoring functions 29 . 
The first step is to use the empirical scoring function to prioritise the raw hits or 
candidate ligands, and the second step is to use a more accurate and computationally 
expensive approach to priontise the top hits or candidate ligands resulting from the 
first step, such as force field calculation. Computationally, the thermodynamic cycle 
perturbation method 30can be used to study ligand modifications. The thermodynamic 
cycle perturbation method is a computational method which can be used to calculate 
the free energy change after 'chemically' modifying the ligands. The relative binding 
strength can be worked out in comparison to the unmodified ligand compound. This 
method has a strong theoretical foundation and the efficiency and accuracy of 
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calculations will increase along with the development of computer power. One 
disadvantage may be that it is difficult to predict accurately the configurations of the 
target protein when one compound binds. 
Water molecules in drug design 
During drug design, it is essential to consider water molecules in the active site. The 
positions of tightly bound water molecules in the active site can be used as a template 
for a potential drug. Water molecules may also be incorporated into the drug design 
plan as hydrogen bond bridges between target protein and potential ligands. Some 
computational methods have been applied to find the water molecules in the active 
site, such as grand canonical molecular dynamics 3 ' and neural networks32 . X-ray 
crystallography may be the most direct method currently available for finding the 
tightly bound water molecules at the active site of a target protein. The replacement 
of tightly bound water molecules at the active site with a ligand does not necessarily 
mean the affinity of the ligand will be improved. It has been reported in the literature 
that the affinity of the ligand, which replaced one bound water molecule in the 
active site, decreased 33 , although a new HIV protease inhibitor which incorporates a 
water molecule, which normally forms a hydrogen bond between the target protein 
and substrate, has a greater inhibitory effect 34 . 
Peptide drugs 
In drug design, an important and emerging branch is in the design of peptide drugs. 
Peptide drugs offer some advantages when compared with other types of drugs: For 
example, lower toxicity, easy synthesis and the possibility of encoding them into the 
host gene. Databases of randomly expressed peptide fragments also provide a great 
source of peptide drugs. A program PEP has been written to design linear polymeric 
peptide ligands35 . PEP generates a new ligand by adding amino acid residues to the 
ligand seed one by one, followed by optimisation of the conformation of each added 
amino acid residue inside the binding site of the target protein. Subsequently, PEP 
evaluates the whole generated ligand in terms of binding energy and electrostatic 
interactions in order to assess the 'best' amino acid to be added. However, there is a 
serious drawback with L peptide drugs. Most of the peptide would be degraded by 
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enzymes before taking effect, therefore making it useless as a drug. However, in 
most biological systems, enzymes do not recognize D peptides. Therefore, the 
discovery of D peptide drugs, which bind L target proteins, may provide a solution to 
the L peptide degradation problem. Schumacher.T.N. etal. 36 proposed a 'mirror-
image phage display' method to look for a D peptide drug and found a cyclic D 
peptide that interacts with the Src homology 3 domain of c- SRC. In this method, the 
first step is to convert the natural L protein target consisting of L amino acid residues 
to its mirror image. D protein target consisting of D amino acid residues, and 
synthesize it. The second step is to use the D protein target as the template to screen 
a randomly expressed L peptide library. Once a bound L peptide ligand is found, the 
third step is to convert the bound L peptide ligand to D peptide. According to the 
mirror symmetry, the D peptide converted from bound L peptide must bind L protein 
target (figure (11)). 
LtypeconverttoDtype R 	$1 Screen L peptides 1lbrar 
Ltarget protein D target protein 
D target protein 
find L peptide 
I 
Dpeptide binds L target protein 
A 	 i L type convert to D type 4 
 
D peptide binds 	 D peptide 
L target protein 
 
Lpeptide 
Figure (11) Discovery of D peptide drug 
7. Prospects 
Structure-based drug design is a young, booming and multi-disciplinary science. It 
depends greatly on computation because of its sophistication. In the future, the 
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combination of structure-based design and combinatorial chemistry, incorporating 
automatic and efficient ligand binding assay systems will become the main approach 
in the drug discovery field. 
Part B. The Basis of this project 
1. Dimedone as a ligand 
By using the 3D structure of the active site of hCypA, the program Lidaeus (Ligand 
Design At Edinburgh University) could be used to generate a template for possible 
ligands. Database mining then identified compound A (Figure (12)) as possibly 
fitting the template. However, experimental studies proved that compound A did not 
bind to CypA (Dr. George Kontopidis PhD thesis, university of Edinburgh). 
Increasing the hydrophobic interactions between CypA and the compound by 
replacing two oxygen atoms of compound A with two carbon atoms, compound B 
was proposed. Compound C (dimedone) is structurally similar to compound B and 
also commercially available. Crystallographic work and binding assay proved that 
dimedone can bind to CypA with a Kd of 22 mM. Dimedone binds to the 
hydrophobic pocket of CypA, with the two methyl groups pointing into the bottom of 
hydrophobic pocket, which was formed by the Phe_1 33, and one carbonyl oxygen 
atom hydrogen bonds with the side chain of Arg55 of CypA. The work about the 
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Figure (12) Discovery of the ligand lead dimedone. Compound A was selected by a 
database mining approach, but it does not bind to CypA. Compound B was proposed 
in order to increase the hydrophobic interactions possibility. Compound C (dimedone) 
is chemically similar to compound B and is also commercially available. 
Experiments showed that dimedone binds to CypA. 
2. X-ray structure of the complex CypA/dimedone 
The crystal structure of the complex CypA with dimedone was solved by Dr. George 
Kontopidis and is shown in figure (13). The crystal structure shows that dimedone is 
accommodated by the hydrophobic pocket in the active site of CypA. The dimethyl 
group of dimedone points into the hydrophobic pocket and make hydrophobic 
interactions with the phenyl ring of Phe_1 13 which is sitting at the bottom of the 
hydrophobic pocket. One carbonyl atom of the dimedone structure forms hydrogen 
bonds with atoms NH! and NH2 of Arg55. 
25 
Ficure (1 3) Crvtal structure Of CpA complexed with climedone DCH Ball-stick 
model represents the bound compound dimedone. The two methyl groups of 
dimedone point into the hydrophobic pocket of CypA and one of the carbonyl 
oxygen atoms hydrogen bonds with NH of Arg_55. This crossed stereo figure was 
made by Molscript37 . 
3. Comparison between structure of CypA/CsA and CypA/dimedone 
The cyclic structure cyclosporin A binds tightly to CypA as described in chapter one, 
the complex structure of cyclosporin A and CypA is known, figure (14). When CsA 
binds to CypA, half of the CsA molecule inserts into the active site of CypA and 
makes contacts with CypA and another half molecule remains in the solvent, which 
is the part that binds calcineurin 38 . The superposition of the complex structure of 
CypA!CsA and CypA/dimedone shows that the two methyl groups of dimedone 
occupy the same position in the active site of CypA as the valine group of 
cyclosporin A, figure( 1 5). By incorporating the binding features of dimedone and 
cyclosporin A, a series of new ligands derived from the dimedone structure could be 
designed to mimic the strcuture of cyclosporin A. 
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Figure( 14) Complex crystal structure ot CypA and ccIosporin . The green ligand is 
cyclosporin A, the residues in black (Trp_121, Phe_1 13, Arg_55, Asn_102) are at 
the active site of CypA and form direct hydrogen bonding or hydrophobic contacts 
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Figure (15) The superposition of the crystal structures of the complexed CypA with 
dimedone and CypA with cyclosporin A. Cyclosporin A structure is represented as a 
thin cylinder model and dimedone structure is represented as a ball-stick model. The 
two methyl groups of dimedone and the valine group of cyclosporin A occupy the 
same space at the active site of CypA, which is marked by the black box in the figure. 
4. The application of combinatorial chemistry 
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Based on the chemical structure of dimedone and knowledge of the complex 
structure of CypA and dimedone. a compound library can be generated by applying a 
combinatorial chemistry strategy shown in the figure (16). 
Apart from the two methyl groups and one carbonyl oxygen atom which form 
hydrogen bonds with residue Arg_55 of CypA, the other positions on the dimedone 
can be modified by extending the dimedone molecule in different directions by 
adding different functional groups. 
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Figure (16) Strategy for the generation of compounds library. Two methyl groups of 
dimedone make hydrophobic interactions with the hydrophobic pocket of CypA and 
one of the carbonyl oxygen atoms makes hydrogen bond with atom nitrogen of 
Arg_55. The unoccupied positions on the dimedone structure are subject to the 
modification to make new derivatives. 
As shown in figure (16), dimedone interacts with residue Arg55 of CypA by 
hydrogen bond through one of its carbonyl oxygen atoms and hydrophobic 
interaction with the hydrophobic pocket through the two methyl groups. The 
dimedone molecule can therefore be extended in different directions using different 
functional groups to form a large family of compounds specific to CypA. Screening 
of this library of compounds should then identify any potentially effective CypA 
ligands. 
Dr. Elizabeth Moir in the Chemistry Department of Edinburgh University 
synthesized a series of dimedone derivatives for this project. 
5. Aims 
The aims of the work on the CypA project presented in this thesis are as follows: 
to optimise the CypA expression conditions in E. coli in order to produce 
enough CypA for crystallographic studies. 
to characterize the binding features of several synthesized ligands in order to 
generalize the relationship between the structural features of the complexes of 
CypA with these ligands and their binding strength. 
to provide guidance based on the crystallographic studies for the design of 
further and better CypA ligands. 
The aim of the work on the complex of FKBP with Leu-Pro is to explore the 
mechanism of PPIase activity from a structural point of view. 
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In a project such as this, which involves protein crystallisation trials and ligand 
binding assays, it is necessary to ensure a good supply of stable, pure and active 
protein. Manufacturing a reliable supply of protein can be difficult, often proving to 
be a major bottle-neck in the progress of work involving the study of enzyme 
structure and mechanisms, and is an aspect which generally requires much repetition 
and refinement. 
Before protein can be expressed, it is necessary to select a good expression system, 
the selection of which can depend on various factors, such as whether the vector is 
suitable for the host system, whether the expressed protein may be toxic to the host 
cell, or whether the protein will be correctly folded. Host systems can generally be, 
bacterium', yeast 2 , plants, filamentous fungi, insect or mammalian cells 3 . 
In this project, the immunophilin CypA is expressed in the bacterium E.coli. 
transformed with plasmid DNA bearing the recombinant CypA gene. 
Materials and Methods 
2. 1 Materials 
Agar, LB broth, Ampicillin, petri-dishes 
LB broth ingredients: 
. 1.0 liter of distilled water 
15.0 g Bacto Agar 
10.OgNaCl 
10.0 g Bacto Tryptone 
5.0 g Yeast Extract 
2.2 Equipment 
Bunsen burner, incubator shaker (Model G25, New Scientific Co. Inc), incubator 
(WTC Binder), spectrometer (Perkin Elmer Lambda 20) 
2. 3 Method 
2. 3. 1 Storage of bacterium cell lines 
The bacterium were stored in the LB broth (Amp lOOtg/m1) with 15% (v/v) glycerol 
at —80 °C. 
2.3. 2 Protein production procedure 
Pick bacteriuml from storage solution 
Streak on the solidified agar plate containing Amp lOOpg/ml for selection 
Keep the streaked agar plate in the incubator at a constant 37°C overnight 
Transfer one colony from the Agar plate to the 50m1 LBamp broth 
Shake in the incubator at 37°C 
At 0D600=0.4 induce the cells with 0.6 mM 1PTG (isopropyl J3o 
thiogalactoside) 
Harvest the cells 
Purify target protein 
2.3.3 Pouring agar plates 
Melt agar, allow to cool (to around 60°C), add ampicillin to a concentration of 
lOOjig/mi, and mix gently. 
Pour agar into petri dish to a depth of about 2-3 mm, cover. 
Once agar has solidified, seal gap between lid and base, invert plates and store at 4 
°C for future use. 
2. 3. 4 Streak agar plates 
Remove plates from 4°C environment, allow warming up to room temperature, 
keep plates inverted. 
Remove cell stock from -80 °C freezer, transfer to liquid nitrogen. 
Sterilise loop in bunsen flame, introduce loop to stock cells, streak agar plate in 
one continuous non-overlapping movement. 
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4. Cover plate, invert and place in 37 °C incubator for overnight growth. 
2. 3. 5 Transfer of bacterium from the plate into the LBamp broth 
After the colonies appeas on the surface of the agar plate, take out the plate for 
use. 
Prepare 50m1 LBamp broth by putting ampicillin into the LB broth to a 
concentration of lOOj.tg/mI. 
Ignite the Bunsen burner, sterilise the wire in flame. 
Use the wire to touch the single colony, and then quickly dip the wire into the 
LB amp broth. 
Put the LBamp containing bacterium into the 37 °C shaker. 
2. 3. 6 Induction of protein synthesis 
1. Monitor 0D600 of culture, when 0D6 00=0.4, induce protein synthesis by addition 
of IPTG to a final concentration of 0.6 mM. 
2. Continue to grow, shaking at 37°C for 4 to 25 hours. 
2. 3. 7 Harvesting the cells 
1 Take sample from culture for SDS-page electrophoresis 
2. Transfer culture to centrifuge bottles 
3. Centrifuge at 4000rpm for 60 minutes at 4°C 
4. Discard supernatant; retain cell pellets for protein purification 
3. Results and discussion 
3.1 E. coli growth curve 
In order to understand the growth rate of E. coli and to simplify the experimental 
operation procedures of protein expression, an experiment was done to work out the 
growth rate graphically. 
The experimental procedure is as follows: 
Transfer an E.coli colony from the agar plate to a 50 ml flask filled with 
LBamp broth, as described in 2. 3. 5. 
Shake the flask gently to mix and take 1 ml sample for measuring the 0D600. 
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Put the flask into the shaker at 37°C 
Every hour, take 1 ml sample from the flask to measure the 0D600. 
Plot the values of 0D600 against growth time, as shown in figure (1). 
E.coli for CypA growth cuive 
25T- 
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Figure (1) Growth curve of E. coli 
3. 2 Optimisation of the expression condition for human CypA 
The cell system used for CypA production was E. coli 101-521 1 C, which was 
obtained from Sandoz. In order to obtain high protein yield, some work has been 
successfully done to optimize the expression and purification conditions of CypA. 
There are many factors affecting the protein expression in E.coli. Conditions that can 
be controlled include the concentration of IPTG and ampicillin, the time point when 
IPTG is added and the growth time of bacterium. In this project, concentration of 
IPTG, time point when IPTG was added and growth time of bacterium have been 
controlled. Finally the optimal expression conditions have been determined as 
follows: 
Concentration of arnpicillin: 50.tg/m1 
Concentration of IPTG: 0.6mM 
Cell density when IPTG added: 0600=0.415 
Growth time of E.coli: 25hours 
'r1 
3. 2. 1 SDS page to check the expression of CypA using different IPTG 
conditions 
E.coli was grown in 8 different flasks filled with 800m1 LBamp broth in each flask. 
Induction was carried out by adding IPTG to 0.6mM concentration at different times. 
When the values of OD600  of the E.coli in all the flasks reach 2.0, imi samples were 
taken from each flask. The samples were centrifuged on the desk centrifuge 
(Biofuge, Heraeus) at 13000rpm for 5 minutes. The supernatant was discarded and 
the pellets were kept. The pellets were treated by adding electrophoresis sample 
buffer, and then SDS page electrophoresis (see appendix) was carried out. 




Figure (2) Electrophoresis of proteins produced by E.coli at different 
conditions 
A: Molecular weight marker 
Cl: when OD6=0.415, IPTG added; when OD 6 =2.003, take sample for SDS-page. 
C2: when OD0.415, IPTG added; when OD=2.130, take sample for SDS-page. 
Dl: when OD6 =0.542, IPTG added; when OD 6 =2.033, take sample for SDS-page. 
D2: when OD=0.542, IPTG added; when OD y =2. 145, take sample for SDS-page. 
El: when 0D600=0.360, IPTG added; when 0D600=2.002, take sample for SDS-page. 
E2: when 0D600=0.360, IPTG added; when OD=2.092, take sample for SDS-page. 
Fl: when OD=0.592, IPTG added; when OD=2.004, take sample for SDS -page. 
F2: when 0D600=0.592, IPTG added; when OD6=2.130, take sample for SDS-page. 
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From figure (2), lanes C2, Dl, El and Fl contain the strongest CypA bands 
compared with other lanes. In group D(Dl, 132), E(El, E2) and F(Fl, F2), one lane 
shows very strong expression of CypA(D 1, El, Fl), however, other lane (132, E2, 
F2) shows a relatively faint CypA band, therefore it seems the longer growth time 
decreases the yield of CypA expression. However, in group C (Cl, C2) both lanes 
show strong expression of CvpA and longer growth time results in better expression 
of CypA. 
3. 2. 2 SDS page to check the expression of CypA at different growth time 
Grow E.coli in 3 different flasks filled with LBamp broth. The E.coli in all the 3 
flasks was induced when the values of 0D600 of E.coli reach 0.4 15. Take 1 ml 
E.coli sample from the flask at different growth time: 4 hours, 14 hours and 25 hours. 
Centrifuge the sample on the desk centrifuge (Biofuge, Heraeus) at the speed 
13000rpm for about 5 minutes. Discard the supernatant and keep the pellets. Treat 
the pellets by adding electrophoresis sample buffer, and then run the SDS page 
electrophoresis (see appendix). 
A B Cl C2C3 







Figure (3) Electrophoresis of proteins produced by E.coli at different conditions. 
Lane C3 contains the strongest band of CypA 
A: Molecular weight marker 
B:CypA 
Cl: grow for 4hours, when 0D600=O. 415, IPTG was added 
grow for 14hours, when 0D600=0.415, IPTG was added 
grow for 25hours, when 0D600=0.415, IPTG was added 
Lane Cl, C2, and C3 show almost the same, strong, expression of CypA, but lane C3 
shows a slightly stronger band of CypA. 
Conclusion from expression optimization experiments 
According to the bacterium growth curve, the concentration of bacterium in 
solution remains constant at a certain level, depending on other factors 
remaining constant such as the volume of the culture and the shaking speed. 
The SDS-page electrophoresis results show that in the growth stage the time 
point when JPTG was added affects the expression of CypA. The possible reason 
is that E.coli at different life cycle stages has a different sensitivity to IPTG. 
The growth time (4 hours, 14 hours, and 25 hours) of bacterium seems not affect 
the CypA expression too much, although 25 hours growth results in a slightly 
stronger band of CypA. 
39 
5. Separation and purification of CypA 
5.1 Description of method 
For enzymatic assays and crystallisation, protein of high purity and activity is 
necessary. After the over expression of CypA in E.coli, the procedure of the 
separation and purification of CypA was as follows: 
5. 1. 1 Lysis of the cells 
Since the CypA expressed inside the E.coli cells can not be secreted into the culture, 
the first step in separation of the CypA is to lyse the cells. Usually there are two 
widely-used methods to lyse the cells, one is to use lysozyme to degrade the cell wall 
and another is to use sonication to break the cell. Some other lysis methods include 
freeze-thraw, french press and homogenisation. In this project, lysozyme was used to 
lyse the cell, at the same time, some EDTA and -mecaptoethanol were used to help 
stabilise and maintain the activity of the protein. EDTA was added as protease 
inhibitor and to chelate the magnesium which stabilises the cell wal14. 1-
mercaptoethanol was added to prevent the oxidation of cysteine residue of protein. 
5. 1. 2 Techniques for purification 
Corresponding to the different purification targets, there are many different types of 
chromatographic techniques that can be applied. Affinity chromatography separates 
proteins by specific affinity between the resin and the target protein; ion exchange 
chromatography separates the proteins by the electrostatic interactions between the 
protein and resin; hydrophobic interaction chromatography separates proteins by the 
hydrophobic interaction between the hydrophobic side chains of proteins and the 
hydrophobic groups of the resin and gel filtration separates proteins by the shape and 
molecular weight of the proteins. 
5. 1. 2. 1 Ion exchange chromatography 
The isoelectric point of a protein (p1) depends on the ratio of positively charged (Arg, 
Lys) and negatively charged (Glu, Asp) amino acids. When a protein carries a net 
charge, it can be bound to a support that carries the opposite charge. The use of ion-
exchange chromatography, then, allows molecules to be separated based upon their 
ELI 
charge. This is perhaps the most frequently used chromatographic technique for 
protein purification 5 . 
5. 1. 2. 2 Hydrophobic interaction chromatography (IUC) 
Some amino acids have a neutral or hydrophobic side group. Normally most 
hydrophobic side chains are buried inside the protein structure, but some may have 
their hydrophobic side chains distributed on the surface of protein. The hydrophobic 
groups can cluster together with other hydrophobic groups, such as the hydrophobic 
groups that are immobilised on an HIC support. Since most hydrophobic groups are 
buried inside the protein, therefore, HIC has great selection ability 6 . 
5. 1. 2. 3 Gel filtration (size exclusion). This technique does not involve protein 
binding. In this technique, the gel matrix consists of beads which have lots of small 
holes or pores of given size. Larger molecules pass through the space around the 
beads, and therefore travel faster than the small molecules that penetrate the pores 
and are retarded, allowing the separation of molecules according to size 7 . 
5. 1. 2. 4 Affinity chromatography 
This technique allows proteins to be purified to homogeneity in a single step. The 
technique involves the immobilisation, on a support matrix, of a ligand specific to the 
protein of interest. Passing a heterogeneous protein solution across this matrix causes 
the target protein to be bound to this ligand, which can then be eluted by 
competitively binding substrate to either the column or to the enzyme, or by 
adjusting the pH. Proteins can be expressed which incorporate a tag, such as a 
histidine tag, which will bind a Nickel-agarose column, and can then be eluted by 
competitively binding imidazole to the column 8 . 
5.2 Purification of CypA 
According to previous work with CypA, a three-step purification protocol is 
followed for CypA involving two ion exchange chromatography steps, and a final gel 
filtration step. 
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Since a pH of 7.5 is optimal for the activity of lysozyme, the cell extract was 
adjusted to pH 7.5. It has been reported that the p1 of the CypA is above 9.0 9or above 
7410 The calculated p1 from sequence is 7.7(http://www.expasy.ch/cgi-binlpi_tool),  
and during the chromatography purification stage, a negatively charged colunm was 
used, and the pH of the raw sample after lysis was kept at pH 6.8 until the final stage 
of the purification. At pH 6.8 CypA will be positively charged so that it can bind to 
the negatively charged colunm. 
5. 2. 1 Material and methods 
5. 2. 1. 1 Material 
Lysis buffer: 
Hepes pH 7.5 50mM, 
Benzamidine 5mM 
3-mercaptoethano1 5mM 
EDTA 	 5mM 
Buffer for chromatography: 
Buffer A: 
Hepes pH 6.8 	50mM 
f3-mercaptoethanol 5mM 
EDTA 	 5mM 
Buffer B: 
Hepes pH 6.8 	50mM 
3-mercaptoethano1 5mM 
EDTA 	5mM 
NaC1 	 1M 
Buffer for adjusting pH 
Hepes pH 6.6 	1M 
5.2. 1.2 Equipment 
Centrifuge facility (Biofuge, Heraeus; Avanti' J-25, Beckman; Megafuge 1 .OR, 
Heraeus), SDS-page electrophoresis facility (Bio Rad, Criterion), 5kD cutoff 
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concentrator (Vivaspin 6 and 20 ml, Vivascience), 0.45 pin filter (Cellulose nitrate 
membrane filters, Whatman), 3.3kD cutoff dialysis tube (Spectrum). 
FPLC and GradiFrac system (Pharmacia) 
SP Sepharose colunm (cation exchanger) (Pharmacia) 
Source 15S column (strong exchanger) (Pharmacia) 
Sephacryl S-200 HR column (gel filtration column) (Phannacia) 
5. 2. 1. 3 Method 
5. 2. 1. 3. 1 Cell lysis 
Resuspend cell pellet in lysis buffer (see 5. 2. 1. 1 for composition). 
Add lysozyme to a final concentration of 0.1% (w/v). 
Incubate on ice for 1 hour, with occasional gentle mixing. 
Centrifuge at 16,000g for 30 minutes. 
Retain supernatant, adjust the pH to 6.8 using buffer Hepes pH 6.6, 1 M. 
Filter the supernatant using 0.45p.m filter. 
5. 2. 1. 3. 2 Purification with SP-sepharose columns 
Equilibrate the SP-sepharose column with buffer A. 
Load supernatant onto column (60m1 resin). 
Wash non-specially bound proteins off column with buffer A. 
Elution of CypA with buffer B, NaCl gradient from 0 to 1M. 
Run SDS-page electrophoresis to determine the fractions containing CypA. 
Pool together all the fractions containing CypA and dialyse them in 5 liter buffer 
A overnight (ration of protein volume to dialysis buffer is 1:200). 
5.2. 1.3.3 Purification by Mono-S(SOURCE 15s) column 
Filter the dialysed sample with 0.45pm filter. 
Equilibrate Mono-S column with buffer A. 
Load the filtered sample onto column. 
Wash non-specially bound proteins off column with buffer A. 
Elute protein with buffer B, NaCl gradient from 0 to 1M. 
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6. Determine the fractions containing CypA by SDS-page electrophoresis and pool 
them together. 
5. 2. 1. 3.4 Purification by S-200 (S-200 HIR) 
Equilibration of column with buffer A. 
Concentrate the sample containing CypA from Mono-S column to a volume of 
about 3m1. 
Load sample onto column (lOOmi resin). 
Elution of protein with buffer A, flow rate of 0.5m1 per minute. 
Determine the fractions containing CypA by SDS-page electrophoresis, and then 
pool them together. 
Concentrate the pure CypA to suitable concentration (36mg/mi for 
crystallization trials). 
5.2.2 Results 
The following figure (4) shows the 3-step column purification process. After each 
step of column purifications, the sample from peak was confirmed by SDS page, 
shown on the top of figure (4), and eventually the pure CypA was obtained with the 
yield of 5.5mgIl culture. 
Evil 
ii!. 
I 	 - 
' CypA 	> £ <= CypA 	c> 
SP-sepharose 
ckomatography 
Mono-S chrontoaphy S-200 chromatography 
Figure (4) Separation and purification of CypA by chromatography. SDS-page was 
used to confirm the components of protein fractions. The thin red lines in the figures 
represent the salt NaCl gradient (0-0.5 M for SP-sepharose column and Mono-S 
column). The flowing speed is 1 ml/min for both SP-sepharose column and Mono-S 
column and 0.4 ml/min for S-200 column. 
5. 2. 3 Discussion 
I. During the first step of the purification procedure (ion-exchange chromatography 
using SP-sepharose), much of the CypA did not bind to the column because 
CypA came off the Mono-S column at the salt NaCl concentration 0 M, figure 
(4). Possible reasons may be that the amount of CypA in the sample exceeds the 
capacity of the column or that the presence of salt is weakening the binding of 
protein to the matrix (the intracellular salt concentration of E.coli can be up to 
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3% of the dry weight of the pellet"). By dialysing the flow through, and re-
applying to the colun-m, it is possible to overcome these problems. 
Before pooled samples from first ion-exchange step are applied to the mono-S 
column, it should be thoroughly dialysed. Salt from the first step will be present 
in the sample, and hinder binding to the Mono-S, causing CypA to pass straight 
through the column. 
The volume of the sample applied to S-200 (size-exclusion) column should be 
less than 3m1, otherwise the protein peaks on the chromatography will diffuse 
into one another, and the resolution of the column will decrease leading to poor 
protein separation. 
The final yield of CypA is 5mg per liter culture. 
46 
Reference List 
Chen,E. Methods in Enzymology 241, 29-46 (1994). 
Bathurst,I.C. American Journal of Tropical Medical Hygiene 50, 20-26 
(1994). 
Werner,R.G., Noe,W., Kopp,K., Schluter,M. Arzneimittelforschung. 48, 870-
880 (1998). 
Daniel R.Marshak. Strategies for protein purification and characterization. 
(1996). 
Amersham Pharmarcia Biotech. Ion Exchange Chromatography, Principles 
and Methods. Edition AA. www.apbiotech.com  
Queiroz, J.A., Journal of Biotechnology 87(2), 143-159. (2001). 
Regnier, F.E. Science 222(4621), 245-252. (1983). 
Hengen, P. Trends Biochemistry Science 20(7), 285-286. (1995). 
Liu,J., Albers,M.W., Chen,C.M., Schreiber,S.L., Walsh,C.T. Proceedings of 
The National Academy of Sciences of The United States of America 87, 2304-
2308 (1990). 
Holzman,T.F. Journal of Biological Chemistry 266, 2474-2479 (1991). 
Stainier R, Ingraham J., Wheelis M., Painter P. General microbiology. The 




Part A. Purity and concentration determination 
Introduction 
After the protein has been purified, its concentration, purity and activity should be 
examined, as these factors obviously affect ligand binding assays and crystallization 
trials. 
Techniques for checking the purity of protein 
Commonly used methods for assessing purity of a protein sample are SDS page 
electrophoresis and mass spectroscopy. 
2. 1 SDS page electrophoresis 
Electrophoresis is the migration of charged particles in solution under the driving 
force of an electric field. The migration rate of a charged particle in solution depends 
on the net charge of the particle, the strength of the electrical field, the size of the 
particle, and the ionic strength and viscosity of the solution in which the particle 
moves. Electrophoresis is a very handy, rapid and sensitive technique for the study of 
the properties of charged particle. In particular, capillary electrophoresis which 
allows small amount sample and quick analysis becomes more and more popular in 
analysing the trace sample 1 ' 2 . 
In protein science the most widely used electrophoresis technique is SDS 
polyacrylamide page electrophoresis. Polyacrylamide is a kind of porous gel, which 
allows the proteins to be separated by their size. SDS (Sodium dodecyl sulphate) is 
an anionic detergent which denatures proteins by forming a hydrophobic 
environment around the proteins. An important property of SDS is that it binds to the 
protein very specifically with a mass ratio of 1.4:1, meaning that the net negative 
charge of the protein molecule will be proportional to the mass or size of the protein 
molecule3 . Normally the disulphide bridges of proteins should be reduced, using a 
reducing reagent such as -mercaptoethanol, when preparing a sample for SDS-page 
electrophoresis. 
2. 2 Mass spectroscopy 
Mass spectrometry is a very powerful method for checking the purity of a sample by 
the mass distribution of the sample. Mass spectroscopy can be used to determine a 
protein mass with a high precision. ES! (Electrospray !onisation) mass spectrometry 
is a popular system and has a feature that the ions carry multiple charges, which 
reduces their mass-to-charge ratio compared to a singly charged species and allows 
mass spectra to be suitable for large molecules. In ES! mass spectrometry, a sample 
is dissolved in a solvent with low boiling point and passed through a FPLC system to 
be purified. The pure sample comes off the FPLC system and passed through a 
narrow capillary tube at the end of which there is an electric field of about 3.5kV. 
The sample leaves the end of capillary as a mist of charged droplets, and then goes 
into a small evaporation chamber, in which the low boiling solvent flows into the 
atmosphere so that the droplets become smaller and smaller particles, consequently, 
the charge density on the particles increases. Finally, the highly charged particles fly 
into the mass spectrometer to produce mass spectrum. The ES1 technique is a soft 
ionisation method and can maintain non-covalent bond during the ionisation process, 
which make it a potentially powerful technique to analyse the interactions between 
protein targets and drugs. 
A 	 Mass entrance 
I 	1 




Ions in magnetic field of mass spectrometry 
Figure (1) ES!-Mass system 
2. 3 Materials and Methods 
2. 4 Equipment for checking purity 
Electrophoresis system (Bio-Rad) 
Electrospray mass spectrometry system (HP 1 100 series LCJMSD API) 
2. 5 Results of checking CypA purity 
4 	 30K 
CypA ______ 	 4 	 20K 
4 	 14K 
Figure (2) SDS-page electrophoresis of sample after size-exclusion chromatography 
and CypA band is around the 18K. 
The sample after size-exclusion chromatography was mixed with electrophoresis 
sample buffer and heated for 5 minutes at the temperature of 100 °C and then run the 
gel at the voltage of 200V for about 45 minutes (See Appendix for the buffer 
composition and technique details). The SDS-page electrophoresis gel in figure (2) 
shows that the sample after size-exclusion chromatography has two very close bands, 
located at a position slightly below 20kDa. The cyclophilins produced in this lab and 
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M. weight Calcu Mass spec 
CypA 	18012.60 	18012.5 
CypA-Met 	17881.40 17875.78 
Figure (3) Mass spectrum of sample after size-exclusion chromatography. 
(CypA-Met represents the sample without terminal Met residue) 
The sample after size-exclusion chromatography was dissolved in the solvent of 
10mM NH4OAc with pH 6.8, and then injected into the ESI-Mass system. The mass 
spectrum in figure (3) shows that the main part of the sample has the molecular 
weight of 1801 iDa, which is exactly the calculated molecular weight of Human 
CypA. Beside the main peak of 18011, there is a small peak with a molecular weight 
of 17875.78. The molecular weight difference between peak 18011.26 and peak 
17875.28 is 135.22 which is very close to the molecular weight of the amino acid 
Met which has a molecular weight of 131.19 and is the N-terminal residue of human 
CypA, hence it is likely that the N-terminal Met is lost in some CypA molecules. 
3. Protein concentration determination 
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3. 1 Techniques for the determination of protein concentration 
There are several recognised methods for determining the protein concentration of a 
sample. Examples include the Warburg and Christian Method, the Bradford method, 
the Lowry method, the BCA (bicinchoninic acid) method and the absorbance 
coefficient method. 
3. 1. 1 Warburg and Christian method 
The Warburg and Christian method 4 utilises the light absorbance properties of 
tyrosine and tryptophan at 280nm to measure the relative amount of the protein. 
Different proteins have different absorbance scales since different proteins contain 
different amount of tyrosine and tryptophan. The advantage of this method is that it 
can measure the relative amount of protein very quickly and consumes very little 
sample. 
3. 1. 2 Bradford method 
In the Bradford method 5 Coomassie Brilliant Blue G-250 dye binds to the protein, 
forming a complex that absorbs light with the wavelength of 595nm. The advantage 
of the Bradford method is that it is fast and the colour intensity of the complex 
between protein and dye is relatively stable. 
3. 1. 3 Lowry method 
The Lowry method6 used to be a very common method in protein concentration 
determination. The Lowry method involves a biuret reaction between protein and 
Cu2 ions in the basic solution and needs more than one reagent to be added 
sequentially. The colour intensity produced in the Lowry method is measured by 
light at 500nm. 
3. 1.4 BCA method 
BCA7 is a relatively quite new and sensitive method to assay a protein concentration. 
The principle is based on the reaction between Cu' ions and Bicinchoninic acid, 
which produces a purple coloured complex in the solution. Cu' comes from the 
reaction between the protein and Cu 2 in the basic environment. 
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3. 1. 5 Absorbance coefficient method 
The absorbance coefficient method 8 is easy to carry out. Proteins absorb ultraviolet 
light with a wavelength of 275 to 280, due to the presence of the tryptophan, tyrosine 
and phenylalanine residues. The absorbance coefficient can be obtained in two 
different ways; the experimental absorbance value can be used to scale the protein 
concentration, obtained from a standard sample. Another way to get the absorbance 
coefficient is by calculation according to the amino acid content of the protein. 
The formula for the calculation: 
Absorbance coefficient (per molar and per cm) 
Ntrp x 5690 + Ntyr x 1280 + Ncys x 120 
Ntrp: number of tryptophan residues; Ntyr: number of tyrosine residues; Ncys: 
number of cysteine residues. 
Once the absorbance coefficient is known, the protein concentration can be worked 
out by multiplying the absorbance value by the calculated absorbance coefficient of 
the protein. 
3. 2 Material and Methods: 
3.2. 1 Bradford method 
Prepare BSA to the following concentrations (.Lg/m1): 
125, 250, 500, 750, 1000, 1500 
20pJ of each of above standard solutions were mixed well with imi dye reagent 
solution (Pierce Coomassie Protein Assay Reagent) 
Measure the absorbance at 595nm against the blank sample which consists of the 
20Rl sample buffer and imi dye reagent solution 
Plot the concentration of BSA against the absorbance at 595nm 
3. 2. 2 Absorbance coefficient method 
Prepare 20p1 hCypA sample 
Measure the concentration with Bradford method described previously 
Calculate the concentration of the protein 
53 
Take another 800u1 hCypA sample and measure the absorbance at 280nm 
Calculate the absorbance coefficient by absorbance value divided by the 
concentration value from Bradford method 
3.2.3 BCA method 
Mix protein standards (BSA, Pierce)with buffer (Hepes 50mM, pH6.8) to 0.02, 
0.04, 0.06, 0.08, 0.10, 0.12mg/mI. 
Mix protein sample with buffer (Hepes 50mM, pH6.8). 
Mix BCA reagent (available as kit from Pierce). 
Incubate all for 30mins at 37 °C. 
Measure absorbance of protein standards at 562nm, plot standard curve. 
Measure absorbance at 562nm of unknown protein sample. 
Extrapolate concentration of unknown from standard curve. 
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3. 1 2. 2 Theoretical absorbance coefficient 
There is one tryptophan residue, two tyrosine residues, and four cysteine residues in 
the primary structure of hCypA sequence, therefore according to the following 
formula, 
Absorbance coefficient (M'cm') 
= Ntrp x 5690 + Ntyr x 1280 + Ncys x 120 
Then, 
Absorbance coefficient (M'cm') 
= 1 x5690+2x 1280+4x 120=9000 
And the molecular weight of human CypA is 18011, 
Then the calculated absorbance coefficient (mg cm') is 9000/18011 = 0.50 
As for the absorbance coefficient method, the experimental result (0.48) is quite 
close to the calculated result from the sequence (0.5). 
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3. 3. 3 Concentration determined by the BCA method 
Plot protein concentration against 0D562 
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Figure (5) Determination of CypA concentration by BCA 
CypA: A562nm Corrected A562nm mg/mi 
20 times 	diluted 0.232 0.105 0.0920 
10 times 	diluted 0.398 0.177 0.1563 
Control buffer 
20 times diluted 	0.127 
10 times diluted 	0.221 
Therefore, according to BCA method, the concentration of CypA is 
(0.0920x20+0. 1563x10)/2=1 .7015mg/mi 
The longer incubation increases the sensitivity of the assay. The heating time can 
be shorter to prevent the colour from becoming too dark. The assay can be performed 
57 
at room temperature, but there is greater variability among proteins and the assay is 
less sensitive. 
Part B. PPIase activity assays 
1. Introduction 
None of the methods described above give any information regarding protein 
activity. In this project two methods were used to determine the activity of CypA. 
These methods are an enzymatic assay and a fluorescence assay. 
1. 1 Chymotrypsin coupLed PPIase assay 
Peptidyl prolyl cis-trans isomerase (PPIase) or rotamase activity was first reported in 
1984. Cis-trans isomerization has frequently been found to be the rate-limiting step 
in the protein or peptide folding processes. In proteins, the frequency of occurrence 
of the cis proline is affected by the side chain present on the amino acid preceding 
the proline residue. In solution pH and temperature also play a role. As well as this, 
constraints imposed by the whole structure may also be an important factor. 
Generally, the trans conformation is favoured due to the lower energy state. Why 











Figure (6) Chymotrypsin coupled PPIase assay 
M. 
The active site of the isomerization function of CypA is the same as the binding site 
for an inhibitory ligand. Inhibitors compete with the substrate containing a peptidyl-
prolyl bond; therefore inhibitor binding can also be followed by monitoring the 
reduction of the PPIase activity of CypA. 
In this project the PPIase assay was carried out using the chymotrypsin coupled 
PPIase assay method. In the PPIase assay the substrate is the cis conformer of Xaa-
Pro, and converted to trans by CypA. Chymotrypsin hydrolyses exclusively the C-
terminal p-nitroanilide bond of the trans conformer of Xaa-Pro. The hydrolysis 
reaction generates the chromophore 4-nitroaniline whose concentration can be 
measured at an absorbance of 400nm. Therefore according to the amount of the 
product released by the hydrolysis reaction in a certain time interval, the catalysis 
ability or enzymatic activity of CypA can be deduced. Only when the protein is 
stable and can resist degradation from the chymotrypsin, can the method be 
employed. 
2. Material and methods 
2.1 Materials 
Plastic cuvettes, ice, mixer 
Solutions: 
Buffer for dilution of proteins: Hepes : 50mM, PH 8.0 
NaCl: 100mM 
CypA: 2.5 - 30nM 
a-Chymotrypsin in HC1 (10mM): 	6mg/mi 
Suc-Ala-Ala-Pro-Phe-pNA in LiC1IFFE: 	3.7pM 
HC1: 	 10mM 
LiC 1iTFE: 	 470mM 
Equipment: 
Spectrometer (Perkin Elmer, lambda 20) 
2.2 Methods 
1. All reactions take place at 4 T. 
Cuvette is preincubated on ice for 30 minutes. 
840.11 buffer A is added to 30j.tl of 2.5-3OnM CypA to give a volume of 8701.11 in 
cuvette. 
1001.tl chymotrypsin (6mg/mi in 10mM HCI) is added into the cuvette. 
301.tl 3.7mM Suc-Ala-Ala-Pro-Phe-pNA in LiC1/TFE (470nM) is added into the 
cuvette to give a final volume of 1 ml. 
Monitor the reaction in the cuvette by the absorbance change at 400nm. 
3. Results 
in order to analyse the results the following procedure was carried out. 
1. Plot the values of absorbance at 400nm (A400) (amount of product) against 
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Figure (7) PPlase assay at different CypA concentration (0. 2.5nM. 5nM. lOnM, 
15nM), but constant substrate concentration. 
The slope of each curve was measured from the above graph (figure (7)) for each 
reaction (at an A400 value of between 0.75 and 0.78). This is represented graphically 
in Figure (7). In each experiment, the initial concentration of substrate was the same, 
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and in the initial stage of the reactions, the reaction model is of a first order reaction 
which can he represented by the equation y=ax+b, where y is the absorbance, x is the 
time; 'a' is the slope which represents the enzymatic reaction rate. 
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Figure (8) Straight line plots at initial phase for each reaction 
Each line in the graph (8) has been generated by applying the least squares method 
onto the points fitted to the line: the slope of each line represents the enzymatic 
reaction rate at particular enzyme concentrations. Plotting the enzymatic reaction rate 
against the enzyme concentration gives kcatlKm, which represents the activity of 
enzyme. 
Plot the concentration of CypA (nM) against reaction rate. 
PPIase assay of CypA 
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Figure (9) Protein concentration plotted against reaction rate 
Calculation of kcat/Km 
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According to the graphic data: 
V/ [E 0.0019 
And [S ] is 0. IlijiM 
Therefore, 
kcat/Km=O.19 x 109 i 11.1 s M'= 1.7 x 107 s M 1 
Part C. Determining the Kd of ligands using PPIase inhibition 
Introduction 
Once the active site of CypA is occupied by ligand, then CypA will lose its catalytic 
enzymatic function, which is the basis of determining inhibitior Kd values. 
A series of small molecule inhibitors have been examined in this work. In the 
following example the inhibitor EM234 is used to describe the general method. The 
results are described later. 
PPIase method 
2.1 Method principle 
For any enzymatic reactions, the following relationship holds: 
kcat x [S] / Km = V / [E] t  
[S], substrate concentration; [E], total enzyme concentration; V, reaction rate; 
kcatlKm, characteristic constant of specific enzymatic reaction. 
For a specific enzyme, the kcat/Km is a constant, and in the enzymatic activity assay 
of this project, the concentration of substrate was kept the same, 
Therefore, 
V/[E]=kcatx[S]/Km= Constant 
Then, V is linearly proportional to [E], the concentration of active protein in the 
system. Hence, the enzymatic reaction rate in this project can reflect the total activity 
of protein in the enzymatic reaction system. 
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This method used to measure the K d of the ligand is based on the assumption that 
50% of the total enzyme concentration has been bound by ligand when the catalytic 
rate decreases by 50%. 
The mathematic calculation of Kj is as follows: 
P-4-L 4 	11 PL 
[P] = free protein concentration 
[P]b = bound protein concentration 
[L] = free ligand concentration 
[PL] protein ligand complex concentration 
[P] 0 = total protein concentration 
[LI 0 = ligand concentration needed to reach the equilibrium between protein and 
ligand 
[L] b = bound ligand concentration 
IQ=[P]x[L]/[PL] 
when 50% decrease in the reaction rate occurs: 
[P] = [PLI = 1/2 [P] 0 
[L] 0 = [L] b + [U 
[L]b = [P],, = 1/2 [P] 0 
Kd = [P] x [L] / [PL] 
= 1/2 x [P] 0 x ([L]0 - [L]b) / (1/2 x [P]0) 
= [L]o -[L] b 
= [U0 - 1/2 [P] 0 
2.2 Operation procedure 
All reactions take place at 4 °C. 
Cuvettes are preincubatcd on ice for 30 minutes. 
M. 
840il buffer A is added to 30tl of lOnM CypA with different concentration 
of EM234 (a small molecule inhibitor) from Op.M to 90.tM to give a volume 
of 870.tl in cuvette. 
lOOpi chymotrypsin (6mg/mi in 1OmMHCI) is added into the cuvette. 
30p.i 3.7mM Suc-Ala-Ala-Pro-Phe-pNA in LiC1/TFE (470nM) is added into 
the cuvette to give a final volume of I ml. 
Monitor the reaction in the cuvette by the absorbance change at 400nm. 
3. Results 
Plot the values of A400 (amount of product) against the reaction time (seconds). 
PPIseof CypAw$th EM234 
OUM I OLN 
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Figure (10) PPIase assay of the inhibition of EM234 on CypA. Each curve in the 
above graph represents the enzymatic reaction system with the same CypA 
concentration, but different EM234 concentration, as shown in the above figure. 
Plot the reaction rate, which is extracted from figure (10), as described in part B. 
by measuring the initial reaction rate graphically, against the concentration of 
EM234, shown in figure (11). 
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Figure (II) The value of Kd of EM234 determined by PPIase. The EM234 
concentration at which the reaction is inhibited by 50% is the Kd . For EM234 
therefore, the Kd is 22 .tM. 
Ligand 	Structure 	Kd 	Ligand 	Structure 	Kd 
•(p.M) 




70±2 EM4211 EM4 181 	 68±2 
o ,,\ 
EM34821 130±2 EM5123 	 85±2 
EM4 101 20±2 EM4351 45±2 
Y &T1o__ 0 	 o 
0 
Table (1) The binding constants of eight synthesized ligands to hCypA. All the Kd 
values of the ligands are measured using the same method as described for measuring 
the Kd value of ligand EM234. 
Discussion of PPIase assay 
The kcatlKm calculated from an assay of protein activity can only be accurate 
if the concentration of active protein and substrate in solution is precise. For 
this reason, fresh protein should be used to minimise the amount of inactive 
protein in solution, and fresh substrate solution should also be used to 
minimise the amount of trans conformer by adding LiC1iTFE solution. 
After the enzyme CypA has been added to the reaction vessel, the solution 
should quickly be well mixed since poor mixing results in a non- 
homogeneous reaction, causing error. 
The enzymatic reaction rate is a first order reaction only in the initial stage of 
the reaction, therefore the data should be recorded as quickly as possible after 
the reaction starts. 
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As shown in figure (7), the reaction without CypA does not starts from 0 and 
the good reason for that is because the substrate is a mixture of the cis (minor 
amount) and trans (major amount) conformers. 
kcat/Km value (1.7 x 10 7 s M) of CypA obtained in the course of project is 
close to the value published by Liu (1.37 x 10 7 s' M 1 ). 
Part D. Fluorescence assay 
1. Introduction 
1. 1 Tryptophan fluorescence 
The amino acids tryptophan, tyrosine and phenylalanine have intrinsic fluorescence 
properties, and these properties can be used to examine the characteristics of a 
protein. Tryptophan, for instance, excited of 280nm, fluoresces at 340nm, and the 
chromophore of indole is highly sensitive to a polarity change in its local 
environment. Monitoring the fluorescence of a tryptophan residue, therefore, can 
provide information regarding conformational changes of a protein, interactions 
between the protein and other molecules, and the accessibility of the fluorescence 
quencher. 
Tryptophan fluorescence can be examined by monitoring changes in fluorescence 
intensity, wavelength maxima, peak shape, anisotropy, fluorescence lifetime and 
energy transfer. With the development of protein engineering, it has been possible to 
replace selected amino acids in a protein with tryptophan, where this does not 
significantly affect the conformation of the protein, a procedure which has led to 
increased use of tryptophan fluorescence in protein studies. 
At one end of the active site of CypA, there is a tryptophan residue, 'whose 
conformation changes upon the binding of some ligands. This causes a change in 
intensity of fluorescence emission 9 ; therefore tryptophan fluorescence can be used to 
monitor the interactions between the enzyme and ligands, without the need for site-
directed mutagenesis. 
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1.2 Measurement of Kd (dissociation constant) by fluorescence 
The method is based on the assumption that a change in the intensity of fluorescence 
of a protein is proportional to the amount of protein bound by ligand. 
To measure the Kj, the ligand is titrated into the protein. After each addition of 
ligand to a protein solution the fluorescence is measured and the signal provides a 
measure of the concentration of ligand-protein complex. When 50% of the binding 
sites are filled, the fractional fluorescence change is 50% and the protein ligand 
stoichiometry is 1:1. The Kd (dissociation constant) has been estimated by assuming 
a 50% occupancy of the protein at a fractional fluorescence change of 50%. At this 
point the concentration of the bound ligand equals that of the free protein (Husi and 
Zurini 1994). The mathematical basis of calculation is as follows: 
P+L 4 
[P] = free protein concentration 
[P]b = bound protein concentration 
[L] = free ligand concentration 
[PL] = protein ligand complex concentration 
[P]0 = total protein concentration 
[L]0 = ligand concentration needed to reach the equilibrium between protein and 
ligand 
[L]b = bound ligand concentration 
Kd = [P] x [L] / [PL] 
when 50% fluorescence change occurs: 
[P] = [PL] = 1/2 [P]0 
[L] 0 = [L]b +[L] 
[L]b= [P]b = 1/2[P] 0 
Kd = [P] x [L] / [PL] 
= 1/2 x [P]0 x ([L]0 - [Li b) / (1/2 x [P]0) 
= [L]o -[L] b 
= [L]0 - 1/2 [P]0 
In comparison to the PPIase assay, the fluorescence assay is much more convenient 
in terms of operational ease. 
2. Materials and methods: 
2. 1 Materials 
CypA, ligand solution (in 100% ethanol), quartz cuvette, tryptophan solution (Hepes, 
50mM, pH6.8) 
2.2 Equipment 
Perkin Elmer LS50B fluorescence spectrophotometer 
2. 3 Methods 
2. 3. 1 Assay methods for CypA and ligands 
Switch on the temperature control system and adjust to 20 °C. 
Switch on the fluorimeter and set excitation wavelength to 280nm and emission 
wavelength to 340nm. 
Pipette 800pi CypA solution into the quartz cuvette and place cuvette. 
in spectrometer. Once emission intensity stabilises, note reading. 
Add ligand solution into the cuvette containing CypA, mix 
well, then record the reading. 
Repeat step 4 to add more ligand solutions until there is no emission 
intensity change. 
2.3.2 Assay methods for tryptophan control 
Evacuate the cuvette, and rinse with water. 
Pipette 800p1 tryptophan solution, which has the same emission intensity as the 
native protein, into the cuvette. 
Set the excitation wavelength to 280nm, and emission wavelength to 340nm. 
Wait until there is no more change in emission intensity, and record reading. 
Add the ligand solution to the cuvette as before, and record all readings. 
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3. Results 
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Figure (12) Fluorescence titration of CypA against CsA. Excitation wavelength 
280nm, emission wavelength 340, slit width 6. 
Determination of Kd of CsA against CypA by florescence approach. 
As shown in figure (12), intensity at half inhibition is about 490, which corresponds 
to CsA with the concentration of about 2.1 p.M, therefore, according to the following 
equation: 
Kd = [CSA] —½ [CypA] 
The concentration of CypA is 4. 195uM 
Therefore 
Kd=2.l - 1/2x4.195 
= 2.5nM 
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3. Plot the emission intensity against concentration of EM234. Kj Determination of 
EM234 ligand by fluorescence. 
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Figure (13) Fluorescence titration of CypA against ligand EM234. The intensity 
value has been corrected by the tryptophan control experiments. Excitation 
wavelength 280nm, emission wavelength 340, slit width 6. 
4. Determination of Kd of EM234 against CypA by fluorescence approach. 
From figure (13), it is known that at a half change in intensity the concentration 
of ligand EM234 is 2.8 .tM. 




[P]0 = 3.7p.M 
Therefore 
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Kd=2.8- 1/2x 3.75 
= O.92tM 
In this project, eight ligands in four different families, table (1), synthesized by 
Dr. Elizabeth Moir of the Chemistry Department of Edinburgh University, were 
proved to bind hCypA using the method described in this chapter. 
Discussion 
As for the Kd of CsA against CypA, from this project, the value of 2.5nm 
was obtained, and the reported values are the same' ° ' 11 . 
During the procedure, control experiments with tryptophan should always 
be done in order to eliminate the effect of the ligand absorbance of 
fluorescence and the dilution effect of CypA solution caused by the 
successive addition of ligand solution 
For some ligands, no binding signal was detected by the fluorescence 
method. The possible reason is that the ligands are too small to make contact 
with tryptophan so that there is no fluorescence signal change. 
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Chapter five 
Part A. Crystallography 
1. Introduction 
In biology there is a basic and important principle that structure determines function, 
and the function is dictated by the structure, therefore, any basic explanation about 
the function of the biological system will be traced down to the structure of the 
biological system. Protein plays so many important roles in the biological system that 
many scientific methods have been developed to examine that structure. For instance, 
circular dichroism (CD) and Raman spectroscopy can be used to measure the 
secondary structure of the protein molecule. NMR and X-ray crystallography can be 
employed to determine the high resolution 3D structure of the protein molecule; 
electron microscopy and atomic force microscopy can actually visualise the protein 
molecule.The 3D structure of a protein describes what a protein looks like on the 
atomic level, and indicates how a protein may interact with other structures, such as 
drugs and enzyme substrates. X-ray crystallography is regarded as the most effective 
method for measuring the 3D structure of macromolecules. 
1. 1 X-ray crystallography 
The reason why objects can be seen with the naked eye is that they are larger than the 
wavelength of visible light or about the same size. However, atoms have sizes of 
around 0.1 nanometre, far less than the wavelength of visible light, and therefore 
they cannot be 'seen' in visible light. The wavelength of X-ray radiation is of the 
same magnitude as that the of atom, therefore X-rays can be used as the light source 
to 'view' the molecules. 
A typical protein of 165 amino acids contains about 10,000 electrons, which interfere 
with X-rays through the magnetic field generated by the spinning of electrons. The 
X-rays can 'see' only electrons. However, the electrons are assumed to be evenly 
distributed around the nucleus, so that atoms can be located in the centre of the 
electron density. Since there is no X-ray microscopy, the protein molecules cannot be 
seen directly. In practice the computer replaces the function of the lens of the 
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microscope. The computer is used to analyse the X-ray diffraction pattern of protein 
molecules to provide an electron density map.One single protein molecule will 
diffract the X-rays too weakly to be detected above the noise level. A crystal 
however contains a large number of identical protein molecules in related 
orientations, therefore the intensity of the scattered X-rays will add up to a 
measurable level. 
1. 2 Phase problem in X-ray crystallography 
There is a well-known phase problem in X-ray crystallography. The electron density 
of the protein molecule can be represented mathematically by the Fourier transform 
of the structure factor, which consists of two parts: intensity and phase. It is easy to 
measure the intensity experimentally, but it is impossible to measure the phase 
experimentally. In order to get the phase information, several methods such as MIR 
(Multiple Isomorphous replacement), SIR (Single Isomorphous Replacement), SAD 
(Single Anomalous Diffraction) experiments, MAD (Multiwavelenghts Anomalous 
Dispersion), direct method and MR (molecular replacement) have been developed. 
1. 2. 1 Mathematics in the phasing problem 
The measured intensity for a reflection is proportional to the square of the structure 
factor amptitude I FjI 2 
atoms 
F(1) = Ef () exp [27ri (hx(1) + kY () + 1Z() )] 
The Fourier transformation of F(hjJ)  is the electron density P(x,y,z).  The relationship is 
shown in the following formula. 
P(x,y,z) = 1/v F E 1EFexp[-27ri  (hX () + 	+ 1Z (j) )] 
f 	: atomic scattering factor for an atom at the position with the coordinate 
(xi, yj , z) 
(h, k, 1): Miller indices of a reflection. 
IF(,I : the structure factor amplitude of reflection (hkl) 
x, y, z : fractional coordinates in the unit cell of crystal 
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P(x,y,z) 	electron density at the position with the coordinate (x,y,z) 
1.2.2 Obtaining phases by MIR 
Multiple isomorphous replacement (MW) requires the introduction of heavy metal 
atoms into the protein crystal without significantly altering the crystal unit cell and 
space group. Due to the presence of many electrons in heavy atoms, the intensity of 
diffraction is enhanced. 
The first step in MW is to determine the position and occupancy of heavy atoms, 
using the Patterson function: 
P(u v w) = 1/V I i2Iso  (hkl) cos[2it(hu + kv + 1w)] 
Also (hkl) = (IFpHI - IFI) 
(u v w): coordinate in the Patterson cell 
(hld) : Miller index 
FpH 	Structure factor of heavy atom derivative 
Fp Structure factor of native protein 
FH2 : Structure factor of the second heavy atom derivative 
From the Patterson peak P (u v w), the heavy atoms can be located. One heavy atom 
derivative produces two possible protein phase angles with an equal possibility of 
being correct (figure (3)), therefore more than one heavy atom derivative is needed to 
produce the one correct phase angle. 
In figure (3), one circle has the radius with the value of IFpI, and the other circle has 
the radius of IFpH I. The vector between the origins of the two circles is PH. The figure 
(3) shows that there are two intersect points (phase solutions) between the two 
circles. 
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There is the third heavy atom derivative (FH2) information available which is 
represented in figure (4) as the circle with the radius of IF H2 I. Figure (4) shows that 
there is only one point at which all the three circles intersect each other. 
Figure (3) One heavy atom gives two ambiguous phase angles 
Figure (4) More than one heavy atom derivatives give the only phase angle 
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1. 2. 3 Obtaining phases by Molecular Replacement (MR) 
If the new structure (X2) is similar to another, whose structure is known (Xl), then 
molecular replacement (MR) can be a very convenient way to deduce the phase 
angles of the unknown structure. The search model can be used to search through all 
possible orientations and translations to determine a solution for the unknown 
structure. 
X2=[A]xXI +T 
[A] is the rotation matrix, which determines the orientation between the objects Xl 
and X2. T is the translation vector, which determines the relative position between 
the object Xl and X2 and is mainly related to the inter-molecule vectors. 
The aim of molecular replacement is to find solutions for the rotation matrix [A] and 
translation vector [T]. Coordinates obtained from a molecular replacement solution 
can be used as a starting point for structure refinement. 
1. 3 Crystallization 
1. 3. 1 Crystallization theory 
Generally, the crystallization process involves nucleation, growth and cessation of 
growth. Nucleation is the process by which the molecules or non-crystalline 
aggregates pack together to form a repeated lattice. When the size of the lattice 
reaches or exceeds a critical size, defined by the ratio between the aggregate volume 
and the surface area, it is a microcrystal t . After microcrystals are formed, they will 
grow into crystals, provided the concentration of the solute is still in a supersaturated 
state. The growth rate of a crystal is related to two characteristics of the solute, its 
surface properties, and the diffusion rate of solute in the solution' 2 . Cessation of 
crystal growth can be caused by a lower concentration of the solute in the solution, a 
point at which the diffusion rate of molecules onto the crystal surface is equal to the 
diffusion rate of the molecules off the crystal surface. Other reasons for cessation of 
growth include lattice strain effects 3 or damage to crystal lattice by defective 
molecules or impurities which are incorporated into the crystal lattice, thus 
preventing the proper incorporation of other molecules necessary for crystal growth. 
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In the process of crystallization, many factors play important roles so that the process 
becomes unpredictable. In general the properties of the solution and the solute to be 
crystallized are partially controllable. For example, the purity and the concentration 
of the sample, the type and the concentration of precipitants, salts and buffer, and the 
physical environmental conditions of the place where the crystal grows that includes 
the temperature, vibration, magnetic field, etc. 
1. 3. 2 Screening crystallization condition 
Due to the wide range of conditions required for crystal growth, screening of 
crystallisation conditions is usually the first step. 
The design of a crystallization screening experiment generally involves five major 
factors: pH, precipitant, salt, additives and protein concentration. The most widely 
used crystallization technique is the hanging drop method 4 . 
Figure (1) Hanging drop method to crystallize protein. The well solution consists of 
precipitant, buffer and additives. The hanging drop consists of protein solution and 
well solution in the ration of 1:1. 
1. 3. 3 Seeding techniques 
Once preliminary crystallization conditions have been determined a range of 
techniques can be employed to produce crystals that diffract to higher resolution. 
Sometimes crystallization of a protein is not reproducible, and then crystal seeding 5 '6 
is employed. This includes two techniques, streak seeding, and micro seeding. 
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Streak seeding introduces some nuclei into a crystallization drop in order to trigger 
crystallization of protein. The operational procedure is as follows: 
Use a very fine glass needle to gently touch the surface of a crystal so that 
some microcrystals or nuclei attach to the glass. 
Quickly streak the glass needle across a pre-equilibrated crystallization drop 
which contains no crystals. 
Leave the seeded drop for some time, crystal should appear along the streak 
line in the drop. 
Figure (2) Protein crystal growing along the streak after streak seeding. The crystals 
shown in the picture are FKBP12 crystals from this project (described in later 
chapter). 
Microseeding is normally used to enlarge the size of a crystal. in this method, a small 
single crystal is transferred to a completely equilibrated crystallization drop, so that 
protein molecules in the solution may attach to the crystal surface and the crystal will 
grow larger. 
There are many screening kits commercially available for protein crystallization 
some manufacturers are listed here for completeness: Hampton Research, Molecular 
Dimension, Emerald Biostructures, and Jena Bioscience. 
2. Crystallization of CypA 
The hanging drop method was used to crystallize CypA. The initial concentration of 
CypA in the hanging drop is about l8mg/ml, and the temperature is 17 °C. The 
crystal usually appears within 24hours. 
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The crystallization conditions which produced the same form crystals are listed in 
table (1). 
Condition I 











19% - 24% 
0.02% 
100mM 
Table (1) Crystallizations for CypA 
Figure (5) CypA Crystals 
3. Making complex crystals 
3.1 Soaking 
The soaking method 7 is a way of preparing complex crystals of protein and relatively 
small ligands. Ligands may diffuse into the crystal via channels in the crystal lattice 
and bind to protein molecules located in the crystal lattice. Ligands which are larger 
than the channel cannot diffuse into the lattice. In such cases co-crystallisation may 
be an alternative. Most crystal complexes described in this project were prepared by 
the soaking method. 
The soaking procedure used in this project is as follows. 
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1. 	Make a soaking solution exactly the same as the well solution of the native 
CypA crystallization system, but with a high concentration of ligand. 
Transfer the native CypA crystal from the drop to the soaking solution 
Leave the native crystal in the soaking solution for some time: from 
seconds to hours. 
Figure (6) Drop 1 shows the native CypA crystal in the native crystallization drop. 
Drop 2 has the same components as drop 1 except the existence of a high 
concentration of ligand. Drop 3 shows the native CypA crystal being soaked in the 
soaking solution. 
3.2 Co-crystallization 
For bigger ligands, there are two methods for preparing a complex crystal. One is to 
first make a complex of protein and ligand, and then perform the crystallization. The 
other method is to add ligand solution directly to the crystallization drop before 
nucleation, so that the ligand reacts with the protein in the drop and the complex is 
crystallized in the same drop. 
Discussion 
Protein concentration can be an important factor in crystal screening 
experiments. It has been found that CypA could not been crystallized at an 
initial concentration of less than 7mg/mi in this project. 
83 
From the crystallization screening results, it would appear that for 
crystallization of CypA, the buffer pH is related to the concentration of NaC1 
in the sample. CypA crystals have been grown under the following 
conditions: 0mM NaC1—pH8.0, 50mM NaC1—pH8.4, 100mM NaC1—pH8.6. 
CypA has been previously crystallized in the presence of DMSO and it has 
been reported that DMSO is required for the crystallization of CypA (Dr. 
George Kontopidis PhD thesis). DMSO has to be removed from the active 
site before soaking experiments because DMSO binds to and occupies the 
active site of CypA. In order to minimize possible damage to the CypA 
crystal during transfer, DMSO was removed from the crystallization 
solution. In this work it has been found that CypA can be crystallized in the 
absence of DMSO. 
There is an interesting phenomenon in CypA crystallization: After about two 
months from a CypA crystal first appearing in the drops, the crystals start to 
shrink and the surface becomes coarse and eventually all the crystals in the 
drops disappeared completely. The life span of the CypA crystal in this 
project was only about 5 months. 
In this project, ligands were dissolved in the soaking solution to as high a 
concentration as possible, because most ligands used had a low solubility. 
When dealing with ligands of high solubility, ligand concentration in the 
soaking solution should be carefully considered, as sometimes a high ligand 
concentration can cause the crystal to crack 
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Part B. Data collection 
1. Introduction 
The collection of data from a crystal may be regarded as the most important step in 
crystallography and requires great care. If problems occur during other stages (such 
as protein purification, crystal growth and soaking or data processing) they can 
merely be repeated. However valuable machine time, i.e. synchrotron time, has been 
lost, if problems are encountered during data collection. The crystal may also be lost, 
as it may not survive beyond the first round of data collection. Therefore it is always 
worthwhile taking great care to obtain the best possible data from a crystal first time. 
In this project all data was collected either in house or at the synchrotron radiation 
source in Daresbury SRS (synchrotron radiation laboratory). 
1. 1 X-ray source 
X-rays are electromagnetic radiation with a wavelength between 0.1 A and 100 A. 
For crystallographic purposes, X-rays are commonly generated by high speed 
electrons from a cathode hitting static or rotating anode metal which determines the 
characteristic wavelength of the X-ray. In protein crystallography, the X-ray 
wavelength used is around iA. Two types of metals are widely used as anode 
materials to generate X-rays of suitable wavelength. Cu and Mo anodes produce X-
rays of wavelength 1.5418 A and 0.7093 A respectively. The synchrotron radiation 
facility produces X-rays in a different way. The in-house X-ray generator is an 
FR57 1 (Enraf Nonius) and has a rotating Cu anode and produces X-rays at 1.5418 A. 
The rotating anode helps to dissipate heat. If the high speed electrons from the 
cathode always hit the anode in the same area, the heat will eventually melt the 
anode. The synchrotron radiation facility consists of three main parts: a linear 
accelerator, a booster and a storage ring. Electrons are produced and initially 
accelerated in the linear accelerator, then injected into the booster and accelerated to 
the operating energy. Finally the electrons are injected into the storage ring, which 
maintains the electrons at operating energy. 
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1.2 X-ray detector 
The detector is a key component in data collection. In order to get complete and 
accurate data, apart from the quality of the crystal and intensity of the beam, the 
detector should be sensitive, have wide dynamic range and good linear response of 
intensity. 
The most commonly used detector is the area detector which has some advantages as 
follows: 
Simultaneously recording many reflections 
Data collection time independent of the structure size 
Not necessary to know the cell dimension before data collection 
High redundancy data possible 
Wide dynamic range 
Image plates and CCD detectors are the most often used detectors. Image plates 8 
store images using phosphor, in the form of trapped electron colour-centres. These 
colour-centres can then be read-out by stimulation with laser, making them emit their 
own characteristic light. After being read-out, the image plate is erased by laser 
before another image is taken. The main disadvantage of image plate is that the read-
out process takes several minutes rather than seconds. This disadvantage can be 
compensated for by using two image plates at the same time, one for exposure and 
another for reading-out. The in-house image plate used in this work is a MAR345. 
The CCD is a kind of semiconductor in which incident radiation causes electron-hole 
pairs. Electrons are trapped in the potential wells and then read out as current. The 
main advantage of CCD is the very fast read-out which takes seconds or fractions of 
second. At the synchrotron facility at Daresbury the detector is an ADSC CCD. 
1.3 Crystal handling 
Crystal freezing and mounting 
The reason for collecting data at low temperature is to minimise radiation damage to 
the crystal 9. Normally lOOK is the temperature used. Crystals are usually soaked in a 
suitable cryoprotectant, such as PEG, glycerol, MPD and oil, which help prevent the 
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formation of ice crystals. In this project the cryprotectant was made up from a 
mixture of glycerol and mother liquor, oil (Polymers in oil, Exxon Chemical Ltd.) 
was also found to work well. 
The composition of the cryoprotectant was determined experimentally: an empty 
mounting ioop was simply dipped into the cryoprotectant solution and flash frozen, 
then exposed to X-rays. The lowest concentration of glycerol which does not produce 
ice rings on the diffraction pattern was chosen. The crystal was frozen by flash-
freezing and stored in liquid nitrogen or surrounded by the lOOK gaseous nitrogen 
during the data collection. In this work the composition of cryprotectant normally 
consists of crystallization mother liquor and glycerol. The concentration of glycerol 
was obtained by 'trial and error' and found to be between 18% and 22%. 
Fish and transfer crystals 
Before opening the well to fish out the crystal, a loop (Hampton Research) with 
suitable size should be chosen according to the size of the crystal to be picked up. 
Generally, the radius of the loop should be slightly larger than the longest dimension 
of the chosen crystal so that the crystal can sit in the centre of loop. 
Annealing crystals 
Annealing is a method that thaws the frozen crystal and flash freezes it again. 
Sometimes a crystal does not diffract well and produces poorly shaped or otherwise 
irregular spots, overlapping spots or streaks. This may be due to the unsuitable 
cryoprotectant or radiation damage, etc. An often used trick is to anneal the damaged 
crystal. There are two way to do annealing. One is to take the crystal off from the 
goniometer, thaw the crystal and refreeze with cryoprotectant. The other way to do 
annealing is to anneal the crystal on line. In this approach, the cryostream is blocked 
for some time (1 second to 10 seconds) and then released again. Once again the 
crystal goes through a thaw/freeze cycle; however this might have to be repeated 
several times. 
1.4 Data collection and data reduction 
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There are several variable parameters in data collection such as crystalldetector 
distance, oscillation angle for each frame, exposure time for each frame, number of 
frames to be collected and the position of the backstop. 
Once the raw data has been obtained, it is reduced to an 'hkl file' which can be 
recognised by structure determination and refinement programmes. The diffraction 
pattern on each frame may contain symmetry related equivalent reflections, being 
measured more than once. The X-ray beam intensity may also vary from frame to 
frame. All reflections should therefore be accurately scaled together. Two commonly 
used programmes in data reduction are DENZO' ° and MOSFLM". 
In this project all raw data was processed using DENZO. 
DENZO: 
Program DENZO includes 3 components: 
.XDISPLAY - Image display and measurement 
.DENZO - Auto-indexing, refinement and integration 
.SCALEPACK - Data scaling 
.XDISPLAY - Image display and measurement: 
Display the image and visually check the image to make sure there are no unusual 
features on the image, also the highest resolution can be estimated by visually 
checking the image. 
.DENZO - Auto-indexing, refinement and integration 
Using the 'peak search' button incorporated in the display interface, choose a number 
of reflections from the image and manually discard any which appear suspicious 
(such as reflections around ice-rings, and those which are not harmonious with the 
diffraction pattern as a whole) 
The output from auto-indexing is a table containing a list of 14 Bravais lattices and 
possible unit cells, as well as a penalty score indicating the goodness of fit for the 
unit cell. The lattice with highest symmetry and lowest penalty score is regarded as 
the most likely solution for the diffraction pattern. 
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After auto-indexing, all the values obtained for the parameters are used in the 
refinement and integration processes. The values from the auto-indexing need to be 
refined to convergence so that the programme can predict accurately the positions of 
the reflections. Before processing all the frames, the appropriate estimated mosaicity 
value should be input. Most of the spots on the image should be covered by the 
predictions. Denzo will integrate intensity of spots which do not overlap with 
neighbouring spots covered by the predictions. The final output from this stage is a 
list of unscaled intensity values for each indexed reflection, along with the intensity 
standard deviation. The final steps in data reduction are to scale all the reflections 
together and to merge all the symmetry-related reflections together, to produce the 
unique reflection list and intensity file (HKL file). 
After each iteration of scaling, the chi square (x2) test is applied to check the 
accuracy of statistics. x2  should be close to 1, if not, then the estimated errors in the 
command files are adjusted, and the Scalepack program is re-mn to scale and merge 
the reflections again until the value of X2  is close to 1. In the output file, some 
important parameters should be carefully checked. 
2. Results 
Datasets of nine complexes of CypA with different ligands are included in this thesis 
and summarised in the following table (1). 
1. Mosaicity 
Scalepack can refine the mosaicity of the crystal, if the mosaicity value obtained 
from the scalepack is quite different from the value given to the programme during 
the refinement and integration step, then the new mosaicity value should be entered 
into the command file for refinement and integration process. All the frames should 
then be re-processed using the new mosaicity value, and the mosaicity values of all 





Effort should always be invested in order to get as complete a data set as possible. 
The minimum completeness for structure determination is generally regarded as 
about 80%. Incomplete data may result for three reasons, either the rotation angle of 
the crystal is too small for all reflections to be recorded by the detector, or too many 
reflections have been rejected during data processing because of overlapping 
integration boxes on the image or unusually the crystal is aligned along a cell edge so 
that the reflections in the 'blind area' will never be recorded no matter how many 
degrees of data are collected. II the completeness of data is less than 90%, rejected 
reflections should be carefully examined, and the coincidence between predictions 
and spots on the image during data integration is checked. The overall completeness 
values of the nine datasets are in the range from 64.5% to 98.9% and the range from 
35.0% to 100% for the last shell completeness, table (1). 
Figure (1) Crystal diffraction Ewald sphere construction. The Ewald sphere radius is 
iiA (k is the X-ray wavelength), the crystal sits in the centre of the Ewald sphere. 
When the reciprocal lattice rotates about a symmetry axis, then the lattice inside the 
blind area will never intersect the Ewald sphere. 
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Rmerge : 
Rmerge = jhkIli I Ii(hkl) -<I(hkl)>I / IhMEJOW 
I: intensity 
<I(hk)>: average intensity of symmetry related reflections 
Bad data results in a high value for Rmerge, however, highly redundant data or data 
from a high symmetry space group also tends to produce a higher value for Rmerge . A 
shell with an Rmerge of over 30% may be thrown away by some, but others think all 
the reflection even those with high Rmerge will do no harm to the structure refinement. 
For the whole data set, data with an Rmerge of less than 5% is regarded as good data, 
between 5%-10% is acceptable, but data with an Rmerge greater than 10% should be 
treated with caution. The overall Rmerge values of the nine datasets are from 4.2% to 
18% and most values are around 8.0%. For the last shells the Rmerge values are from 
13.6% to 3 1.5%. 
Percentage of <I /a(I)>: 
Dauter(1997) 12 suggested that as a rule of thumb, the highest resolution data should 
have more than 50% of data with <I / a (I)> greater than 2, however it is regarded 
that the inclusion of all the data in the structure refinement does not do any harm. 
The overall values of <I / a (1)> of the nine datasets are from 5.1 to 22.9 and the 
range of 2.2 to 4.5 for the last shells. 
Value of Chi square 
The value of Chi square should be close to 1, if not, change the estimated errors in the 
command file, and scale all the data again until all the final values for Chi square 
approaches 1. 
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Ligands resolution (A) 	X-ray source detector completeness(%) mosaicity Rm ge(%) <1/0(1)> Cell dimensions (A) Number of reflections 
a, b.c 
EM234 1.9 SRS CCD 97.4(99.2) 0.85 6.6(28.2) 6.8(4.4) 41.6,51.8,87.9 15569 
EM4181 1.8 home IP 64.5(35.0) 0.75 6.4(17.6) 13.8(4.5) 42.6, 53.0,88.3 11698 
EM34821 2.9 home IP 93.3(95.5) 1.62 18(31.5) 5.1(2.9) 41.1, 51.8, 88.0 4942 
EM4331 2.1 SRS CCD 91.6(92.6) 0.9 8.2(31.3) 11.2(3.8) 43.0, 54.3, 88.9 11039 
EM4101 2.5 home IP 94.4(92.9) 1.45 10.2(21.9) 10.2(4.4) 42.4, 52.5, 88.7 7211 
EM9 2.2 SRS CCD 91.1(66.9) 0.8 6.3(15.5) 14.1(4.0) 42.6, 53.3, 89.7 9419 
EM4351 1.9 SRS CCD 84.1(84.1) 2.5 8.9(22.2) 9.6(4.1) 42.2,53.1, 89.2 12993 
EM5123 2.0 SRS CCD 82.6(38.4) 0.9 4.2(13.6) 22.9(2.9) 42.9,53.6, 88.9 10843 
EM4211 2.1 home IP 92.3(100) 1.3 9.1(33.4) 8.8(2.2) 42.4, 52.9, 88.3 9952 
FKBP_LP 2.2 home IP 98.8(99.4) 1.2 6.9(29) 7.9(1.8) 102.6, 35.9, 54.5 9046 
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Chapter six 
Crystal structure determination of native CypA structure at lOOK 
1.1 The structure of native hCypA 
The native crystal structure of CypA and over ten crystal structures of CypA 
complexed with different peptide ligands have been published' 5 . The overall 3D 
structure of CypA consists of 8 n-sheet strands with two a helices sitting on the two 
ends of the a-barrel, shown in figure (1). The active site for isomerization or ligand 
binding is a cleft on the CypA surface surrounded by 3 short 3-sheet strands and part 
of ioops consisting of amino acids from number 67 to 76. Around the active site, a 
number of residues which are represented by ball-stick model in Figure (1) are 
involved in the interaction between the protein and substrate or ligands. These 
residues are Arg55, 11e57, Phe60, Met6l, G1n63, Asn7l, G1y72, Thr73, Ala101, 
AsnlO2, Ginill, Phell3, Trpl2l, Leu122 and His126 6 . 
1.2 Low temperature effects on protein crystal structures 
Nowadays a low temperature data collection strategy is widely used since the low 
temperature protects crystals from radiation damage and increases the lifespan of the 
crystals as described in data collection chapter. However the low temperature also has 
some other effects on protein crystal structures. Tilton et. al. 7 reported that low 
temperature can make protein shrink so that the surface area of the protein decreases 
and they showed that the volume change of protein molecule was linearly 
proportional to the change of temperature from 98K to 320K by the coefficient of 
0.4% per lOOK. Temperature factors of protein molecules and the mosaic spread of 
protein crystals were also observed to decrease with decreasing temperature 8 . An 
interesting effect of low temperature on protein crystal structures is the water structure 
changes around protein molecules. Experiments showed that more water molecules 
can be identified in the low temperature 120K trypsin crystal structure than the room 
temperature 295K trypsin crystal structure 9. Nakasako 10 reported that the number of 
hydration water molecules around bovine beta-trypsin at low temperature lOOK is 1.5 
to two times of the number of hydration water molecules of bovine beta-trypsin at 
room temperature 293 K. 
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In this work the structure of native hCypA has been re-determined and re-refined at 
the low temperature lOOK in order to facilitate comparison with the series of 
CypA/ligand structures also solved at lOOK. 
Trpl2l 
Figure( 1) CypA overall structure and the residues around the active site. Arg55, 11e57, 
Phe60, Met6l, G1n63, Asn7l, G1y72, Thr73, Ala101, Asn 102, GIn! 11, Phel 13, 
Trpl2l, Leu122 and His126. 
2. Materials and methods 
Native CypA crystals were obtained as described in chapter five. A crystal was flash 
frozen using liquid nitrogen and cryoprotected by 20% glycerol plus crystallization 
mother liquor. Data collection was carried out in house at lOOK using a gaseous 
nitrogen stream. Data reduction was done using program DENZO and the native 
structure was solved by molecular replacement using the program MOLREP and 
refined using the program REFMAC. When the refinement of protein structure had 
converged (R t' rec did not decrease), water molecules were located by calculating the 
Fo-Fc difference Fourier map and were picked up by using ARP/WARP. The cy level 
for adding water molecules is over 3 a. The distances between waler molecules and 
protein atoms are in the range 2.2 A to 4 A. The refinement ended when Riiee  did not 
decrease. The electron density maps were converted and re-scaled in order to be 
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viewed with program WITNOTP' 2. Fo-Fc map are drawn with a contour level of 
around 2, and 2Fo-Fc with a level of around 1 .2cy. 
3. Results 
3.1 Summary of CypA crystal dataset 







Space group P2 1 2 1 2 1 
Resolution (A) 2.2 
Rmerge (%) 7.4(23.7) 
15.0(4.7) 
Overall completeness (%) 97.8(99.8) 
Unique reflections 13516 
Total No. of reflections 209448 
R factor (%) (5% data are used in calculation) 20.0 
Free R factor (%) 24.7 
Mosaicity (°) 1.25 
No. of water molecules 125 
Ramachandran plot, most favored (disallowed) (%) 86.5(0) 
B factor (protein average) (A) 35.9 
B factor (water average) (A2) 44.7 
Bond length RMS (A) 0.012 
Bond angle RMS (°) 1.518 
Table (1) hCypA data and refinement parameters 
3.2 Water structure in the active site of CypA 
me 
The water molecules positions around the active site of CypA are well determined, 
and are presented in figure(2) and figure (3). 
Figure(2) water IIIOICCLIICS around the active site ol CypA. Red halls represent water 
molecules, the green electron density of 2Fo-Fc contoured around the active site. The 
same structure (900  rotation) is shown in figure (3) but with labels and without 
electron density. 
LLV.74 


















Figure (3) Interactions between water molecules and protein or water molecules. Red 
balls represent water molecules, nitrogen atom on CypA is coloured in blue. oxygen 
atom in red, and green number indicates the distance between atoms. 
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All the water molecules form direct or indirect contacts with protein atoms. Some 
water molecules are bound tightly to CypA through strong hydrogen bonding 
interactions. For example, HOH_50 forms a hydrogen bond with Arg55 and the 
distance is 2.73A; HOH_16 interacts with Trp_121 through a hydrogen bond of 
2.83A. All the interactions between water molecules and the active site of CypA or 
water molecules are listed in table (1). 
CypA Water Water B factor (Az) Distance (A) 
Ser_ll0/N HOH_4 27.99 3.17 
Giy_74/0 HOH_4 27.99 3.01 
Gin_ill/N HOH_4 27.99 3.40 
Gin_i/O HOH_7 29.07 2.85 
Gln_i 1 1/N HOH_7 29.07 3.26 
Gly_109/N HOH_7 29.07 2.96 
Ala_101/0 HOH_7 29.07 2.69 
Gly_72/0 HOH_53 43.53 2.93 
His_54/N HOH_28 36.66 2.84 
Arg_551NH1 HOH_50 46.19 3.37 
Arg_55/NH2 HOH_50 46.19 2.73 
Arg_551NH1 HOH_1 12 52.87 3.29 
Trp_121/NH HOH_16 29.84 2.83 
Asn_102/0131 HOH_70 44.26 2.64 
Asn_102/0 HOH_70 44.26 3.18 
Asn_102/0 HOH_6 37.26 3.38 
Asn 102/N HOH 6 37.26 3.18 
Table (1) Distance between water molecules and CypA around the active site. 
Water 	B factor (A) Water 	B factor (A2) 	Distance (A) 
HOH_51 36.69 HOH_112 52.87 3.22 
HOH_51 36.69 HOH_16 29.84 2.78 
HOH_92 42.37 HOH_6 37.26 3.12 
HOH_92 42.37 HOH_112 52.87 3.16 
HOH_15 35.08 HOH_6 37.26 2.26 
HOH_20 41.73 HOH_6 37.26 2.91 
HOH_73 50.91 HOH_28 36.66 2.68 
Table (2) Distance between water molecules and water molecules around the active 
site of CypA. 
The active site of CypA is filled with water molecules in the native CypA structure. 
These water molecules form an interaction network. When a ligand binds to the active 
site, some water molecules around the active site, especially those that have no direct 
contacts with CypA will be replaced. Some water molecules, especially those which 
have direct contacts with CypA will remain and bridge the interactions between 
ligand and CypA. Some water molecules are considered to be of catalytic 
importance 3 . 
3. 3 The effects of flash freezing on the water structure of hCypA 
The hCypA structure from human T cell was solved at a resolution 1 .63A at room 
temperature 7 . In this project hCypA structure expressed in E. coli was solved at a 
resolution of 2.2A at lOOK. The two hCypA structures are superimposed (figure (4)) 
to give an R.M.S.D. of 0.218A for main chain atoms. No significant side chain 
movements of the residues around the active site were observed. 
Figure (4) Structure superposition of hCypA at 1 .63A (green) and 2.2A (multicolour). 
The water structure around the active site comparison between the two hCypA 
structures show that most water molecules appear in both structures without 
movements, HUH 4, HOH 6, HOH 7, HUH 16, HUH 20, HUH 28. HUH 50, 
HOH_53. HUH_70, figure (5). However, four water molecules are in the low 
temperature lOOK structure, but not in the room temperature structure; namely 
HOH_15, HOH_51, HUH_92. HUH_I 12 (table(3)); another four water molecules 
appear in room temperature structure, but not in the low temperature lOOK structure; 
HUH_204, HOH_205, HOH_229. HOH_282 (table (4)). The distance between 
HUH_I 12 (B factor. 52.87) and HOl-1_205 (B factor, 59.55) is 2.2k therefore it 
might be regarded that HUH_i 12 and l-IOH_205 are actually the same water molecule 
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Figure (5) Water structure comparison between the two hCypA structures. Yellow 
balls represent the water molecules in the active site of room temperature structure. 
Red ones are from low temperature lOOK structure. 
water HOH_15 HOH_51 HOH_92 HOH_l 12 
B factor (A 2 ) 35.08 36.69 42.37 52.87 
Table (3) Water molecules present in low temperature (lOOK) structure, but absent in 
room temperature structure 
/ 	 \ 
4' 
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Water 	HOH_204 HOH_205 W-229 	HOH_282 
Bfactor(ki 43.13 	59.55 
	
55.40 	66.87 
Table (4) Water molecules present in room temperature structure, but absent in low 
temperature (100K) structure 
4. Summary and discussion 
The main chain structure of hCypA does not change significantly no matter whether 
the diffraction data were collected at low temperature lOOK or at room temperature. 
The r.m.s.fit is 0.21 8A for the superposition of backbone atoms of the room 
temperature structure and the low temperature (lOOK) structure. 
The cell dimensions of the low temperature lOOK crystal are 42.1 A, 52.7 A and 88.5 
A for a, b and c respectively, which give a cell volume of 196352.3 A3 . The cell 
dimensions of the room temperature crystal are 43.0 A, 52.60 A and 89.20 A for a, b 
and c respectively7 , which give a cell volume of 201752.7 A 3. The volume of the unit 
cell of the low temperature lOOK structure is 5400.3 A 3 smaller than the volume of the 
unit cell at room temperature. If the room temperature is assumed to be 289K (the 
publication7 did not mention the value of room temperature), the cell volume decrease 
is 1.5% per lOOK, which is 3.75 times greater than for the ribonuclease-A study' 1 . 
The water molecule arrangements in the active site changed when temperature 
decreased from room temperature to lOOK, although the number of water molecules 
in the room temperature (119 water molecules) is almost the same as the number of 
water molecules in the low temperature lOOK structure (125 water molecules). 
Compared with the room temperature structure, the low temperature lOOK structure 
shows 4 extra water molecules at the active site of hCypA which includes 3 tightly 
and 1 loosely bound water molecules in terms of their B factors (HOH_15, B factor 
35.08A 2 ; HOH_51, B factor 36.69A2; HOH_92, B factor 42.37A 2 ; HOH_1 12, B 
factor 52.87A 2). These four water molecules form a hydrogen bonding network. 
HOH_15 has hydrogen bonds with Gln_63; HOH_l 12 makes a hydrogen bond with 
Arg.55; HOH_51 was connected to Trp_121 through water bridge HOH_16 and 
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HOH_92 makes hydrogen bonds with HOH_1 12 and HOH6 which makes a 
hydrogen bond with Asnj02. 
On the other hand three loosely bound water molecules present at the active site of 
hCypA at room temperature disappeared in low temperature lOOK structure, see table 
(4). The disappearance of water molecules in the low temperature structure was 
possibly a result of the lower resolution of the low temperature lOOK structure. 
The conclusions from this work about the effects of low temperature on protein 
crystal structure are listed as follows: 
Low temperature does not significantly affect the protein structure. 
Low temperature may have significant effects on the number and position of 
bound water molecules in protein structure. 
Low temperature reduces the cell volume of protein crystals. 
The lOOK structure presented here is used for comparison with the subsequent CypA-
ligand complexes presented in this thesis. 
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Chapter seven 
Complex structures of CypA with family_A ligands 
1. Introduction 
There are a number of complex crystal structures of CypA with peptides published, 
as described in chapter one, but to date, there is no published complex crystal 
structure of CypA with a non-peptide ligand. However non-peptide ligands may have 
more medicinal relevance than peptide ligands. For example, non-peptide ligands can 
have low molecular weights and can be designed to have a number of chemical 
properties that may give them a better pharmacokinetic profile. Also non-peptide 
ligands are normally not digested by enzymes. It will therefore be of interest to 
design a family of non-peptide ligands and look at their interactions with CypA. 
In this project the nine ligands described in chapter three are divided into four 
different families in terms of their chemical and structural similarity, scheme (1). The 
structural description of the complexes, therefore, correspondingly consists of four 
chapters. In each chapter the crystallographic parameters are listed. For each 
structure the first difference map without ligands and the last difference map with 
ligands are shown; the water molecule arrangements and changes of the side chain 
conformation for residues at the active site are described upon the binding of ligands. 
Finally, the binding mode of each ligand family is presented schematically. 
In this chapter, the complex structures of CypA with family_A ligands that are 
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2. Method 
Crystallization, complex preparation, data collection and data reduction were 
described in chapter five. All the complex structures in this project were solved by 
molecular replacement, with subsequent refinement by REFMAC'. The original 
model for all molecular replacement solutions was the native structure which was 
solved at a resolution of 2.OA with data collected at lOOK. This native structure has 
been described previously in chapter six. Water molecules were located by using Fo-
Fc Fourier map and placed using the programme ARP/WARP 2 . The CF level for 
adding water molecules is 3. Once most of the water molecules had been added 
into the active site and the refinement converged (R& e did not decrease), the water 
molecules at the active site were removed and the structure was refined again to 
produce a Fo-Fc Fourier omit map to locate binding ligand. The models of ligands 
were then built and energetically minimized using program WITNOTP 4 . The 
stereochemistry restraints of ligands were produced by using program SKETCH in 
CCP4 suits. The minimized ligands with stereochemistry restraints were modelled 
into the difference electron density map and refined together with CypA. The 
electron density maps were converted and re-scaled in order to be viewed with 
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program WITNOTP. All the structural and electron density diagrams were made 
using W1TNOTP. 
3. Results 
3. 1 Family_A ligands and crystallographic parameters of complex structures 
of CypA with family_A ligands 
All three ligands of family_A are derivatives of the structure X00,  and are 
synthesized through a DCC (1 ,3-dicyclohexylcarbodiimide )IDMAP(4 - 
dimethylaminopyridine) activated O-acylation. Scheme (2) shows the synthesis of 
ligand EM234 and ligand EM3482 1. The chemical structures of the family_A 















The synthesis reaction of ligand EM234 shows that it is possible in principle to 
attach any of the 20 amino acids with different protecting groups, to the dimedone 
template to produce novel ligands. Ligand EM234 is the dimedone derivative of a 








Table (1) Family_A ligands. 
The crystallographic parameters of the complex structures of CypA with family_A 
ligands are listed in tables (2), (3) and (4). 
Ligand 	Rfactor(%) R f (%) 	Resolution Water 	Bond length Angle 
(A) 	molecules 	r.m.s. (A) 	r.m.s.(°) 
EM234 18.2 22.6 1.85 250 0.015 1.6 
EM34821 21.8 28.4 2.7 61 0.02 2.2 
EM4181 19.8 26.0 1.8 243 0.011 1.5 
Table (2) Crystallographic parameters of complex structures of CypA with family_A 
ligands. 
Ligand 	 temperature factor(Ah) 
protein 	ligand 	solvent 
EM234 	24.7 	57.7 	43.7 
EM34821 49.6 	64.2 	51.4 
EM 4181 	25.7 	57.8 	40.7 
Table (3) Average temperature factors of complex structures of CypA with family_A 
ligands. 
Ramanchadran plot 
Ligand Favoured (%) Additional General (%) Disallowed 
(%) (%) 
EM234 86.5 12.8 0.8 0 
EM34821 77.4 21.8 0.8 0 
EM4181 85.7 14.7 0 0 
Table (4) Stereochemical quality of Complex structures of CypA with family_A 
ligands 
3.1.1 Complex structure of CypA with EM234 
The complex structure CypA/EM234 was refined and the difference maps were made 
as described previously in the methods section. In figure (1) a continuous density 
clearly appears in the active site of CypA, however, around the protein chain, little 
electron density is visible. Therefore, the bulk of the residual electron density in that 
map could be interpreted as bound ligand EM234. Figure (2) shows the final ligand 
nindcl hound to Cvp:\. 
Figure (1) The trst Fo-Fc map around active site. The electron density map was 
calculated using only protein coordinates without the inclusion of ligand EM234. 
The shape of the electron density is like the shape of ligand EM234. 
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Figure (2) The final 2Fo-Fc electron density map around ligand. The electron density 
map was calculated after water molecules and ligand EM234 were placed into the 
electron density shown in figure (1) and refined together with protein. 
The final model is shown in figure (2) and the interactions between ligand EM234 
and CypA were analysed using the program LIGPLOT 3 . as is shown in the tables (5), 
(6) and figure (3). 
Donor Acceptor Distance (A) 
lOU 379 0 EM234 166 028 2.51 
HOH 309 0 EM234 166 09 2.73 
GLN 63 NE2 EM234 166 019 2.70 
HIS 54 NE2 EM234 166 019 3.33 
Table (5) Hydrogen bonding interactions between ligand EM234 and protein and 
water molecules. 
Atom 1 	 Atom 2 	 Distance (A) 
EM234 166 C6 HIS 126 CEI 3.83 
EM234 166 C7 LEU 122 CD1 3.52 
EM234 166 C7 PHE 113 CD2 3.38 
EM234 166 C7 PHE 113 CE2 3.27 
EM234 166 C7 PHE 113 CZ 3.26 
EM234 166 C7 PHIE 113 CE1 3.34 
EM234 166 C6 P1-lIE 113 CD1 3.79 
EM234 166 C7 PHIE 113 CD1 3.43 
EM234 166 C7 PHE 113 CG 3.47 
EM234 166 C17 ASN 102 C 3.65 
EM234 166 C15 ASN 102 C 3.72 
EM234 166 C17 ASN 102 CA 3.67 
EM234 166 C17 ALA 101 C 3.70 
EM234 166 C17 ALA 101 CB 3.52 
EM234 166 C6 ALA 101 CB 3.79 
EM234 166 C24 THR 73 CG2 3.72 
EM234 166 C23 THR 73 CG2 3.52 
EM234 166 C21 GLY 72 C 3.87 
EM234 166 C21 GLY 72 CA 3.85 
EM234 166 Cli GLN 63 CD 3.74 
EM234 166 C8 MET 61 CE 3.72 
EM234 166 C8 MET 61 SD 3.40 
EM234 166 C8 MET 61 CG 3.81 
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Figure (3) Interactions between ligand EM234 and CypA with water molecules. 
The ligand makes a number of hydrogen bonds with CypA and water molecules. 
Around the CypA active site, the residues, His_54, GIn_63, are involved in hydrogen 
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bonding contacts with the ligand. Leu_122, Ala_101, Met_61, Phe_1 13, Asn_102, 
His_126, Thr_73 and Gly_72 make hydrophobic interactions with ligand EM234, 
figure (3). 
The comparison of the active sites between the native CypA and the complex 
CypAIEM234 (figure (4)) shows that some water molecules around the active site 
keep the same position, HOH_4, HOH_16, HOH_50, HOH 67, HOH_70, HOH_92, 
HOH_98 and HOH_1 12. Eight water molecules were displaced by the bound ligand 
EM234, namely HOH_6, HOH_15, HOH_20, HOH_28, HOH_51, HOH_53, 
HOH_73 and HOH_1 12. Three new water molecules were introduced into the active 
site by forming hydrogen bonds with ligand EM234. It appears that HOH_ 112 in the 
native structure moves to adopt the position of HOH_379 in the CypAIEM234 
complex structure. 
The conformation of the side chains around the active site have been monitored and 
compared to those of native CypA structure. The r.m.s. fit of the main chain atoms 
between native CypA structure and complex CypAIEM234 is 0.178A. In the native 
CypA structure the 7  (CE-SD-CG-CB) torsion angle of Met_61 is 115.50 . In the 
complex CypAJEM234 structure, the y  (CE-SD-CG-CB) torsion angle of Met_61 is 
-137.3 °. The NH 1 atom of Arg_55 in the complex structure of CypAIEM234 moves 
0.869A compared with the NH 1 atom position of Arg_55 in native CypA structure. In 
the complex CypAIEM234, Gln_63 and His_54 have hydrogen bonding interactions 
with ligand EM234. Compared with the atoms position in the native CypA structure, 
the NE2 atom of Gln_63 moves 0.364A and NE 2 atom of His_54 moves 0.277A. 
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Figure (4) Active site structure cotliparison hetween native C pA structure and 
CypAIEM234 complex structure. Red balls represent water molecules in the native 
structure, and green for new water molecules in the complex CypAIEM234 structure. 
The distance values showed in the figure are hydrogen bond distances between water 
molecules and ligand EM234. 
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3.1.2 Complex structure of CypA with EM4181 
In figure (5), around the active site of CypA. there is a region of continuous electron 
density, whilst around the chain of CypA, there is little electron density. Therefore, 
the continuous electron density around active site of CypA clearly indicates the 
presence of bound ligand EM4 181. Figure (5) shows the final model of ligand 
EM4181 bound to CypA. 
Figure (5) The initial Fo-Fc map contoured around the active site ol Cvp:\. The 
electron density map was calculated before ligand EM4 181 was included in the 
model. The electron density distribution around the active site of protein is clear and 
the continuous electron density at the active site convincingly indicates the binding 
of ligand EM4181. 
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Figure (6) The final .1u-Fc electron densn) map contoured around the active site of 
CypA and ligand EM4 181. The electron density map was calculated using the full 
model including protein, water molecules and ligand EM4 181. 
The final model is shown in figure (6) and the interactions between ligand EM4181 
and CypA are analysed using program LIGPLOT, which is shown in the following 
tables (7). (8) and figure (7). 
Donor 	 Acceptor 	Distance (A) 
HUH 383 0 EM4181 166 019 3.31 
HUH 379 0 EM4181 166 019 3.06 
HUH 379 0 EM4181 166 012 2.55 
H0H 396 0 EM4 181 166 09 3.08 
HUH 309 0 EM4181 166 09 3.25 
GLN 63 NE2 EM4181 166 020 2.87 
Table (7) Hydrogen bonding interactions between ligand EM4181 and CypA with 
water molecules. 
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Atom 1 	 Atom 2 	 Distance (A) 
EM4181 166 C7 
EM4181 166 C7 
EM4181 166 C7 
EM4181 166 C8 
EM4181 166 C8 
EM4181 166 C8 
EM4181 166 C8 
EM4181 166 C8 
EM4181 166 C8 
EM4181 166 C15 
EM4181 166 C14 
EM4181 166 C6 
EM4181 166 C18 
EM4181 166 C21 
EM4181 166 C21 
HIS 126 CE! 
LEU 122 CD2 
LEU 122 CD1 
PHE 113 CD2 
PHE 113 CE2 
PHE 113 CZ 
PHE 113 CEI 
PHE 113 CD1 
PHE 113 CG 
ALA 103 CB 
ASN 102 C 
ALA 101 CB 
GLY 72 CA 
ARG 55 CD 
















Table (8) Van der Waals interactions between ligand EM4 181 and CypA. 
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Figure (7) Interactions between ligand EM4 181 and CypA with water molecules. 
Ligand EM4 181 has a number of hydrogen bonding interactions with water 
molecules which are located around the active site. There is only one residue, 
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G1n63, involved in a hydrogen bonding interaction with ligand EM4 181, however, a 
number of residues, Arg_55, Phe_1 13, His_126, Leu_122, Asn_102, Ala_103, 
Ala_101, Gly_72 and His_54 have hydrophobic interactions with ligand EM4181, 
figure (7). 
The active site structure comparison between native CypA and the complex structure 
of CypAJEM4 181 (figure (8)) shows that some water molecules positions are 
conserved, as described previously in the complex structure of CypAIEM234. Five 
water molecules in the native structure, HOH_6, HOH_15, HOH_20, HOH_53 and 
H0H28, are replaced by the bound ligand EM4 181 in the complex structure of 
CypAIEM4 181. Three water molecules in the native structure move slightly when 
ligand EM4181 binds. HOH_51 shifts 2.38 A to the position of HOH_396. 
HOH_ 112 shifts 3.71 A to generate a new binding position of HOH_309. HOH_73 
moves 1.49 A to another new binding position of HOH_398. 
In the complex structure CypAJEM234, it is clear that HOH_73 is replaced by bound 
ligand EM234 (figure (4)). However, in the complex structure CypAIEM4181 
HOH_73 remains but its position is shifted because ligand EM4 181 is smaller than 
ligand EM234 and a new modified water binding site is generated. The comparison 
also shows that HOH_379, which forms a hydrogen bond to ligand EM234, again 
forms a hydrogen bond to ligand EM4 181, but the position of HOH_379 shifts 1.1 A 
compared to the position in the structure of CypAIEM4 181, figure (8). 
The r.m.s. fit of main chain atoms between native CypA and complex CypAIEM234 
is 0.152A. Upon ligand EM4181 binding to CypA, the side chain conformation of 
Met_61 changed. The X3  (CE-SD-CG-CB) torsion angle of Met_61 is -134.2 °, 
compared to 115.50  in the native CypA structure. The NE2 atom of Gln_63 moved 
0.452A from its position in the native CypA structure. Other side chain 
conformations of the residues that make contacts with ligand EM4 181 remain in their 
positions with shifts less than 1.5 A. 
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Figure (8) Active site structure comparison between native CypA structure and the 
CypAJEM4181 complex structure. Red balls represent water molecules in the native 
structure. Green balls represent new water molecules in the complex CypAIEM4181 
structure that are absent in native CypA structure. The distance values shown in the 
figure are hydrogen bond distances between water molecules and ligand EM4 181. 
3.1.3 Complex structure of CypA with EM34821 
The data for the complex structure of CypA with EM3482 1 is to a resolution of 
2.7A, therefore the details of water structure in the active site are not as accurate as 
the native structure of 2.OA and the other two complex structures of family_A 
ligands described previously. The difference map showed the bound ligand in the 
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active site of CypA. figure (9). Figure (10) shows the electron density map after the 
full refinement that includes CypA and ligand EM34821. 
Figure t9. Red electron density map represents the first Fo-Fc map. green one 
represents first 2Fo-Fc map. Both maps were calculated before the ligand EM34821 
was fitted into the model. 
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Figure (10) The linal 2Fo-Fc electron density map contoured around ligand 
EM3482 1. The electron density map was calculated using the fully refined model 
that includes water molecules, protein and ligand EM34821. 
The program ligplot was used to the model shown in figure (10) to analyse the 
interactions between ligand EM34821 and CypA. The results are shown in table (10) 
and figure (11). 
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Atom 1 Atom 2 Distance(A) 
EM34821 166 C4 HIS 126 CE1 3.23 
EM34821 166 C5 HIS 126 CE! 3.74 
EM34821 166 C8 LEU 122 CD2 3.68 
EM34821 166 C8 LEU 122 CD1 3.72 
EM34821 166 Cl PHE 113 CD2 3.10 
EM34821 166 Cl PIlE 113 CE2 3.22 
EM34821 166 Cl PHE 113 CZ 3.32 
EM34821 166 Cl PHE 113 CE1 3.30 
EM34821 166 Cl PHE 113 CD1 3.16 
EM34821 166 Cl P1-LB 113 CG 3.08 
EM34821 166 Cl PHE 113 CB 3.88 
EM34821 166 C16 GLN 111 CD 3.80 
EM34821 166 C17 GLY 72 C 3.79 
EM34821 166 C17 GLY 72 CA 3.74 
EM34821 166 C3 MET 61 CE 3.63 
EM34821 166 C3 PHE 60 CE2 3.88 
EM3482 1166 C8 PHE 60 CZ 3.51 
Table (10) Van der Waals interactions between ligand EM34821 and CypA 
123 
Gly 72 











40mmme Ligarid bond 	 His 5.3 Non-ligand residues involved In hydrophobic 
- 	Non-ligand bond 	
contact(s) 
•- -- Hydrogen bond and its length • Corresponding atoms involved in hydrophobic conta 
EM3482 1 
Figure (11) Interactions between ligand EM3482 1 and CypA with water molecules. 
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There is only one residue of CypA, Arg_55 that contributes to the hydrogen bonding 
(ARG55-NIH1 ----- 012-EM34821=2.74 A). Other residues, Gly.72, Gln_l 11, 
Phe_ 113, Met_6 1, Leu_ 122, His_ 126 and Phe_60 make hydrophobic interactions 
with ligand EM3482 1, figure (11). 
The relatively low resolution of this structure did not allow unambiguous 
identification of any water molecules in the active site. 
The r.m.s. fit of main chain atoms between native CypA and complex 
CypAIEM34821 is 0.254A. In the complex CypAIEM34821 structure, the bound 
ligand EM3482 1 pushes away the side chain of Met_6 1. The torsion angle of CE-
SD-CG-CB of Met_61 changes from 115.5 0 in native CypA to -140.9 ° in the 
complex CypAIEM3482 1 structure. The NH 1 atom of Arg_55 moved slightly by 
0.839A, although it makes a hydrogen bond with ligand EM34821. 
3. 1. 4 Summary of the complex structures of CypA with family_A ligands 
The three complex structures, CypAIEM234, CypAIEM4181 and CypAIEM34821, 
were superimposed onto the native CypA structure in order to compare the binding 
mode of these three ligands and the active site changes upon the ligand binding. The 
superposition is shown in figure (12). 
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Figure (12) Superimposition of active sites of CypA. CypA-EM234, 
CypAIEM34821. CypAJEM4181. The thick stick models represent the bound 
ligands. The thin stick models represent protein. 
These three ligands bind to CypA in a quite similar mode. All the dimedone groups 
of the three ligands which are highlighted in figure (12) by the green square are 
located at the same area in the active site of CypA, and the two methyl groups on the 
dimedone group point into the hydrophobic pocket which consists of the side chains 
of non-polar residues Met_61, Phe_l 13, Leu_l22. The Val groups on the three 
ligands that are highlighted by the yellow square in figure (12) make hydrophobic 
interactions with residues Ala_103, Ala_101. Thr_73 and Gly_72 of CypA. 
Side chain movements upon the binding of ligands 
Figure (12) shows the three complexes of EM234. EM34821 and EM4181 fitted onto 
native CypA. The r.m.s. values for all the main chain atoms (C. CA. N) are 0.1 78A. 
0.152A and 0.254A corresponding to CypA/EM234. CypAIEM4I81 and 
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CypAIEM3482 1, respectively. The active site of CypA is relatively rigid. After 
ligands bind to CypA, the only significant change is the conformation of the methyl 
group on the side chain of Met_6 1 that points to the active site in the native structure 
and points away from ligand in complex structures. The torsion angle of CE-SD-CG-
CB lies in the range from -134.2 ° to -140.9° for the three complexed structures. This 
change has been highlighted by green ellipse in above figure (11). The side chain of 
Arg_55 movement ranges from 0.87A to 0.45A for atom NH1. The side chain atom 
NE2 of Gln_63 shifts between 0.37 A and 0.45 A and the side chain atom NE2 of 
His_54 shifted around 0.28 A. Since the side chain conformation change occurred 
after the ligands bound to protein, therefore it is regards that the side chain 
conformation changes were caused by the interactions between the side chains and 
ligands. 
Water molecule rearrangement upon the binding of ligands 
When the ligand binds the active site of CypA, some water molecules that occupy the 
same space as the ligands are displaced. In the complex CypA/EM234, HOH_6, 
HOH_15, HOH_20, HOH_28, HOH_51, HOH_53, HOH_73 and HOH_l 12 are 
replaced by bound ligand EM234, figure (4). In complex CypA/EM4181, HOH_6, 
HOH_15, HOH_20, HOH_53and HOH_28 are replaced by bound ligand EM4181, 
figure (8). Therefore HOH_6, HOH_15, HOH_20, HOH_53 are always expelled by 
the bound family_A ligands. 
Some water molecules close to the bound ligand are shifted in order to accommodate 
the bound ligand. In the complex CypAIEM4 181 structure as described previously, 
HOH_1 12 moves 2.2 A to adapt to the bound ligand EM234. In the complex 
structure of CypA/EM4181 HOH_51, HOH 73 and HOH_1 12 move 2.4A, 1.5 A 
and 3.7 A respectively to adapt to the bound ligand EM4181. Some new water 
molecules were introduced into the active site by forming hydrogen bonds with 
ligands. In complex CypA/EM234, HOH_408 and HOH_309 are two new water 
molecules that are introduced into the active site of the complex CypAIEM234 and 
are directly hydrogen bonded to ligand EM234, figure (4). 
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Hydrogen bonding interactions between family_A ligands and water molecules 
Family_A ligands make at least one hydrogen bond to CypA as well as between four 
to five hydrogen bonds to water molecules besides the hydrogen bonding interactions 
with protein CypA. In the complex structure of CypAIEM234 atom 0_9 of ligand 
EM234 makes a hydrogen bond with HOH_379. Atom 028 of ligand EM234 makes 
a hydrogen bond with HOH_309; In the complex structure of EM4181 five water 
molecules are involved the hydrogen bonds with ligand EM4 181, table (7).The 
hydrogen bond length between water molecules and family_A ligands varies from 
2.5 A to 3.3 A and two water molecules, HOH_309 and HOH_379, are conserved in 
making hydrogen bonds with family_A ligands. 
Direct hydrogen bonding interactions between CypA and ligands 
The CypA residues of Gln_63, Arg_55 and His_54 are involved in the hydrogen 
bonding interactions with family_A ligands EM234, EM4 181 and EM3482 1. Atom 
0_19 of ligand EM234 makes hydrogen bonds with atom NE2 of His_54 and atom 
NE2 of Gln_63, figure (3). Atom 0_20 of ligand EM4 181 also makes a hydrogen 
bond with atom NE2 of Gln_63, figure (7). Ligand EM3482 1 makes a hydrogen 
bond with NH1 of Arg_55 through its atom 0_12, figure (11). The hydrogen bond 
lengths between family_A ligands and CypA are from 2.7 A to 3.3 A. 
Van der Waals contacts between CypA and ligands 
Fourteen CypA residues (His_54, Arg_55, Phe_60, Met_61, Gln_63, Gly_72, 
Thr_73, Ala_101, Asn_102, Ala_103, Gin_ill, Phe_1 13, Leu_122, His_126) are 
involved in van der Waals interactions with the three family_A ligands. Only three of 
them, Phe_1 13, Leu_122 and His_ 126, are conserved. Two methyl group carbon 
atoms C_6, C_7 on the dimedone part of ligand EM234 make van der Waals contacts 
with His_126, Leu_122 and Phe_1 13. In the complex CypAIEM4181 structure the 
two methyl groups' carbon atoms on the dimedone part of ligand EM4181 also make 
van der Waals contacts with residues His_126, Leu_l22 and Phe_1 13 with van der 
Waals contact distances from 3.4 A to 3.8 A. However, in the complex 
CypA/EM3482 1, the dimedone moiety adopts a slightly different orientation and the 
two methyl groups of this ligand make van der Waals contacts with residues 
128 
Phe_ 113, Met_6 1 and Phe_60. The interactions of the dimedone methyl groups seem 
to play a dominant role in the ligand-CypA interaction. The only conserved 
interaction is between the methyl groups and the 'face' of the phenyl side chain. This 
provides favoured electrostatic interaction between the hydrogen atoms of the methyl 
groups and the electron-rich it cloud of the aromatic side chain 3 . Other carbon atoms 
on the dimedone part of ligand EM3482 1 make van der Waals contacts with His_ 126 
and Leu_ 122. The van der Waals contacts distance range between CypA and ligand 
EM34821 is from 3.1 A to 3.9 A. A schematic presentation of complex of 
CypA/ligands (family_A) is shown in figure (13). 
His 126 
I' 
Phe 113 11  
II 
Leu 12,l 
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Figure (13) Interactions between CypA and family_A ligands. All the residues are 
involved in the interactions between family_A ligands and CypA by hydrogen 
bonding or van der Waals interactions. The two methyl groups (Cl and C2 in red) on 
the dimedone part of family_A ligands make van der Waals contacts with residues of 
His_126, Phe_1 13 and Leu_122 that are the components of the hydrophobic pocket 
of CypA. The van der Waals contacts are in the range of 3.1 A and 3.9 A. The polar 
residues Arg_55. His_54 and Gln_63 are positioned along one side of the active site 
of CypA and provide the chance to form hydrogen bonds with family_A ligands. The 
hydrogen bond length is in the range of 2.7 A and 3.3 A. The four water molecules 
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(HOH_6, HOH_15, HOH_20, HOH_53) are displaced by all the bound ligand of 
family_A in each complex of CypA with family_A ligand. 
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Chapter eight 
Complex structures of CypA with family_B ligands 
1. Family_B ligands and crystallographic parameters of complex structures of 
CypA with family_B ligands 
Both of the two ligands of family_B highlighted in scheme (1) are the derivatives of 
structurex ,c 0 The chemical synthesis starts from the dimedone structure. As 
shown in scheme (2), dimedone was directly 4-alkylated to ligand EM4331 using 
methyl iodide, generated at -78 °C using lithium diisopropylamide and 
hexamethyiphosphoric triamide. Subsequently ligand EM4331 is coupled to N-
benzyloxycarbonyl-L-valine (ligand EM4 101). The chemical structures of family_B 
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Code 	 EM4101 	 EM4331 
Chemical 
structure 	01"'0 YN,  011~co 	O"i CO 
Table (11) Family_B ligands chemical structures. 
The crystallographic parameters of the complex structures of CypA with family_B 
ligands are listed in tables (12), (13) and (14). 
Ligand Rfactor(%) R(%) Resolution(A) Water molecules Bond length Angle 
RMSD (A) RMSD(°) 
	
EM4101 16.2 	23.5 	2.5 	 187 	 0.024 	1.9 
EM4331 20.1 	26.8 	2.1 	 227 	 0.012 	1.4 
Table (12) Crystallographic parameters of complex structures of CypA with 
family_B ligands. 
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Ligand 	 temperature factor( 
protein 	ligand 	solvent 
EM4101 	36.0 	66.0 	53.2 
EM4331 	29.5 	45.1 	43.1 
Table (13) Average temperature factors of complex structures of CypA with 
family_B ligands. 
Ramanchadran plot 
Ligand 	Favoured (%) Additional (%) General (%) Disallowed (%) 
EM4101 	76.9 	22.4 	0.7 	0 
EM4331 	83.5 	15.8 	0.8 	0 
Table (14) Stereochemical quality of complex structures of CypA with family_A 
ligands 
2. Complex structure of CypA with EM4101 
Figure (14) and figure (15) shows the difference electron density maps. Figure (14) 
shows a continuous electron density in the active site of CypA, and the Fo-Fc map is 
weaker than the 2Fo-Fc map. Figure (15) shows the final model of CypA with ligand 
EM4 101. 
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Figure ( 14) The electron density map around CypA active site was calculated in the 
absence of ligand EM4101. 2Fo-Fc map is in green and Fo-Fc map is in red. 
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bigure 1 5) 2Fo-Fc electron density map around ligaiid LM4 It) 1 bound to the active 
site of CypA. The map was calculated with the presence of ligand EM4I01. 
The final model is shown in figure (15) and the interactions between ligand EM410I 
and CypA have been analysed using ligplot as shown in tables (15) and (16) and also 
figure (16). 
Donor Acceptor • Distance (A) 
EM4101 166 N13 	HOH 	311 	0 3.29 
HOH 50 0 	EM4101 	166 09 2.96 
ARG 55 NH2 	EM4101 	166 09 3.20 
Table (15) Hydrogen bonding interactions between ligand EM4I0I and CypA with 
water molecules. 
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Atom 1 Atom 2 Distance (A) 
EM4101 166 C29 HIS 126 CE1 3.72 
EM4101 166 C7 HIS 126 CE1 3.29 
EM4101 166 C6 HIS 126 CE1 3.37 
EM4101 166 Cl HIS 126 CE1 3.86 
EM4101 166 C7 HIS 126 CG 3.85 
EM4101 166 C7 LEU 122 CD2 3.88 
EM4101 166 C7 LEU 122 CD1 3.29 
EM4101 166 C7 PHE 113 CZ 3.30 
EM410I 166 C7 PHE 113 CE2 3.87 
EM4101 166 C7 PHE 113 CE1 3.29 
EM4101 166 C8 PHE 113 CD2 3.78 
EM4101 166 C8 PHE 113 CD1 3.57 
EM4101 166 C7 PHE 113 CD1 3.81 
EM4101 166 C8 PHE 113 CG 3.48 
EM4101 166 C23 ALA 103 CB 3.76 
EM4101 166 C6 ALA 101 CB 3.81 
EM4101 166 C27 THR 73 C 3.90 
EM4101 166 C16 GLY 72 CA 3.56 
EM4101 166 C8 MET 61 CE 3.30 
EM4101 166 C8 MET 61 SD 3.36 
EM4101 166 C17 ARG 55 CZ 3.75 
EM4101 166 C17 ARG 55 CD 3.28 
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Figure (16) The interactions between ligand EM4101and protein CypA with water 
molecules. The plot was made using program LIGPLOT. 
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There is only one direct hydrogen bond between ligand EM4 101 and protein 
(Arg_55 ---- Ligand). Ligand EM4 101 forms hydrogen bonds with two water 
molecules, HOH_207 and HOH_3 11. Ligand EM4 101 has hydrophobic interactions 
with residues Met_61, Phe_1 13, Ala_101, Leu_122, His_126, Ala_103, Gly_72 and 
Thr_73, figure (16). 
The superposition of native CypA and complex of CypA/EM410I (figure (17)) 
shows that HOH_6, HOH_15, HOH 51, HOH_92, HOH_1 12, HOH 20, HOH_28 
and HOH_53 are replaced by the bound ligand EM4101. Upon the binding of ligand 
EM4101 HOH_73 and HOH_50 shifted 2.02A and 0.80A respectively. Four new 
water molecules, HOH_173, HOH_256, HOH_285 and HOH_311, were introduced 
into the active site by the binding ligand EM4 101. HOH_3 11 makes hydrogen bond 
with ligand EM4I01, and both HOH_256 and HOH_271 make hydrogen bonds with 
HOH_311 (figure (16)). 
The main chain atoms r.m.s. fit between native CypA and complex CypAIEM4181 is 
0.316A. The side chain of Met_61 was pushed away from its original position in the 
native CypA structure. In complex CypAIEM4 181 the torsion angle of y (CE-SD-
CG-CB) of Met_61 is -17 1.9° in contrast with the value of 115.5 ° in native CypA. 
The CZ atom of Arg_55 shifted 0.173 to make a hydrogen bond with ligand 
EM4 101. 
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Figure ( I 7) Active site superposition of native CvpA and complex of 
CypA/EM4 101. Red balls represent water molecules in the native structure and 
yellow balls in the complex structure. 
3. Complex structure of CypA with 4311 
Figures (18) and (19) show the difference electron density maps. The electron 
density in the active site of CypA (figure (18)) clearly indicates the bound ligand 
EM433 1. Figure (19) shows the good electron density for final model of bound 
ligand EM4331 and CypA. 
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calculated without ligand in the model. 
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Ficu re (1 () The final 2Fo-Fc election denslt\ iiiap ut und I iund Fv14 	I hound to 
the active site of CypA. The electron density map was calculated with the presence 
of ligand EM433 1. 
The final model is shown in figure (19) and the interaction between ligand EM4331 
and CypA have been analysed using program Iigplot, shown in tables (17), (18) and 
figure (20). 
Donor 	 Acceptor 	Distance (A) 
1-101-1 374 0 	EM4331 166 09 	3.27 
ASN 102 N 	EM4331 166 09 	3.08 
Table (17) Hydrogen bonds between ligand 4331 and CypA with water molecules. 
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Atom 1 Atom 2 Distance (A) 
EM4331 166 C3 HIS 126 CE! 3.89 
EM4331 166 C8 LEU 122 CD1 3.82 
EM4331 166 C29 PHE 113 CE! 3.78 
EM4331 166 C29 PFIE 113 CD1 3.30 
EM4331 166 C29 PHE 113 CG 3.79 
EM4331 166 C29 ALA 101 CB 3.66 
EM4331 166 C29 ALA 101 CA 3.89 
EM4331 166 C7 MET 61 CE 3.61 
EM4331 166 C7 MET 61 SD 3.34 
EM4331 166 C7 MET 61 CG 3.57 
Table (18) Van der Waals contacts between CypA and ligand EM433 1 
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Figure (20) Interactions between ligand EM433 I and protein CypA with water 
molecules. The plot was made by program ligplot. 
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Ligand EM4331 forms a hydrogen bond with CypA through Asn _102. Hydrophobic 
interactions take place between ligand and residues of CypA. Leu_l22, His_l26, 
Met_61, Phe_1 13 and Ala_101. figure (20). 
Ligand EM433 1 is a small ligand comparing to EM4 101. Therefore there are less 
water molecules replaced by the bound ligand EM433 1. Shown in figure (17), 
HOH_6. HOH_1 5, HOH_5 1 and HOH_92 were replaced by bound ligand EM433 1. 
HOH_1 12 was pushed away by the distance of 3.16A to form a hydrogen bond with 
Ar 55 
liLU 	 i i 	 dilU 	1Iijit\ 
Red balls represent the water molecules in the native structure and blue balls 
represent the water molecules in the complex structure. 
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The main chain atoms superposition of native CypA structure and complex 
CypAIEM433 I gives an r.m.s. fit of 0.286A. The active site structure comparison 
between native CypA and complex CypAIEM433 I shows that the side chain 
conformation of Met_61 change. The torsion angle X3 (CE-SD-CG-CB) of Met_61 
is -132.3° . Main chain atom N of Asn_102 makes a hydrogen bond with ligand 
EM433 1, however, it moved very slightly, only 0.1 99A. Atom CZ of Arg_55 moves 
0.64 A. 
4. Summary of the complex structures of CypA with family_B ligands 
The two complex structures. CypA/EM4 101 and CypAJEM433 1, were superimposed 
onto the native CypA structure in order to compare the binding modes and the active 
site changes upon the ligands binding. The superposition is shown in figure (22). 
FiL' 	 JCpA/EM4331. 
The main chain (C. CA, N) r.m.s. fit between native CypA and CypAIEM4I01 is 
0.316A, and the r.m.s. fit between CypA and CypAIEM4331 is 0.286A. Although the 
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active site of CypA is relatively rigid, several residues shift upon the binding of 
family_B ligands. The dimedone groups of the ligands marked by the white square in 
figure (22) are located in the hydrophobic pocket of CypA. The two methyl groups 
on the dimedone groups of ligands point inside the hydrophobic pocket and make 
electrostatic interactions with the phenyl side chain. 
Side chain movements upon the binding of ligands 
As described previously, around the active site of CypA the movements of residues 
of Met_61, Arg_55 and Asn_102 which involved in the interactions with family_B 
ligands are quantified. The side chain of Met_6 1 moves dramatically upon the 
binding family_B ligands and torsion angle X3 (CE-SD-CG-CB) of Met_61 moves 
from -171.9° in the complex CypAIEM4101 to -132.3° in the complex 
CypAIEM4331 in contrast to the value of 155.50 in the native CypA structure, 
highlighted in the white ellipse in figure (22). The side chain of Arg_55 moves 
slightly by the distance of between 0.173 A and 0.643 A. Main chain atom N of 
residue Asn_102 moves maximally 0.2 A in the complex CypA/EM4 101. 
Water molecule rearrangement upon the binding of ligands 
When ligands bind to the active site of CypA, water molecules that occupy the same 
space as ligands are inevitably expelled and the water molecules that are in the 
vicinity of the bound ligands rearranged to adopt the bound ligands. Ligand EM4101 
is bigger than ligand EM433 1; more water molecules are displaced in the complex 
structure of CypAIEM433 1 than in the structure of CypA/EM433 1. Eight water 
molecules are displaced by ligand EM4101 in the complex CypA/EM4 101 structure, 
HOH_6, HOH_15, HOH_51, HOH_92, HOH_112, HOH_20, HOH_28 and 
HOH_53. However, only four water molecules, HOH_6, HOH_15, HOH_51, 
HOH_92, are replaced by ligand EM433 1. Therefore, in the complex structure of 
CypA with family_B ligands, four water molecules (HOH_6, HOH_15, HOH_51, 
HOH_92) that occupy the same space as the dimedone parts of family_B ligands are 
displaced. 
A number of water molecules are shifted from their positions in the native CypA 
structure in order to adopt the bound ligands. In complex CypA/EM4 101 HOH_50 
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and HOH_73 move 0.8 A and 2.02 A respectively, and HOH_1 12 in complex 
CypAJEM433 1 moves 3.16 A to generate a new binding site. 
Four new water molecules (HOH_173, HOH_256, HOH_285 and HOH_31 1) are 
introduced into the active site of CypA along with the bound ligand EM4 101. There 
is no new water molecule are observed in the complex structure of CypAIEM433 1. 
Hydrogen bonding interactions between ligands and water molecules 
Both ligands of family_B make water-bridged hydrogen bonds with CypA and the 
hydrogen bond length is in the range of from 2.9 A to 3.3 A. Atom 0_9 of ligand 
EM4181 makes hydrogen bonds with NH! and NH2 of Arg_55 through water 
molecule HOH_50, figure (16). However, atom 0_9 of EM433 1 makes a water-
bridged hydrogen bond with atom 0 of Asn_102 through water molecule of 
HOH_20, figure (20). 
In the active sites of the complexes of CypA with family_B ligands, several water 
molecules form hydrogen bonds with one to another. In complex CypA/EM 4101, 
three water molecules (HOH_73, HOH_256 and HOH....3 11) form a hydrogen 
bonding network, and atom N13 of ligand 4101 is connected to this network by 
forming a hydrogen bond with HOH....3 11, figure (13). In complex CypA/EM433 1 
two water molecules (HOH_20 and HOH_53) are connected by a 2.6 A hydrogen 
bond and atom 0_9 of ligand EM433 1 is hydrogen bonding this two-water hydrogen 
bonding network through HOH_20. 
Direct hydrogen bonding interactions between CypA and ligands 
There are two direct hydrogen bonds within the bond length range 3.1 A to 3.2 A 
between family_B ligands and CypA (0_9 ------NH2Arg_55 = 3.2 A, 
0_9 ------NAsn_ 102 = 3. 1A). 
Van der Waais contacts between CypA and ligands 
The schematic presentation of the interactions between CypA and family_B ligands 
is shown in figure (23). A number of CypA residues (Arg_55, Met_61, Gly_72, 
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Thr_73, Ala_101, Ala_103, Phe_1 13, Leu_122, His_126) make van der Waals 
contacts with ligands and the Val de Waals contacts distances are in the range 3.3 A 
to 3.9 A. Among all those residues involved the van der Waals contacts, five residues 
(Met_61, Ala_101, Phe_113, Leu_122, His_126) are involved van derWaals 
interactions in complexes of both EM4 101 and EM433 1. Atom C_7 and C_8 on the 
dimedone part of ligand EM4101 make van der Waals contact with residues Met_61, 
His_126, Leu_122and Phe_1 13. In the complex CypAIEM4331 structure these two 
atoms (atom C_7 and C_8) of ligand EM433 1 make van der Waals contacts with 
residues Met_61 and Leu_ 122. Another atom C_29 on the dimedone part makes van 
der Waals contacts with residue only His_126 in the CypAJEM4101 complex (table 
(16)), however, the atom C_29 of EM433 1 makes van der Waals contacts with 
residues Phe_1 13, Ala_101, table (18). This difference is caused by the size 
difference between these two family_B ligands. Ligand EM4101 is much bigger than 
ligand EM43 11 and the orientation of the dimedone group of EM4 101 is affected by 
the overall binding mode of the EM4101 ligand. For ligand EM4331, however, there 
is no long 'tail' attached to its dimedone part. 
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Figure (23) The van der Waals and hydrogen bonding interactions between family_B 
ligands and CypA. The chemical groups represent the variant groups among 
family_B ligands. Four water molecules (HOH_6, HOH_15, HOH_5 1, HOH_92) are 
displaced by both bound family_B ligands. The conserved van der Waals contact 
distance is between 3.3 A and 3.9 A. Residues Asn_102 and Arg_55 are involved 
hydrogen bonding interactions with family_B ligands and the hydrogen bond length 
falls into the ranges of from 3.1 A to 3.2 A. 
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Chapter nine 
Complex structures of CypA with family_C ligands 
1. Family_C ligands and crystallographic parameters of complex structures of 
CypA with family_C ligands 
Both of the two ligands of family_C highlighted in blue in scheme (1) are the 
derivatives of structure0 	0 Family_C ligands are structurally similar to the 
family_A ligands described in chapter eight, however the position of dimethyl group 
relative to the 1 .3-dione in the cyclohexane ring is different. The synthesis of this 
family of ligands starts from the commercially available compound EM9, and the 
synthesis process is similar to the synthesis of the family_A ligands, scheme (2). The 



















DCC (1 ,3-dicyclohexylcarbodiimide) 
DMAP (4-dimethylaminopyridine) 
Code 	 EM42 11 	 EM9 
Chemical 
0 
structure 	PhOy oj:zto 	0j 0 
0 
Table (19) Family_C ligands chemical structures. 
The crystallographic parameters of the complex structures of CypA with family_C 
ligands are listed in tables (20), (21) and (22). 
Ligand 	Rfactor(%) R(%) 	Resolution Water 	Bond length Angle 
(A) 	molecules RMSD (A) RMSD(°) 
EM4211 	21.2 	28.6 	2.5 	187 	0.014 	1.8 
EM9 	19.7 	25.3 	2.2 	136 	0.015 	1.6 
Table (20) Crystallographic parameters of complex structures of CypA with 
family_C ligands. 
Ligand 	 temperature factor(A 2) 
protein 	ligand 	solvent 
EM4211 	42.5 	67.5 	53.8 
EM9 	31.5 	48.4 	40.1 




Ligand 	Favoured (7d Additional (%) General (7) Disallowed (%) 
EM42II 81.3 	17.2 	 1.5 	0 
EM9 	83.5 	15.8 	0.8 	0 
Table (22) Stereochemical quality of complex structures of CypA with family_C 
ligands 
2. Complex structure of CypA with EM421 I 
The first omit map in figure (24) shows that there is electron density located in the 
active site of CypA, while the density around the chain of protein CypA is little. 
Therefore, the density sitting in the active site of CypA must be produced by the 
bound ligand EM42 11. However, the electron density was not strong enough to show 
the whole bound ligand EM42 11. Figure (25) shows the final electron density of 
ligarid model together with protein. 
liLII- c (24) The 11!\I K-I-c eIeetrn deiiu 	utp aloijild tile IUAIN e iic 01 ( p\. 
electron density map was calculated without the presence of ligand EM42 11. 
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Figure (25) The final 2Fo-1 clectrc)11 delisit) map around ligand LN14.2 11 bound u 
CypA. The map was calculated with the presence of ligand EM42 11. 
The final model of the complex structure is shown in figure (25) and the analysis on 
the interactions between ligand 4211 and CypA was done with program LIGPLOT, 
as is shown in the figure (26) and tables (23) and (24). 
Donor Acceptor Distance (A) 
HOH 53 0 EM4211 166 020 2.64 
HUH 28 0 EM4211 166 028 2.71 
HOH 92 0 EM42 11 166 09 2.77 
GLN 63 NE2 EM421 1 166 019 2.66 
HIS 54 NE2 EM4211 166 019 2.67 
Table (23) Hydrogen bonds between ligand EM42 11 and CypA with water 
molecules 
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Atom 1 	 Atom 2 	Distance (A) 
EM4211 166 C4 HIS 126 CE1 3.54 
EM4211 166 C3 HIS 126 CE1 3.81 
EM4211 166 C17 ALA 103 CB 3.75 
EM4211 166 C16 ASN 102 C 3.70 
EM4211 166 C16 ASN 102 CA 3.84 
EM4211 166 C5 ALA 101 CB 3.25 
EM4211 166 C6 ALA 101 CB 3.32 
EM4211 166 CS ALA 101 CA 3.52 
EM4211 166 C6 ALA 101 CA 3.68 
EM4211 166 C21 GLY 72 CA 3.42 
EM4211 166 C18 GLY 72 CA 3.33 
EM4211 166 C6 GLN 63 CD 3.57 
EM4211 166 C27 ARG 55 CD 3.67 
EM4211 166 C21 ARG 55 CD 3.74 
EM4211 166 C21 HIS 54 CD2 3.42 
Table (24) Van der Waals interactions between ligand EM42 11 and protein. 
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Figure (26) Interactions between ligand EM42 11 and CypA with water molecules. 
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As shown in tables (23), (24) and figure (26), ligand 4211 interacts with CypA 
through hydrogen bonding to Gln_63, His_54. Besides hydrogen bonding 
interactions, there are some hydrophobic interactions between ligand 4211 and CypA 
through residues Arg_55, GIy_72, Ala_103, Ala_101 and Ala_102. 
Water molecules arrangements in the active site of the native structure and complex 
structure are compared, figure (20). HOH_6, HUH_iS, HOH_20. HOH_51, 
HOH_73 and HOH_1 12 are replaced upon ligand EM421 1 binding to CypA. Three 
water molecules are shifted to have good contacts with ligand or protein. HOH_53 
shifted 3.48A to a new binding site to make a good hydrogen bond with the distance 
of 2.64A. HOH_28 moved to a binding site by 2.7A to have hydrogen bond with 
ligand and Gln_63 of protein. The newly positioned HOl-1_92 have hydrogen bonds 
with ligand. His_l 26 of protein and a newly introduced water molecule HOH_33 I. 
HOH_98 shifts 0.6 iA to make the distance to HOH_331 change from 2.0IA to 
2.62A. 
Figure () I he 	t1\c fle 	 i 1ii 	C 	 L1uIpIe\ ul 
CypAJEM42 11. Red balls represent the water molecules in the native structure and 
yellow ones for the water molecules in the complex structure. 
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The r.m.s. fit of main chain atoms between native CypA and complex 
CypAJEM42I 1 is 0.314A. The bound ligand caused some side chain conformation 
changes comparing with the side chain conformation in native CypA. The significant 
change of side chain is the side chain of Met_61 whose dihedral angle X3  (CE-SD-
CG-CB) is -103.8°, however it is 115.5 ° in native CypA structure. Another apparent 
side chain conformation change happened on the side chain of His_126. The NE2 
atom of His_I 26 moved 0.765A to form a hydrogen bond with ligand EM42 11. 
3. Complex structure of CypA with EM9 
The first omit map was shown in figure (28). The electron density in the active site of 
CypA implies the bound ligand EM9, although the shape of electron density is not 
complete compared to the structure of EM9. Figure (29) shows the final model of 
ligand F\11) \ ith the clectr ii dcnit\. 
1 - u ic 	The Ii rt Fo-Fe e1cctrtn den1t\ iiitp around the acti e site o  
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Iiguic (29) [he linal 2Fo-Fc election dcl1it) map around the Iigaiid EM9. 
The final model is shown in figure (29) and the interactions between ligand and 
CypA are analysed using LIGPLOT, as is shown in the following tables (25), (26) 
and figure (30). 
Donor 	Acceptor 	Distance (A) 
HOH 183 0 EM9 166 08 	2.67 
ASN 102 N 	EM9 166 08 	3.04 
Table (25) Hydrogen bonds between ligand EM9 and CypA with water molecules 
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Atom 1 
EM9 166 C9 
EM9 166 C3 
EM9 166 C4 
EM9 166 C3 
EM9 166 C2 
EM9 166 C3 
EM9 166 C3 
EM9 166 C4 
EM9 166 ClO 
EM9 166 ClO 
EM9 166 ClO 
Atom 2 
LEU 122 CD2 
PHE 113 CE1 
PFIE 113 CE1 
PHE 113 CD1 
ALA 101 CB 
ALA 101 CB 
MET 61 CE 
MET 61 CE 
MET 61 CE 
PHE 60 CE2 
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Figure (30) Interaction between ligand EM9 and protein CypA with water molecules. 
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Ligand EM9 interacts with CypA through one hydrogen bond to Asn_ 102 and 
hydrophobic interactions with Ala_101, Phe_1l3, Leu_122. Met_61 and Phe_60, 
figure (30). 
Figure (31) shows the comparison of the water molecules arrangements at the active 
sites of native CypA and complex CypAIEM9. Most of water molecules at the active 
site keep the same positions since ligand EM9 is small so that it does not affect too 
much on its environment. HOH_6. HOH_15. HOH_51 and HOH_l 12 were replaced 
upon the binding of ligand EM9 
Iigurc (31) The active site superposition ot native CypA and complex CypA/EN19. 
The red balls represent water molecules at the active site of native structure Yellow 
balls for the water molecules in the complex structure. 
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The superposition of main chain atoms of native CypA and complex CypAIEM9 
gives an r.rn.s. value of 0.204A. There are no very significant changes of active site 
side chains upon the binding of ligand EM9. The dihedral angle X3  (CE-SD-CG-CB) 
of Met_61 is 148.9°, which is similar to 115.5° in native CypA structure. Also 
Gln_63 and AsnJ02 that make water-bridged hydrogen bonding interactions with 
ligand EM9 have no significant movement when ligand EM9 binds to CypA. The 
distance of NE2 atoms of Gln_63 in native CypA and complex CypAIEM9 is 0.27A. 
and that for the main chain atom N of Asn_102 is 0.108A. 
4. Summary of the complex structures of CypA with family_C ligands 
The two complex structures. CypA/421 1 and CypAIEM9, were superimposed onto 
the native CypA structure in order to compare the binding mode of these two ligands. 
The Iperp'i t on P, hov ii in ii u re 	2 
[j , uIC (2 ) Siiperpoit ion ol ligatid El) and ligand 42 I I and FIatl\ c (\p.A. 
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The r.m.s. fit of the CypAIEM4211 complex against native is 0.3 iA and the r.m.s. fit 
of the CypAIEM9 complex against native CypA is 0.20 A. There is no significant 
conformation change except the side chain conformation of residue Met_6 1 in 
complex CypAIEM42 11. Ligand EM9 and the dimedone group of ligand EM42 11 
are located in the hydrophobic pocket, as is shown in the white square in figure (32). 
The methylene groups on the dimedone moiety are still in electrostatic contact with 
the it electron cloud of the phenyl ring. The two methyl groups on ligand EM9 and 
ligand EM421 1, which are shown as solid spheres in the white square in figure (32), 
point away from the hydrophobic pocket. This unusual binding mode happens 
because of the special structure of family_C ligands. Family_C ligands have a 
different molecular structure where the carbonyl oxygen atom is next to the two 
methyl groups, 0 	O It appears the onentation and location of the carbonyl 
oxygen atom is determined by hydrogen bonds to CypA and this in turn determines 
the orientation and location of the two methyl groups. As shown in figure (27), the 
carbonyl oxygen atom makes water-bridged hydrogen bonds with His_126 of protein 
and another water molecule, HOH_33 1. The dimedone part of ligand EM42 11 is 
located at the hydrophobic pocket. There is no possibility for the carbonyl atoms to 
make hydrogen bonding interactions with the hydrophobic pocket. Therefore, both 
the water molecules arrangements and the hydrophobic pocket environment force the 
carbonyl oxygen atom to point away from the hydrophobic pocket, along with the 
two methyl groups. The situation for ligand EM9 is similar to ligand EM42 11, 
although there are two chemically inequivalent carbonyl oxygen atoms. As shown in 
figures (30) and (31), ligand EM9 makes hydrogen bonds with Asn_102 and Gln_63 
through HOH_20. If the orientation of the bound EM9 shown in figure (31) is 
maintained, two methyl groups of EM9 then must point away from hydrophobic 
pocket. 
Side chain movements upon the binding of ligands 
By comparing the side chain conformations of native CypA structure and the 
complex structures of CypA with family_C ligands, the side chain movements of the 
residues that are caused the bound ligands are monitored. In the complex CypA with 
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family_C ligands the bound ligands push the side chain of Met_6 1 away to make the 
torsion angle X3 (CE-SD-CG-CB) of Met_61 -103.8 ° in the complex CypAIEM421 1 
and 148.9° in the complex CypAIEM9, in contrast to the value of 115.5° in the native 
structure. The side chain atom NE2 of Gln_63 and atom N of Asn_ 102 in the 
complex CypA!EM42 11 move 0.27 A and 0.11 A from their original positions in the 
native CypA structure. The side chain atom of NE2 of His_126 moves 0.77 A 
compared to its position in the native CypA structure. 
Water molecule rearrangement upon the binding of ligands 
Where family_C ligands bind to CypA, six water molecules (HOH_6, HOH_15, 
HOH_20, HOH_5 1, HOH_73 and HOH_1 12) are displaced by bound ligand 
EM42 11, and four water molecules (HOH_6, HOH_l 5, HOH_5 1 and HOH_1 12) are 
expelled by the smaller ligand EM9. 
As well as the water molecules that occupy the same space as the bound ligands in 
the native CypA structure and are displaced by the bound ligands in the complex 
CypA with family_C ligands, some other water molecules' positions shift under the 
influence of the bound family_C ligands. Four water molecules in the complex 
structure of CypA/EM42 11 shift from their original positions in the native CypA 
structure to generate new water binding sites. HOH_53 moves 3.48 A, HOH_28 
shifts 2.7 A, HOH_92 moves 2.8 A, and HOH_98 shifts 0.61 A. There are no 
measurable movements for the water molecules in the complex structure of 
CypA/EM9. 
In the complex CypA/EM42 11 a new water binding site appears, which is occupied 
by water molecule HOH_33 1. 
Hydrogen bonding interactions between ligands and water molecules 
There are three water molecules (HOH_92, HOH_28, HOH_20) bridging the 
hydrogen bonding interactions between CypA and family_C ligands. Water molecule 
HOH_92 connects atom NE2 of His_ 126 and atom 0_9 of ligand EM42 11; HOH_28 
connects atom OE 1 of Gln_63 and atom 0_28 of ligand EM42 11; HOH_20 connects 
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atom NE2 of Gln_63 and 0_8 of ligand EM9. The water-bridged hydrogen bond 
length range is from 2.7 A to 3.3 A. 
Water molecules in the active site are not only involved in the interaction between 
family_C ligands and CypA, but also form the hydrogen bonding network. In 
complex CypAIEM9, water molecules HOH_20, HOH_53, HOH_28, HOH_73 are 
connected to each other sequentially through the hydrogen bonds. In complex 
CypAIEM421 1 new water molecule HOH_33 1 is connected to HOH_92 through a 
hydrogen bond. 
Direct hydrogen bonding interactions between CypA and ligands 
In complex structure CypAIEM42 11 there are two direct hydrogen bonds between 
CypA and ligand EM421 1. Both hydrogen bonds originate from atom 0_19 of ligand 
EM42 11 and end on the atom NE2 of Gln_63 and atom NE2 of His_54. There is 
only one direct hydrogen bond between ligand EM9 and CypA, which is from atom 
0_8 of ligand EM9 to atom N of Asn_ 102. 
Van der Waals contacts between CypA and ligands 
As shown in tables (24) and (26), family_C ligands have van der Waals contacts with 
protein through residues, Arg_55, Met_61, Phe_60, Gln_63, Gly72, Ala_101, 
Asn_102, Ala_103, Phe_l 13, Leu_122, His_126 and His_54. However there is only 
one conserved residue Ala_101 involved in the van der Waals interactions between 
both family_C ligands and CypA. In complex CypAIEM421 1 atoms C5 and C6 of 
ligand EM421 lwhich are chemically equal to atoms C2 and C3 of ligand EM9 
(figures (26) and (30)) make Van der Waals contacts with atoms CA and CB of 
Ala_101A. In complex CypAJEM9, the atoms C2 and C3 of ligand EM9 make van 
der Waals contacts with atom CB of Ala_101. The conserved van der Waals contacts 
distance is from 3.3 A to 3.8 A. A schematic summary of the interactions between 
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Figure (33) Hydrogen bonding and van der Waals interactions between CypA and 
family_C ligands. Four water molecules (HOH_6, HOH_15, HOH_5 1 and 
HOH_1 12) are expelled by the bound family_C ligands. Carbon atoms C2(5) and 
C3(6) of ligand EM9 (EM421 1) make van der Waals contacts with atoms CA and 




Complex structures of CypA with family_D hgands 
I. Famils_D ligands and crystallographic parameters of complex structures of 
CypA with family_D ligands 
Both of the two ligands of family_D highlighted in blue in scheme (1) are the 
x 
derivatives of structure 	° 	0 . The dimedone structure is also the starting material 
for the synthesis of the family_D ligands. The family_D ligands are generated by a single 
alkylation step with the corresponding bromides. Scheme (2) shows the synthesis of ligand 






















HMPT ( Hexamethyiphosphonc triamide) 
THF (Tetrahydrofuran) 






Table (27) Family_D ligands chemical structures. 
The crystallographic parameters of the complex structures of CypA with family_D 
ligands are listed in tables (28), (29) and (30). 
Ligand 	Rfactor(%) Rf (%) Resolution Water 	Bond length 	Angle r.m.s. 
(A) 	molecules r.m.s. (A) (°) 
EM43511 22.6 	28.0 	1.9 	261 	0.015 	1.6 
EM 5123 18.3 	24.9 	2.0 	236 	0.018 	1.6 
Table (28) Crystallographic parameters of complex structures of CypA with 
family_D ligands. 
Ligand 	Average temperature factor (AL) 
protein 	ligand 	solvent 
EM43511 23.3 	40.0 	48.8 
EM 5123 	27.1 	64.9 	39.1 
Table (29) Average temperature factors of complex structures of CypA with 
family_D ligands. 
Ramanchadran plot 
Ligand 	Favoured (%) Additional (%) General (%) Disallowed (%) 
EM43511 	83.5 	15.8 	0.8 	 0 
EM5123 	 83.5 	15.8 	0.8 	 0 
Table (30) Stereochemical quality of Complex structures of CypA with family_D 
2. Complex structure of CypA with EM4351 
Figure (34) shows the first omit electron density map at the active site of CypA. The 
density clearly implies the bound ligand EM435 1. The final ligand EM435 1 model 
with electron densit% P, shown in 1i.ure 05). ).
Figure (34) The first Fo-Fe electron density i1ap. The map was calcLIlate(l without 
the inclusion of ligand EM435 1 in the model. 
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Figure (35) The Ii nal 2Fo-Fc electron density map contoured around bound ligand. 
The map was calculated with the presence of ligand EM435 1. 
The final model is shown in figure (35), the interactions between ligand EM435 1 and 
CypA are analysed with program LIGPLOT, which is shown as plot in figure (36) 
and tables (31) and (32). 
Donor 	Acceptor 	Distance (A) 
HOH 212 0 EM4351 166 08 2.92 
HOH 278 0 EM4351 166 07 3.00 
HOH 180 0 EM4351 166 07 2.60 
HOH 389 0 EM4351 166 013 2.35 
ASN 102 N EM4351 166 015 2.88 
Table (31) Hydrogen bonds between ligand EM4351 and CypA with water 
molecules. 
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Atom 1 Atom 2 Distance (A) 
EM4351 166 ClO PHE 113 CD2 3.77 
EM4351 166 ClO PHE 113 CE2 3.84 
EM4351 166 ClO PHE 113 CZ 3.89 
EM4351 166 ClO PHE 113 CE! 3.85 
EM4351 166 ClO PHE 113 CDI 3.76 
EM4351 166 C9 PHE 113 CD1 3.47 
EM4351 166 ClO PHE 113 CG 3.73 
EM4351 166 C9 ALA 101 CB 3.61 
EM4351 166 C12 ALA 101 CB 3.77 
EM4351 166 C14 ALA 101 CB 3.89 
EM4351 166 C9 GLN 63 CD 3.63 
EM4351 166 C6 PHE 60 CE2 3.65 
EM4351 166 Cl PHE 60 CE2 3.86 
EM4351 166 Cl PHE 60 CZ 3.89 
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Figure (36) Interactions between ligand EM435 1 and CypA with water molecules 
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As shown in figure (36) ligand EM4351 has one direct hydrogen bond with CypA 
through residue Asn_102. Residues Phe_6O, Phe_l 13 and Ala_101 make 
hydrophobic interactions with ligand EM4351. 
The active site water molecules arrangements comparison between native CypA and 
comp'ex CypAIEM4351 shows that HOH_6. HOH_15 and HOH_51 were replaced 
by the bound ligand EM435 1 at the active site. Three water molecules are shifted to 
new binding sites to make contacts with protein or ligand. HOH_20 moves 2.94A to 
make a number of hydrogen bonds with ligand EM435 1, Gln_63. HOH_28 and 
HOH_73. HOH_73 shifted 3.43A. HOH_92 shifts 3.3 iA to make hydrogen bonds 
With H k 1 2( tnd 1-1011 I I \ hidi hifN 
It 	u 	ij 	LiIj 0i Ii1 
Red balls represent water molecules at the active site of native structure, and yellow 
ones for water molecules in the complex structure. 
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The side chain conformations of residues around the active site of CypA were 
compared by superimposing the main chain atoms of the native CypA structure and 
the CypAIEM435I complex structure. The superposition reveals the significant 
changes in the side chains of Met_61, Arg_55 and Gln_63. The torsion angle X3 
(CE-SD-CG-CB) of Met_61 is -128.4 ° in complex CypAIEM4351 structure and 
155.50 in native CypA structure. Atom CZ of Arg....55 shifts 0.509A and atom CD of 
Gln_63 shifts 0.638A. The side chains of His_126 and Asn_102 are largely 
unaltered. Atom NE of His_126 moves 0.363A and the main chain atom N of 
Asn_ 102 moves 0.134A upon ligand 4351 binding. Residues Arg55, GIn_63. 
His_126 and Asn..j02 all have direct or water-bridged hydrogen bonding 
interactions with ligand EM435 1. 
3. Complex structure of CypA with EMS 123 
Figure (38) is the first omit electron density map at the active site of CypA. The 
electron density indicates the bound ligand EM5 123. The final ligand EM4351 
1flOdC ith the electron dCllsit\ iiap P, ho\\ n in tiuic ( 
1ure 	lhe !ii,t lo- FL' electron denitv iiiap arouiid the active site of C pA. The 
map was calculated with the absence of ligand EM5 123. 
175 
Figure (39) The final .i 	ic c lCLtIIi dcnii iitp wuu ad hiund ligand EM5 123. 
The map was calculated with the presence of ligand EM5 123. 
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The final model is shown in figure (39) and the interactions analysis is carried out 
with program LIGPLOT, as is shown in figure (40) and tables (33) and (34). 
Donor 	 Acceptor 	Distance (A) 
HOH 70 0 EM5123 166 07 	3.07 
Table (33) Hydrogen bond between ligand EM5 123 and water molecule. 
Atom 2 	Distance 
HIS 126 CD2 3.71 
HIS 126 CE1 3.53 
HIS 126 CE1 3.34 
LEU 122 CD1 3.68 
PHE 113 CZ 3.35 
PHE 113 CE1 3.20 
PHE 113 CD! 3.67 
PHE 113 CD1 3.75 
PHE 113 CG 3.82 
ASN 102 C 3.56 
ASN 102 CA 3.85 
ALA 101 CB 3.76 
ALA 101 CB 3.44 
ALA 101 CB 3.42 
ALA 101 CB 3.47 
ALA 101 CA 3.70 
ALA 101 CA 3.56 
MET 61 SD 3.63 
PHE 60 CZ 3.55 
Atom 1 
EM5123 166 ClO 
EM5123 166 Cli 
EM5123 166 ClO 
EM5123 166 ClO 
EM5123 166 ClO 
EM5123 166 ClO 
EM5123 166 C9 
EM5123 166 ClO 
EM5123 166 C9 
EM5123 166 C15 
EM5123 166 C15 
EM5123 166 Cl5 
EM5123 166 C13 
EM5123 166 C12 
EM5123 166 Cli 
EM5123 166 C12 
EM5123 166 Cli 
EM5123 166 C9 
EM5123 166 C3 
Table (34) Van der Waals contacts between ligand EM5 123 and protein. 
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Figure (40) Interactions between ligand EM5 123 and CypA with water molecules. 
The LIGPLOT analysis shows that ligand EM5 123 makes hydrophobic interactions 
with CypA through residues Leu_1 12, Phe_1 13, Met_61, Phe_60 and Ala_101. A 
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water molecule bridged hydrogen bonding interaction takes place between ligand and 
residue Asn_102. 
Figure (41) shows that seven water molecules (HOH_6, HOH_ 15, HOH_ 16, 
HOH_20, HOH_5 1. HOH_53 and HOH_92) are replaced by bound ligands. 
HOH_112 is pushed 0.9A away by bound ligand EMS 123 to form hydrogen bonds 
!1)11 	I nd }V)I 	56 
Hure 4 U ActiVe itc LrCll)01 ti 0 n ol I1UIIVC CypA and comple\ (' pA/ENI5 123. 
Red balls represent water molecules at the active site of native structure and yellow 
balls for water molecules in the complex structure. 
The active site structure comparison between native CypA and complex 
CypAJEM5 123 was done by superimposing these two structures together, which 
produced an r.m.s. value of 0.215A. The side chain of Met_61 has an obvious side 
chain conformational change. The dihedral angle X3  (CE-SD-CG-CB) of Met_61 is 
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-104.2° rather than 155.5° in native CypA structure. Atom 0 of Asn_102 makes 
hydrogen bond with ligand EM5 123, but it almost does not shift and its movement is 
only 0.122A. 
4. Summary of the complex structures of CypA with family_D ligands 
The two complex structures, CypAJEM435 1 and CypAIEM5 123. were superimposed 
onto the native CypA structure to compare the binding mode of these two ligands 
and the active site changes upon the ligands binding. The superposition is shown in 
figure (4 
Fiii C 1 4-" 	 U 1ithJ 4 	H 1iitnd 	.. 	tiiU IitU\C ( \ pA. 
The r.m.s. fits against native CypA are 0. 166A for CypA/EM435 I and 0.2 15A for 
CypA/EM5 123. The side chain conformation of residue Met_61 change 
MCI  
significantly. The dimedone groups of both ligand EM4351 and ligand EM5 123 are 
located in the hydrophobic pocket of CypA, shown in the white square in figure (42). 
The two methyl groups of ligand 4351 and ligand 5123 point to the hydrophobic 
pocket of CypA, also shown in figure (42) and the two methyl groups on the 
dimedone moiety make electrostatic interactions with the phenyl ring which is 
located on the bottom of the hydrophobic pocket of CypA. 
Side chain movements upon the binding of ligands 
In the native CypA the side chain torsion angle X3 (CE-SD-CG-CB)Met_61 is 
155.50, however it is -128.4 0 in the complex CypAIEM4351 and -104.2 0 in the 
complex CypA/EM5 123. Therefore the bound family_D ligands greatly affect the 
side chain conformation of Met_61. The side chains of residues Arg_55, Gln_63, 
His_ 126 and Asn_ 102 also move and the movement is in the range of from 0.12 A to 
o.64A. 
Water molecule rearrangement upon the binding of ilgands 
(HOH_6, HOH_15 and HOH_5 1) are displaced by both bound family_D ligands. 
Another five water molecules (HOH_20, HOH_28, HOH_73, HOH_92 and 
HOH_ 112) in the complex CypAIEM435 1 shift to adopt the bound ligand EM435 1 
and the movements range is from 2.9 A to 3.1 A. HOH_l 12 in the complex 
CypA/EM5 123 moves 0.9 A. 
Hydrogen bonding interactions between ligands and water molecules 
Four water molecules (HOH_92, HOH_50, HOH_20 and HOH_70) are involved the 
water-bridged hydrogen bonding interactions between family_D ligands and CypA. 
HOH_92 connects atom NE2 of His_ 126 and 0_7 of ligand EM435 1; HOH_50 is 
the bridge between atom NH2 of Arg55 and atom 0_8 of ligand EM435 I; Atom 
OE1 and NE2 of Gln_63 reach atom 0_13 of ligand EM4351 through HOH_20; 
HOH_70 is the bridge between atom 0_7 of ligand EM5 123 and atoms 0 and OD1 
of Asn_ 102. The water-bridged hydrogen bond length is in the range of from 2.4 A 
to 3.2 A. Three water molecules (HOH_20, HOH_28 and HOH_73) in complex 
CypA/EM4351 are sequentially connected by two hydrogen bonds which are 
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between HOH_28 and HOH_20 and between HOH_20 and H0H73 and the 
hydrogen bond lengths are 3.2 A and 2.9 A respectively. 
Direct hydrogen bonding interactions between CypA and ligands 
There is only direct hydrogen bond formed between family_D ligands and CypA, 
which is the hydrogen bond with the bond length of 2.9 A between atom N of 
Asn_102 and 0_15 of ligand EM4351. 
Van der Waals contacts between CypA and ligands 
Tables (32) and (34) shows that CypA residues His_ 126, Leu_ 122, Phe_1 13, 
Asn_102, Ala_101, Met_61 and Gln_63 are involved Val de Waals interactions with 
family_D ligands. The following van der Waals contacts between family_D ligands 
and CypA are conserved: the contact between the residues (Phe_113, Ala_101) and 
the two methyl group's carbon atoms (C_9 and C_lO); the contacts between atom 
C_12 of family_D ligands and residue Ala_101. The conserved van der Waals 
contact distance range is from 3.2 A to 3.9 A. A schematic presentation of the 
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Figure (43) Interactions between CypA and family_D ligands. The residues 
connected to ligand by dash make hydrogen bonds with ligands and the rest residues 
make van der Waals contact with ligands. Three water molecules (HOH_6, HOH_15 
and HOH_5 1) are expelled by the bound family_D ligands. Conserved van der Waals 
contacts appear between family_D ligands atoms (C_9, C_1O and C_12) and CypA 
residues (Ala_101and Phe_1 13). 
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Chapter eleven 
Summary and discussion of structures of CypA-ligand complexes 
This chapter covers the main features important for ligand binding (hydrophobic 
interactions, hydrogen bonding interactions, water molecules and ligand binding 
modes) and the correlation between these structural features and measured binding 
strength. 
1. The binding modes of ligands 
On the surface of CypA, there is a cleft shaped active site and ligand binding site, 
which has been highlighted by the yellow square in figure (1). At the bottom of the 
active site of CypA, lies a hydrophobic pocket. The active site of CypA is relatively 
rigid. 
FT \d i( )pbabic IOCkC 
Figure i ii ( tJiIiIOlI\ 	111 ace ol C\ j.A. B Iuc iej)ieeiit iiitrtgeil. red o.' gen. \\ hi Ic 
carbon, yellow sulphur. WITNOTP was used to produce this figure. 
Upon ligand binding to CypA, some water molecules are displaced and others around 
the active site rearranged. The water molecules close to the bound ligands shift to 
make hydrogen bonds with ligands or CypA. The bound ligands can also introduce 
some new water molecules through hydrogen bonds into the active site of CypA. The 
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water molecules more than 4 A away from bound ligands do not appear to change 
location. 
Although the active site of CypA is relatively rigid and does not change significantly 
when ligands bind to it, the side chain conformations of several residues (Arg_55, 
Met_61, Gln_63 and His_126) change upon the binding of ligands. In particular, the 
side chain conformation of Arg_55 has the maximum movement of 0.87 A. The side 
chain conformation of Met_6lvaries from X3 (CE-SD-CG-CB) 115.50  in the 
unliganded structure to X3 (CE-SD-CG-CB) of 196.4 ° bound to ligands. 
Generally, all the ligands bind to the CypA in a similar mode, as is shown in figure 
(3). All ligands is located in the cleft on the surface of CypA. The dimedone part of 
all the ligands are accommodated by the hydrophobic pocket of CypA. In total 
fourteen residues are involved in the hydrogen bonding or van der Waals interactions 
with all the four families' ligands. These 14 residues are: His54, Arg_55, Phe_60, 
Met_61, Gln_63, Gly_72, Thr_73, Ala_101, Asn_102, Asn_103, Gin_ill, Phe_1l3, 
Leu_122 and His_126. Among the 14 residues, five residues (Arg_55, His_54, 
Gln_63, Asn_ 102 and His_ 126) are conserved in making direct or water-bridged 
hydrogen bonding interactions with all ligands, figure (2). It is shown in figure (2) 
that the fourteen residues cover almost the whole cleft of the active site. 
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Figure (2) CypA active site residues involved in the hydrophobic interactions and 
hydrogen bonding interactions with ligands. The dot surface represents all the 14 
residues which are involved in the interactions with ligands. His54, Arg_55, Phe_60, 
Met_61, Gln_63, GIy_72, Thr_73, Ala_101, Asn_102, Asn_103, Gin_ill, Phe_1 13. 
Leu_122 and His_126. The ball-stick model represents the residues making hydrogen 
bonds with ligands. Arg_55. His_54. Gln_63, Asn_102 and His_126. 
ptIl.j 
Figure (3) Superposition of all ligands of this project. Blue represents the surface of 
CypA. The stick models represent bound ligands. All the bound ligands are located 
in the cleft of the active site. 
The dimedone groups of all the ligands are located in the hydrophobic pocket: 
however the orientations of dimedone groups vary. Dimedone groups of ligands of 
familyA. familyB and family_D adopt similar orientations such that the two 
methyl groups of the dimedone moiety point into the hydrophobic pocket, and the 
two methyl group are conserved in making van der Waals contacts with CypA; 
however, the two methyl groups of dirnedone groups of familyC ligands point away 
from hydrophobic pocket, as is shown in the following figure (4). The different 
binding mode of the familyC ligands is not surprising as they have a rather different 
chemical structures in which the two methyl groups of ligands of familyC are next 
to one of the carbonyl oxygen atom. The hydrogen bonded carbonyl seems to 
dominate the ligand protein interaction and forces the two methyl groups of that 
family to point out of the hydrophobic pocket. Although the orientations of the 
dimedone moieties of all the four families ligands are different, the favoured 
electrostatic interactions between the it cloud of the phenyl ring on the bottom of the 
hydrophobic pocket and the CH3 groups or CH2 groups on the dimedone moiety are 
conserved. 
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Figure (4) Binding mode of dimedone groups in the hydrophobic pocket. Blue dots 
represents hydrophobic pocket surface of CypA. Green balls represents the two 
methyl groups on the dimedone group of ligand EM42 11, and blue balls represents 
the two methyl groups on the dimedone group of ligand EM9. 
Ligand binding is a complicated phenomenon and involves water molecule 
displacements and induced conformation change of the side chains of the residues 
around the binding site. The ligands with the similar chemical structures have similar 
binding modes, although the detailed interactions between each ligand and protein 
are different. Therefore it will be of interest to predict the binding mode of families 
of ligands given the binding mode of one ligand with a similar chemical structure. 
2. The relationship between binding strength and 3D structure 
One basic and important principle between structure and property is that the structure 
determines the property. It is therefore the interactions (binding constant or 
dissociation constant) between a ligand and a target protein can be derived from its 
complex structure. Equation (1) describes the relationship between the dissociation 
constant (Kd) and the free energy change (AG°). 
EiG° = RT1nKd 	(1) 
(EG° = - RT in Ka) 
R: universal gas constant (8.314 J IC 1 mol') 
T: absolute temperature 
Ka: association constant 
Kd: dissociation constant 
The free energy change is reiated to the enthalpy and entropy changes (iH °, tS°), as 
shown in equation (2) 
iG° =LH° -TAS ° 	(2) 
Combine equation (1) and (2) to give equation (3) 
tH° -TES ° =RT1nKd 	(3) 
Therefore, the dissociation constant Kd is reiated to the enthalpy and entropy change. 
In a ligand binding system, the enthalpic changes (AH °) mainly come from the 
formation of hydrogen bonds, salt bridges, hydrophobic interaction and electrostatic 
interaction between ligand and target protein" 2. Especially, the hydrophobic surface 
buried from solvent was found to be proportional to the free enthalpy of binding 3 ' 4 . 
The entropic changes are mainly contributed by the loss of rotational freedom of the 
rotatable bonds in the unbound ligands and the loss of translationallrotational 
freedom of the two unbound molecules (free ligand and free protein target) when 
protein/ligand complex is formed 5 ' 6 . The entropy change caused by displacement of 
bound water also plays an important role. 
The determination of the relationship between structural information and binding 
constant is of importance to computer-aided drug design. All the published empirical 
relationships between structural information and binding constant assume that the 
free energy change (AG °) can be broken up to several additive components (i.e. the 
number of hydrogen bonds, the number of ionic interaction, the buried area, the 
electrostatic interaction, the size of ligand and the number of rotatable bonds of 
ligands)5 ' 7 . In particular, the number of hydrogen bonds and the area of buried 
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surface, which are used to measure the desolvation effect, are of interest. It is 
suggested the hydrogen bond should be divided into strong hydrogen bonds and 
weak hydrogen bond, buried hydrogen bonds and solvent accessible hydrogen bonds 
when taking into account the effects of the number of hydrogen bonds 8 . 
In order to find out a relationship between the binding constants and the structural 
features, in this work the multi-variants regression between the structurally binding 
features and binding constant was carried out along including the parameters of 
buried area and the number of hydrogen bonds which have been divided two 
categories: strong hydrogen bonds with bond length less than 3 A, and weak 
hydrogen bonds with the bond length greater than 3A. 
All the parameters required for multi-variants regression analysis are listed in table 
(1). Table (2) listed the details of the hydrogen bonds and table (3) listed the 
conserved van der Waals contacts among the family_A, family_B and family_C 
ligands.The buried surface area was calculated using program WITNOTP 9 . The 
program uses the method described by Richards' ° . Therefore a probe water molecule 
with a radius of 1.4 A rolls around the protein surface and the area traced by the 
centre of the probe water molecule is the solvent accessible surface area. The buried 
area is the difference of the solvent accessible area between the complex molecule of 
protein with bound ligand and the sum of the solvent accessible surface of protein 
plus the solvent accessible surface of ligand. 
Buried area = (S prote in + S ligand)  S complex 
S: solvent accessible area 
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Ligand Structure 	Kd (JiM) Number Buried area Number of Hb to Number Number 
of water (A2) protein directly or of Hb to of Hb to 
molecules water-bridged protein water 
displaced Hb<3.OA Hb>3.OA directly 
EM4101 20±2 
C r xoJCo 
8 232.2 1 	1 1 2 
EM234 22±2 
cL r5cö o 
8 221.9 1 	1 2 2 
EM4351 45±2 
1 )~10 
3 148.7 4 	0 1 4 





70±2 	5 	190.1 	1 	0 	1 	5 
°A 
EM5123 	 85±2 	7 	179.2 	0 	1 	0 	1 
EM34821 130±2 	- 	 170.8 	1 	0 	1 	0 
EM4331 	 134±2 	4 	110.4 	0 	2 	1 	1 
0 A- 0 
Table (1): Buried area and number of hydrogen bond between the bound ligand and 
CypA and the dissociation constant of ligands to CypA. Buried area: the total buried 
area between ligands and CypA. Hbez3.0 A: the number of hydrogen bonds with a 
distance of less than 3.OA. Hb>3.0 A: the number of hydrogen bonds with a distance 
of between 3.0 A-3.5 A. The low resolution data of EM34821 does not allow the 
ambiguous water determination. 
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Acceptor Donor Distance (A) 
EM410I 166 N13 HOH 311 0 3.29 
EM4101 166 09 HOH 50 0 2.96 
EM4101 166 09 ARG 55 NH2 3.20 
EM234 166 028 HOH 379 0 2.51 
EM234 166 09 HUH 309 0 2.73 
EM234 166 019 GLN 63 NE2 2.70 
EM234 166 019 HIS 54 NE2 3.33 
EM4351 166 08 HOH 212 0 2.92 
EM4351 166 07 HOH 278 0 3.00 
EM4351 166 07 HUH 180 0 2.60 
EM4351 166 013 HOH 389 0 2.35 
EM4351 166 015 ASN 102 N 2.88 
EM4211 166 020 HOH 53 0 2.64 
EM4211 166 028 HOH 28 0 2.71 
EM421 1 166 09 HOH 92 0 2.77 
EM4211 166 019 GLN 63 NE2 2.66 
EM4211 166 019 HIS 54 NE2 2.67 
EM4181 166 019 HOH 383 0 3.31 
EM4181 166 019 HOH 379 0 3.06 
EM4181 166 012 HUH 379 0 2.55 
EM4181 166 09 HOH 396 0 3.08 
EM4181 166 09 HOH 309 0 3.25 
EM4181 166 020 GLN 63 NE2 2.87 
EM5123 166 07 HOH 70 0 3.07 
EM34821 166 012 ARG 55 NH1 2.74 
EM4331 166 09 HUH 374 0 3.27 
EM4331 166 09 ASN 102 N 3.08 
Table (2) Hydrogen bonds between ligands and CypA and hydrogen bonds between 
ligands and water molecules. 
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Ligand atoms CypA atoms Distance (A) 
EM4101 166 C29 HIS 126 CE1 3.72 
EM4101 166 C7 HIS 126 CE1 329 
EM410I 166 C6 HIS 126 CE! 3.37 
EM4101 166 Cl HIS 126 CE! 3.86 
EM4101 166 C7 HIS 126 CG 3.85 
EM410I 166 Cl LEU 122 CD2 3.88 
EM4101 166 C7 LEU 122 CDI 3.29 
EM4I01 166 C7 PHE 113 CZ 3.30 
EM4I01 166 C7 PHE 113 CE2 3.87 
EM4I01 166 C7 PHE 113 CE1 3.29 
EM4101 166 C8 PHE 113 CD2 3.78 
EM410I 166 C8 PHE 113 CD! 3.57 
EM4101 166 Cl PHE 113 CD! 3.81 
EM4101 166 C8 PHE 113 CO 3.48 
EM234 166 C6 HIS 126 CE! 3.83 
EM234 166 Cl LEU 122 CD! 3.52 
EM234 166 Cl PFIE 113 CD2 3.38 
EM234166 Cl PHE 113 CE2 3.27 
EM234166 Cl PilE 113 CZ 3.26 
EM234 166 Cl PI-IE 113 CE! 3.34 
EM234 166 C6 PHE 113 CDI 3.79 
EM234 166 Cl PHE 113 CD! 3.43 
EM234 166 Cl PHE 113 CO 3.41 
EM4351 166 ClO PFLE 113 CD2 3.77 
EM4351 166 ClO PHE 113 CE2 3.84 
EM4351 166 ClO PHE 113 CZ 3.89 
EM4351 166 C!0 PHE 113 CEI 3.85 
EM4351 166 C!0 PHE 113 CDI 3.76 
EM4351 166 C9 PHE 113 CDI 3.47 
EM4351 166 ClO PHE 113 CO 3.73 
EM4211 166 C4 	 HIS 126 CE! 	 3.54 
EM4211 166 C3 	 HIS 126 CE! 	 3.81 
EM4181 166 Cl HIS 	126 CEI 3.59 
EM4181 166 Cl LEU 122 CD2 3.80 
EM4181 166 Cl LEU 122 CDI 3.81 
EM4181 166 C8 PHE 113 CD2 344 
EM4181 166 CS PilE 113 CE2 3.65 
EM4181 166 C8 PilE 	113 CZ 3.15 
EM4181 166 CS PHE 113 CE1 3.67 
EM4181 166 C8 PHE 113 CDI 3.46 
EM4181 166 C8 PHE 113 CO 3.39 
EM5123 166 C!0 	 HIS 126 CD2 
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EM5123 166 Cli HIS 126 CE! 3,53 
EM5123 166 ClO HIS 126 CEI 334 
EM5123 166 ClO LEU 122 CD! 3.68 
EM5123 166 ClO PHE 113 CZ 3.35 
EM5123 166 ClO PHE 113 CE! 3.20 
EM5123 166 C9 PFIE 113 CDI 3.67 
EM5123 166 ClO PFIE 113 CD! 3.75 
EM5123 166 C9 PHE 113 CG 3.82 
EM34821 166 C4 HIS 	126 CE! 3.23 
EM34821 166 C5 HIS 126 CE! 3,74 
EM34821 166 C8 LEU 122 CD2 3.68 
EM34821 166 C8 LEU 122 CD! 3.72 
EM34821 166 Cl PHE 113 CD2 3.10 
EM34821 166 Cl PHE 113 CE2 3.22 
EM34821 166 Cl PHE 113 CZ 3.32 
EM34821 166 C! PHE 113 CE! 3.30 
EM34821 166 C! PHE 113 CD! 3.16 
EM34821 166 C! PHE 113 CG 3.08 
EM34821 166 Cl PHE 113 CB 3.88 
EM4331 166 C3 HIS 126 CE1 3.89 
EM4331 166 C8 LEU 122 CD1 3.82 
EM4331 166 C29 PHE 113 CE! 3.78 
EM4331 166 C29 PHE 113 CD! 3.30 
EM4331 166 C29 PFIE 113 CG 3.79 
Table (3) The conserved van der Waals contacts among family_A, family_B and 
family C ligands. 
The hydrophobic interactions and hydrogen bonding interactions are two important 
factors in ligand binding. For example, ligands EM4101 and EM234 have very 
similar chemical structures (table (1)), and both ligands form the same amount of 
hydrogen bonds to protein directly or water-bridged, also the corresponding 
complexes have similar buried area (232.2 and 221.9 A2), therefore their dissociation 
constants (Kd) are similar to each other (20±2 and 22±2 tIM). However, it is 
suggested by several researchers that the hydrophobic interactions contribute more in 
ligand binding then hydrogen bonding interactions. Chothia" 12 thought for the first 
time that the hydrophobic effect was the main factor rather than hydrogen bonding 
interactions in stabilizing protein-ligand complexes and suggested to relate its effect 
to the contact area and other researchers also proposed similar ideas 13 ' 14 .Some 
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experimental facts also support the proposal that hydrophobic interactions are more 
important than hydrogen bonding interactions in ligands binding. For example, there 
is no hydrogen bonding interaction between the retinal binding protein and retinal, 
whose dissociation constant is in the nanomolar range' 5 . In some complexes, many 
hydrogen bonds are formed between ligand and protein, but the binding affinity is 
low and in the millimolar range, (i.e. glycogen phophorylase/glucose 16 , 
hemagglutinin/sialic acid' 7 , glutathione S transferase/glutathione' 8), and the common 
structural feature is that these ligands do not have significant hydrophobic groups. 
The results from this project also support the idea that the hydrophobic interaction 
plays a more important role than hydrogen bonding interactions. The comparison 
between ligands EM234 and EM435 1 gives a similar result. Both ligands EM234 and 
EM435 1 form 4 hydrogen bonds with protein, but the binding strength of EM234 
(Kd=22±2 pM) is two times stronger than EM4351 (Kd=45±2 .tM) because the 
buried area of EM234/protein complex (221 .9A 2) is almost two times of the buried 
area of EM435 1/protein (148.7A 2). The enthalpy and entropy based explanation on 
the hydrophobic interaction is that the hydrophobic interaction contributes both to the 
enthalpy and to the entropy gain because hydrophobic interactions are mainly caused 
by the replacement or release of ordered water molecules and therefore are entropy-
driven' 9 ' 20. The entropy gain comes from the release of bound water molecules. The 
enthalpy gains come from the hydrophobic interactions between ligand and protein, 
and also the processes that the bound water molecules, which occupy the 
hydrophobic pocket and can not form hydrogen bonds with protein, become to form 
hydrogen bonds with other water molecules 5 . 
The loss of the rotatable bonds results in the loss of entrop' 7. Therefore rigid 
ligands should have stronger binding than the flexible ligands because the rigid 
ligands lose less rotatable bonds than the flexible ligands when binding to protein. 
The results from this project also provide the experimental evidence for that. Both 
ligands EM5 123 and EM34821 form one hydrogen bond with protein and the 
corresponding complexes have almost the same buried area (179.2 A 2 and 170.8 A2) )  
however the binding strength of EM5 123 (Kd=85±2 p.M) is 1.5+ times stronger than 
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the binding strength of EM34821 (Kd=130±2jiM). The good reason for that is 
EM5 123 (three rotatable bonds) is more rigid than EM3482 1 (seven rotatable bonds) 
During computer-aided drug design, it is very important to use a simple equation, 
which defines the relationship between structural features and binding strength, to 
prioritise a large number of candidate compounds selected by docking, building or 
linking strategies 8 . Some simple linear equations have been reported to relate the 
structural features and binding strength. Bohm 7 ' 21 using linear equation containing 
only three parameters, the number of hydrogen bonds, area of buried surface and the 
number of rotatable bonds of the ligands, described well the relationship between 
structural features of complex structures and experimental binding strength of 82 
protein/ligand complexes. McMartin 22 and Schneider23 also observed a linear 
relationship between the binding constant and the number of hydrogen bonds and 
hydrophobic contacts. 
In this project, according to the information in table (1), the variants, Kd, buried area, 
Hb<3.0 A, Hb>3.0 A, are put into one linear equation using a least squares 
regression method. The parameter of the number of displaced water molecules is not 
involved in the regression analysis since the effect of displacing water molecules 
overlaps with the effect of hydrophobic interactions which is measured as the buried 
area. In the ligand binding process, ligands are free in solution and form hydrogen 
bonds with water molecules (ligand --- H --- OH) before they bind to protein. When a 
ligand binds to protein, the formation of direct or water-bridged hydrogen bonds 
between ligand and protein (ligand---H --- protein, ligand --- HOH --- protein) contribute 
to the enthalpy gain. During the process from free ligand in solution to bound ligand 
in the protein/ligand complex, the maintenance of the hydrogen bonds between 
ligand and water molecules (ligand --- H --- OH) makes no net contribution to enthalpy 
or entropy gain if no water-bridged hydrogen bond between ligand and protein 
(ligand --- HOH --- protein) forms. Therefore the parameter describing the number of 
the hydrogen bonds which connect ligands and only water molecules 
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(ligand --- H --- OH) is also excluded from the regression analysis. The regression was 
carried out using Mintab (http://www.minitab.com/)  and the resulting equation is as 
follows and correlation coefficient (R 2) of the equation is 99.5%. 
	
Kd = 238 	- 0.815 x (Buried area) - 17.9 x (Hb<3.OA) - 6.70 x (Hb>3.OA) 	(1) 
It is exciting that the structural features of the complex structures and measured 
binding constants are very well correlated by a simple linear equation. The plot of the 
experimental values of Kd against the calculated values from the regression equation 
Kd = 238 - 0.815 x (Buried area) - 17.9 x (Hb<3.OA) - 6.70 x (Hb>3.OA) shows that 
most points lie close to the diagonal line and only one point representing ligand 
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Figure (5) The plot of experimental Kd against calculated Kd. The calculated Kd 
from the equation: Kd = 238 - 0.815 x (Buried area) - 17.9 x (Hb<3.OA) - 6.70 x 
(Hb>3.OA). Ligand EM421 1 are not consistent with the equation. 
197 
For all the ligands which have been shown to bind CypA in this project, the 
hydrophobic interactions between the dimedone parts of all the ligands and the 
hydrophobic interaction are present and important. All the ligands made in this 
project are the derivatives of the compound dimedone. Therefore the chemical group 
of the dimedone part is a common structural feature among all the ligands made in 
this project. Hence it may be reasonable to compare the binding mode of the 
dimedone parts of all the ligands in order to explain the behaviour of the outlier 
ligand EM42 11. Figure (6) shows the binding modes of all the self-consistent ligands 
and the ligand EM42 11. It's clear that the CH3 groups of the self-consistent ligands, 
which are represented by the red balls, point into the hydrophobic pocket of CypA, 
while the Cl-I 3 groups of the outlier ligand EM42 11, which are represented by the 
green balls, point away from the hydrophobic pocket of CypA. The reason why the 
two CH3 of the outlier ligand EM42 11 point away from the hydrophobic pocket is 
because the two CH 3 on the dimedone part of the ligand EM421 I are on the position 
next to one of the carbonyl oxygen atom, which was discussed in the chapter of 
family....0 ligand. 
Figure (6) Superposition of the dimedone groups of all the ligands. The blue dots 
represent the surface of part of the active site of CypA. The cleft around which the 
ligands are bound is the hydrophobic pocket of CypA. The red ligands represent the 
self-consistent ligands: the green ligand represents the outlier ligand EM421 I that is 
not consistent with the others in terms of the relationship between the structurally 
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binding features and the value of Kd (dissociation constant). The balls represent the 
CH3 groups. Only the dimedone parts of the whole ligands are shown. 
As for the outlier of EM42 11, the different binding mode resulting from the shifting 
of the dimethyl group on the dimedone part from the original position to the next 
position (oo ----- 4  oL).  This breaks the relationship between the structure 
features and binding strength which is represented by the equation. Therefore the 
equation applies only to ligands which bind the protein in the same mode. 
If the ligand binds to the protein in the same mode, then the equation could be used 
to predict the binding strength, combined with modelling and used to guide the 
ligand design. This equation also shows that strong hydrogen bonding interactions 
(17.9 for the coefficient of Hb < 3A) contribute more to the binding strength than 
weak hydrogen bonding interactions (6.7 for the coefficient of Hb> 3A). Hence, 
classification of the hydrogen bonding interactions can possibly increase the 
accuracy of the scoring function. 
It is very complicated to define accurately the binding strength by all the factors that 
are involved in binding, as some factors are difficult to quantify. In this project 
however, the binding strength of the ligands is well defined by only three parameters: 
the buried area, the number of hydrogen bonds greater than 3 A and the number of 
hydrogen bonds less than 3 A. Why can only three parameters effectively describe 
the binding strength? A possible explanation is because the similarity of the binding 
mode and the chemical structures of the ligands, and the constant appearing in the 
equation accounts for all the combined contributions from the unparameterized 
factors, except for van der Waals interactions and hydrogen bonding interactions that 
are present in the equation. 
In order to enable the equation to describe the binding of more ligands, more factors 
than van der Waals interaction and hydrogen bonding need to be parameterised. 
Besides van der Waals interactions and hydrogen bonding interactions, the surface 
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electrostatic potential analysis around the binding interface of protein and ligand can 
be very useful for helping to guide modifications of ligands and improve binding. 
3. The guidance for the next round of CypA ligands design 
As described previously, 14 residues around the active site of CypA (His54, Arg_55, 
Phe_60, Met_61, Gln_63, Gly_72, Thr_73, Ala_101, Asn_102, Asn_103, Gin_ill, 
Phe_i13, Leu_122 and His_126) form hydrogen bonds with ligands synthesized for 
this project. Further, these 14 residues cover most of the active site of CypA. 
Therefore these 14 residues can be considered as a simplified model of the active site 
of CypA for potential hydrogen bonding interactions during the next round ligands 
design. 
All the ligands synthesized in the project are the derivatives of the dimedone 
structure and all the dimedone moieties occupied a similar area around the active site 
of CypA. Hence, this suggests that the dimedone moieties of new ligands to be 
designed will occupy the same general area as those of the ligands presented in this 
thesis, which should help the modelling during the new ligand designs. 
The work presented in this thesis also shows that the rigid ligands have higher 
affinity than flexible ligands, and the hydrophobic interaction plays important role. 
Therefore the new ligands to be designed in next round can be more rigid and 
hydrophobic. 
All the ligands presented in this thesis are small molecules compared to CsA and do 
not occupy the whole active site of CypA (figure (7)). Therefore a new dimedone 
derivative ligand has been designed in order to mimic the extended binding mode of 
CsA (figure (8)) and the modelling shows that the new designed molecule fits well 





Figure (7) Superposition of the complex structures of CypAIEM 234 and CypA/CsA. 
Stick model represents CsA and ball-stick model represents ligand EM234. The 
example in this figure shows that ligarid EM234 occupies the top half of the active 
site of CypA. 
CroL 
Figure (8) Chemical structure of proposed new ligand. 
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Figure 9 Modelling of proposed new ligand oiilo cyclosporin A. The green model 
represents Cyclosporin, and coloured one represents the new ligand. 
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Chapter twelve 
Crystal structure of the complex of FKBP12 with dipeptide Leu-Pro 
1. Introduction 
FKBP12, with the apparent molecular weight of 12kDa, is a member of the FKBP 
immunophilin family and the receptor of the immunosuppressive drug FK506 12 . 
FK506 inhibits T-cell activation by mechanisms that are similar to those of CsA, but 
FK506 is 10 to 100 times as potent 3 . 
The complex of FKBP12 and FK506 interacts with calcineurin so that NFAT 
(nuclear factor of activated T cells) downstream in the immune response pathway 
can not be dephosphorylated, which results in the immunosuppression 4. This 
mechanism is analogous to that of CsA complexed with CypA. FKBPI2 possesses 
peptidyl-prolyl isomerase activity (PPIase), which can be inhibited by FK506 and 
raparnycin" 2 . However, inhibition of PPIase activity is not directly related to 
immunosuppression since a number of compounds were found that inhibited the 
PPIase activity of FKBP12, but did not result in immunosuppressive reaction 5 . 
FKBP12 and cyclophilin A are their receptors of the respective immunosuppressive 
drugs (FK506 and CsA), both show PPIase activities 6, but there is no sequence 
homology or 3D structure resemblance between them. 
Isomerization of peptidyl-prolyl bonds is regarded as the rate-limiting step in protein 
folding. As for the PPIase catalytic mechanism, some possibilities have been 
proposed, such as substrate distortion, covalent binding of substrate, substrate self-
catalysis, desolvation 7 ' 8 . A substrate containing a leucyl-prolyl dipeptide was found 
to be optimal for FKBP9 ' 10, but to date, there is no published crystal structure of a 
complex of FKBP 12 with any peptide ligands. This structure therefore provides the 
first experimental picture of how FKBP interacts with a natural substrate. The 
sequence of human FKBPI2 consists of 107 amino acid residues, which is shown as 
follows. 
GVQVETISPG DGRTFPKRGQ TCVVHYTGML EDGKKFDSSR DRNKPFKFVL GKQEVIRGWE 
EGVAQMSVGQ RAKLTISPDY AYGATGHPGI IPPNATLIFD VELLKLE 
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A number of X-ray structures of FKBP complexed with FK506 and derivatives have 
been published. These show the FKBP12 3D structure consists of five f3—sheet 
strands and a short a-helix sitting above the n-sheets". 
Figure (1) FKBP12 Overall structure, there areS 3-sheet strands and one short 
a-he! ix 
2. Methods 
Preparation of Leu-Pro: Leu-Pro was bought from Sigma-Aldrich. The peptide was 
dissolved in H 20 to make a stock solution with the concentration of 400mM. 
Soaking solution was prepared by diluting the stock solution into the mother !iquor 
from which FKBP12 crystals grow. 
Crystallization of FKBP: A FKBP12 crystal was obtained by the vapour diffusion 
hanging drop method. The crystallization condition was that used by Burkhard. P., 
PhD Thesis (1995). The well solution contains: Tris-HC1 pH8.0 100mM. saturated 
ammonium sulphate 58-61%. DMSO 5%, NaN3 0.02%: The initial FKBP12 
concentration was 15mg/mi, the hanging drop was made by mixing FKBP12 protein 
solution and well solution with the ratio of I j.tl : I 1.1!. 
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Figure (2) Single FKBP12 crystal. The crystallization well consists of Tris-HCI 
pH8.0 100mM, saturated ammonium sulphate 58%. DMSO 5%, NaN1 0.02%. The 
initial FKBP12 concentration is 15mg/mi. 
Soak Leu-Pro into FKBPI2 crystals: As discussed previously, crystals grown in 
the presence of DMSO need to have DMSO removed as it binds in the active site. A 
stepwise approach was taken to soak out DMSO, to maintain crystal quality. The 
concentration gradient of DMSO is 3%, 2%, 1%, 0%, and the concentration gradient 
of Leu-Pro is 20mM. 80mM. and 100mM. The crystal was transferred from the 
highest concentration of DMSO to the highest concentration of Leu-Pro through this 
concentration gradient. 
Data processing and structure refinement: Data was collected at lOOK and 
processed and scaled by DENZO 12 , the structure refinement was done by 
REFMAC' 3 and structure figures and electron density maps were made by program 
WITNOTP. The electron density map Fo-Fc are drawn with a level of around 2 and 
2Fo-Fc are drawn with a level of 1 a. 
3. Results 
The X-ray diffraction data and refinement parameters of complex FKBP12 with 









Space group C2 
Resolution (A) 2.3 
Rmerge (%) 6.9 (29.0) 
7.9(1.8) 
Overall completeness (%) 98.8 (99.4) 
Unique reflections 9046 
Total No. of reflections 100410 
X-ray source home source 
Detector IP mar345 
Wavelength (A) 1.5418 
Rfactor(%) 24.4 
Free R factor (%) 30.0 
No. of water molecules 207 
Ramachandran plot, most favored (disallowed) (%) 87.8(0) 
B factor (protein average) (A2) 53.4 
B factor (water average) (A2) 64.5 
B factor (ligand) (A2) 73.9 
Table (1) The FKBP12-LP complex data and refinement parameters 
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The native structure of human FKBP12 was used as the starting model for molecular 
replacement. Water molecules are added using the program ARP/WARP. After the 
model of protein with water molecules is fully refined, difference electron density 
maps are made around the active site of the model structure. figure (2). The green 
continuous map indicates the bound ligand. The structure was refined using data to a 
Fi.zuie ( ) Electron denitv map around the active site of FKBP- 12: Green density 
represents 2Fo-Fc map, red represents Fo-Fc map. Both maps were made with the 





Figure 4) 2Fo-Fc electron density map contoured at 1.1 a level around the Leu-Pro. 
The map was calculated with the presence of Leu-Pro. 
From figure (3), it is clear that there is continuous electron density in the active site. 
The green 2Fo-Fc map is stronger than the Fo-Fc omit map, but both maps show the 
existence of clear density for bound Leu-Pro. The ligand Leu-Pro was built into the 
density. The structure was then subjected to further rounds of refinement with bound 
Leu-Pro in the active site. The electron density map was improved, showing clearly 
the bound ligand Leu-Pro (figure (3)). The peptide bond of Leu-Pro was observed to 
be twisted. The torsion angle (010-C9-N8-C4) is 154.7 °. The proline ring points 
inside the hydrophobic pocket of FKBP12. The keto oxygen atom 010 points away 
from the active site. The Connolly surface representation (figure (5)) shows that 
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Li Iva, 
Leu-Pro makes good hydrophobic and hydrogen bonding interactions with the active 
site of FKBP12. 
Figure (5) Leu-Pro is well located in the active site of FKBP-12. Ball model 
represents Leu-Pro, the rest represents the Connolly surface of FKBP 12. White 
represents carbon atoms, red for oxygen atoms, blue for nitrogen atoms, and yellow 
for sulphur atoms. 
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Figure (6) Supctp 	un ot We dctl\e i[e 	oc !k'Bl1 and kBl12 
complexed with Leu-Pro. Red balls represent water molecules in the active site of 
native FKBPI2 
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Figure (7) Superposition of main chains of native FKBP1 2 and FKBP1 2 complexed 
with Leu-Pro, R.M.S. is 0.2 iA 
Superimposing of native FKBP- 12 and FKBP- 12 /Leu-Pro, produces an rmsd for the 
main chain atoms of 0.21 A. The main chain of FKBP1 2 shows no significant change 
upon the binding of Leu-Pro, as shown in figure (7). Around the active site, there is 
also no significant movement for side chains after Leu-Pro binds to the protein as 
shown in figure (6), which indicates that the active site of FKBPI2 is quite rigid. 
However, the water structure of native FKBPI2 changed upon the binding of Leu-
Pro. Six water molecules HOH_201. HOH_202. HOH_3, HOH_204, HOH_5 and 
HOH_206 bound in the active site of native FKBPI2 were replaced by Leu-Pro. 
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Figure (8) Hydrogen bond interactions between Leu-Pro and FKBPI2. Red balls 
represent water molecules. 
A number of hydrogen bonds mediate the interaction between Leu-Pro and FKBP- 12 
and anchor Leu-Pro to the active site. All four hydrogen bonds to Leu-Pro are less 
than 3A, as shown in Figure (8). His87 on the symmetry related neighbour molecule 
makes a strong hydrogen bonding interaction of 2.7A with Leu-Pro. The proline ring 
of Leu-Pro makes hydrophobic interactions with the hydrophobic cluster in the active 
site of FKBP12 formed by Trp_59. Phe_99, Phe_46 and Phe_36. 
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PROCHECK 
R amach andran Plot 
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Figure (9) Ramanchandran plot of FKBP-Leu-Pro complex 
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4. Comparsion of the complexes between FKBPILeu-Pro and FKBPIFK506 
Two complex crystal structures are superimposed together in figure (11). The van 
der Waals contacts and hydrogen bonding contacts are listed in tables (3), (4), (5), (6) 
and schematically presented in schemes (1) and (2). 
Donor Acceptor Distance (A) 
TYR 	82 OH FK506 108 03 2.77 
ILE 56 N FK506 108 02 2.81 
FK506 108 010 GLU 54 0 2.67 
FK506 108 06 ASP 37 0D2 2.82 
Table (3) Hydrogen bonds between FKBP12 and FK506 
Donor 	 Acceptor 	Distance (A) 
ILE 56 N 	Leu_Pro 499 016 	2.97 
Table (4) Hydrogen bonds between FKBP12 and Leu-Pro 
Residue 1 Residue 2 Distance (A) 
LEU_PRO 499 C3 IILE B 91 CG1 3.52 
LEU_PRO 499 C3 ILE B 90 CG2 3.61 
LEU_PRO 499 C12 TRP B 59 CZ2 3.09 
LEU_PRO 499 C13 TRP B 59 CZ2 3.31 
LEU_PRO 499 C12 TRP B 59 CH2 3.05 
LEUPRO 499 C13 TRP B 59 CH2 3.76 
LEU_PRO 499 C12 TRP B 59 CZ3 3.61 
LEU_PRO 499 C12 TRP B 59 CE2 3.66 
LEU_PRO 499 C13 TRP B 59 CE2 3.31 
LEU_PRO 499 C15 VAL B 55 CA 3.75 
LEU_PRO 499 Cli PHE B 46 CZ 3.69 
LEU_PRO 499 Ci 1 PHE B 46 CE1 3.40 
LEU_PRO 499 Ci 1 PHE B 46 CD1 3.55 
LEU_PRO 499 Cli TYR B 26 CE2 3.52 
LEU_PRO 499 C12 TYR B 26 CE2 3.36 
LEU_PRO 499 Cli TYR B 26 CZ 3.43 
LEU_PRO 499 C12 TYR B 26 CZ 3.33 
LEUPRO 499 C12 TYR B 26 CE! 3.75 
Table (5) Van der Waals interactions between FKBP12 and Leu-Pro with distance 
less than 3.8 A. 
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Atom 1 Atom 2 Distance (A) 
FK506 108 C35 ILE 91 CD1 3.63 
FK506 108 C4 TRP 59 CH2 3.70 
FK506 108 C4 TRP 59 CZ3 3.77 
FK506 108 C5 TRP 59 CZ2 3.73 
FK506 108 C4 TRP 59 CZ2 3.62 
FK506 108 C4 TRP 59 CE3 3.77 
FK506 108 C4 TRP 59 CE2 3.60 
FK506 108 C3 TRP 59 CE2 3.39 
P1(506 108 C4 TRP 59 CD2 3.67 
FK506 108 C3 TRP 59 CD2 3.56 
FK506 108 C3 TRP 59 CD1 3.72 
FK506 108 C3 TRP 59 CG 3.72 
FK506 108 C41 PFIE 46 CZ 3.72 
FK506 108 C4 PHE 46 CE1 3.52 
FK506 108 CS TYR 26 CZ 3.78 
Table (6) Van der Waals interaction between FKBP12 and FK506 with distance less 
than 3.8 A. 
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Scheme (1) The hydrogen bonding and hydrophobic interactions between FKBP and 
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Scheme (2) The hydrogen bonding and hydrophobic interactions between FKBP and 
FK506. The scheme is made using LIGPLOT. 
Both ligands FK506 and Leu_Pro bind FKBP12 in the active site. Several conserved 
contacts appear through the comparisons of the two complex structures. Tables (5) 
and (6) show that both ligands make van der Waals contacts with residues lle_9 1, 
Trp_59, Phe_46 and Tyr_26. Among the 4 conserved van der Waals contacts, 
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residues Trp_59, Phe_46 and Tyr_26 are the components of the hydrophobic pocket 
of FKBP12. Figure (11) shows that the six-member ring of FK506 and the five-
member ring of Leu_Pro insert into the hydrophobic pocket and make hydrophobic 
contacts with FKBP12. Tables (3) and (4) also show that the hydrogen bond formed 
with the residue lle_56 of FKBP12 is conserved in both the FK506 and Leu-Pro 
ligand structures. 
The peptide bond has the characteristic of a partial double bond, therefore the torsion 
angle formed by the atoms on the peptide bond plane should be theoretically close to 
1800.  The peptidyl prolyl bond of bound FK506 is in trans conformation and the 
torsion angle formed by atoms 03, C8, N7 and C6 of FK506 is 178.1 0, figure (9), 
therefore these four atoms are almost on one plane. However the peptidyl prolyl 
bond of bound Leu-Pro is in cis conformation and the corresponding torsion angle in 
Leu_Pro formed by atoms 010, C9, N8 and C4 is 154.7 ° (figure (4)) in contrast with 
the average value of 173.50  of all the corresponding torsion angle of FKBP, which 
means the peptide bond of Leu_Pro is twisted. 
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Figure (9) FKBPI2 and FK506 complex structure. The FK506 torsion angle formed 
by atoms 03. C8, N7 and C6 is 178.1 °, highlighted in box. The residues in black 
belong to FKBP12. The model in multicolour is FK506. 
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Figure (11) Stereo picture (crossed) of the superimposed complex structures of 
FKBP12_FK506 and FKBP12/Leu-Pro. Ligand Leu-Pro is in green. FK506 is in 
white and FKBP12 residues are labelled with amino acid names. six-member ring of 
FK506 and the five-member ring of Leu_Pro insert into the hydrophobic pocket and 
make hydrophobic contacts with FKBP12. 
5. Discussion 
Mechanism based on biochemistry experiments 
Stein' 4 proposed that the PPlase catalysis mechanism involved partial bond rotation 
in the transition state with no solvent participation. That is based on the observation 
that isomerization rate constants are independent of pH in the range 5-9 and that the 
solvent deuterium isotope effect for the isomerization reaction is equal to 1. Stein 
suggests that the twisted peptide bond decreases the energy barrier by deconjugating 
the resonance of peptide bond. One consequence of the partially rotated C-N bond is 
to enhance the double bond character of the carbonyl group. 
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Mechanism based on molecular mechanics calculation 
Karplus 7 used a tetrapeptide N-acetyl-Leu-Pro-Phe-methylamide, the fragment of a 
preferred experimental substrate of FKBP, to propose a PPIase mechanism based on 
a molecular mechanics calculation. Karplus' calculation results show that the PPIase 
activity results from a combination of factors: decrease of the intrinsic barrier by 
desolvation of the reacting imide group, substrate autocatalysis, destabilization of the 
reactant and preferential transition-state binding, and each of the factors makes a 
significant contribution to the PPIase activity. Figure (12) shows that the bound 
tetrapeptide N-acetyl-Leu-Pro-Phe-methylamide has an intra hydrogen bond between 
the N-H and the C=O of the N-acetyl group at the carboxyl terminus to form a ring. 
This was considered to make self-catalysis possible and also to stabilize the 
transition state. The keto oxygen atom, pointing inwards to the hydrophobic pocket 
and makes O ---- H ---- C contacts with Tyr_26, Phe_36 and Phe_99, causes the 
desolvation of imide bond and consequently helps the rotation of imide bond, shown 
in figure (13). For the isomerization starting from the cis conformer, residues Asp_37 
that form hydrogen bonds with tetrapeptide N-acetyl-Leu-Pro-Phe-methylamide is 
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Figure (12) Tetrapeptide N-acetyl-Leu-Pro-Phe-methylamide. The imide bond for 
cis-trans isomerization is marked in red. The hydrogen bonding interaction for self-
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Figure (13) Hydrogen bonding pattern between FKBP12 and tetrapeptide N-acetyl-
Leu-Pro-Phe-methylamide 7 . 
Mechanism based on crystallographic experiment in this project 
The complex of FKBP12 with Leu-Pro shows that the dipeptide Leu-Pro binds the 
active site of FKBP in a cis conformation with partially rotated imide bond and that 
the torsion angle deviation of the peptide bond of Leu-Pro is 19 ° from the average 
value of torsion angle, figure (3). This observation is consistent with the literature 
reports that the substrate of PPIase preferentially binds to PPIase in the transition 
state of partially rotated imide bond 7 ' 8" 5 . The imide carbonyl atom of Leu-Pro points 
away from the hydrophobic pocket formed by Phe_36, Phe_46 and Phe_99 rather 
inward as suggested by Karplus. No hydrogen bond between any water molecule and 
the imide carbonyl atom is observed and it has been shown that hydrogen bonds 
between water and N-methylacetamide increase the C-N it—bond overlap 
population' 6 . Therefore the rotation energy barrier of the imide bond of Leu-Pro is 
expected to be near the vacuum value. 
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The complex structure of FKBP with Leu-Pro shows that the transition state of 
bound Leu-Pro is stabilized by a number of hydrogen bonding interactions and 
hydrophobic interactions. As shown in figure (8) and scheme (1), the atom N7 of 
Leu-Pro makes three strong hydrogen bonds with water molecules (HOH_77, 
HOH_67) and His_87 which is on the symmetry related neighbouring molecule. The 
strong hydrogen bond between Leu-Pro and the symmetry related neighbouring 
molecule is unique to the crystallographic structure because of the packing of protein 
molecules in a crystal and can not be relevant to the PPIase mechanism. Another 
hydrogen bond between one carbonyl oxygen atom of Leu-Pro and the atom N of 
lle_55 (lle56N --- H--- O=C) appears in the complex structure of FKBP with Leu-
Pro, scheme (1). The five-member ring of bound Leu-Pro inserts into the 
hydrophobic pocket in the active site of FKBP12 and makes a number of van der 
Waals contacts with residues Trp_59, Phe_46 and Tyr_26, which are the components 
of the hydrophobic pocket, table (5), figure (11). The insertion of the five-member 
ring of bound Leu-Pro into the hydrophobic pocket enables the formation of a 
favoured interactions between the three methylene CH2 groups on the ring of proline 
residue of Leu-Pro and the ii cloud 17 of Trp_59, Phe_46 and Tyr_26. 
In summary, the PPIase mechanism shown by the complex structure of FKBP with 
Leu-Pro consists of several factors. These factors are: preferential transition-state 
binding which is supported by twisted torsion angle of imide bond, stabilization of 
the transition-state which is supported by the formation of a number of hydrogen 
bonds and van de Waals contacts between protein and bound Leu-Pro, and a 
desolvation of reacting imide group of the substrate which is supported by the fact 
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Appendix 
SDS page protocol 
Attention: acrylamide monomer is a potent cumulative neurotoxin. Do wear gloves 
when handling unpolymerised solutions. 
Assemble two glass plates (one notched) with two side spacers. Attach the assembled 
glass plates to stand. Pour some water into assembled glass plate to check if it leaks. 
Resolving Gels 
Gel concentration of 15%. 
Volume 
Reagent: 
30% Acrylamide stock* : 
water (distilled) 
1.5 M Tris-HC1 pH 8.8 
10% SDS 
Peroxydisuiphate 10% 







* = 37.5:1 w:w ratio of acrylamide to N,N'-methylene bis-acrylamide 
Mix ingredients gently. Pour into glass plate assembled. Cover gel with water 
Stacking Gels 
Gel concentration of 4% 
Volume 
Reagent: 
30% Acrylamide stock 
water 
0.5 M Tris-HC1 pH 6.8 
10% SDS 
Peroxydisuiphate 10% 
TEMED (stir quickly) 
650 p1 
3 . 05m1 
1. 2 5ml 
50. 0 .L1 
25. 0 j.t1 
5 p.1 
Mix as before, then pour onto top of set resolving gel, insert comb, allow solidifying, 
removing comb, and filling with electrophoresis buffer. 
Electrophoresis buffer 
Electrophoresis buffer is made by diluting the 10*stock  running buffer. 10*stock 
running buffer is made as follows: 30g Tris-HC1, 144g glycine, lOg SDS, add water 
to 1 liter and set pH to 8.3. 
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Sample treatment 
Mix sample with sample buffer and heat the mixture at 100°C for about 5 minutes, 
and then load the mixture into the sample well on the stacking gel. The sample buffer 
is made by diluting 5*stock sample buffer. The 5*stock sample buffer consisting of: 
4m1 water, 1 ml 0.5M Tris pH6.8, imi glycerol, 1.6m1 10% SDS, 0.4m1 f3-
mercaptoenthanol, and 0.2ml 0.1% bromophenol blue. 
Running the gel 
Connect the gel apparatus to the power socket, and adjust the voltage to 240V, run 
for about 45 minutes. 
Stain gel 
Stain solution: 0.2% CBB (Coomassie Brilliant Blue) in 45:45:10 % 
methanol: water: acetic acid. Soak gel in staining solution, and leave on shaker for 2 to 
3 hours at 37. 
Destain gel 
Destain with 25% 65% 10% methanol water acetic acid mix. 
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